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  Zusammenfassung  
Astrozyten gehören zu den Gliazellen. Sie sind der häufigste Zelltyp im zentralen Nervensystem und 
besitzen morphologische und funktionelle Divergenz. Astrozyten sind nicht nur wichtige Metabolit 
Lieferanten, sondern auch ein Bestandteil der Blut-Hirn-Schranke. Sie regulieren Ionenkonzentrationen, 
sind an der Synaptogenese beteiligt und steuern synaptische Plastizität. Trotz ihrer Diversität sind 
Astrozytensubpopulationen bisher kaum funktionell charakterisiert. Dies liegt im Wesentlichen an der 
eingeschränkter Verfügbarkeit von geeigneten Markern. Ziel dieser Studie war die Phänotypisierung 
von Astrozytensubpopulationen anhand von Zelloberflächenmarkern. Mit Hilfe von magnetischer 
Zellsortierung sollten die Subtypen isoliert und anschließend funktionell und molekular untersucht 
werden. Der Astrozytenmarker GLAST ist ein Glutamat Aspartat Transporter, der von Astrozyten im 
ZNS exprimiert wird. Durch Verwendung eines für GLAST spezifischen Antikörpers können diese 
Zellen gezielt isoliert werden. Aus diesem Grund wurden GLAST positive Astrozyten als 
Ausgangspunkt für die Untersuchungen dieser Arbeit definiert. In einem Ansatz wurden GLAST 
positive Astrozyten isoliert, um mit Hilfe von Hybridomzelltechniken neue Antikörper gegen 
Astrozytensubpopulationen zu erhalten. Die Generierung von neuen Antikörpern war jedoch nicht 
erfolgreich. Ein weiterer Ansatz war die Identifikation von neuen Astrozytenzelloberflächenmarkern. 
Dieser Ansatz basierte auf einem durchflusszytometrischen Screening einer Antikörperbibliothek. Es 
wurden ingesamt 232 Zelloberflächenmarker auf ihre Expression auf Astrozyten getestet. In diesem 
Experiment wurden 15 Marker identifiziert, die anschließend mit Hilfe von Immunhistochemie (IHC) 
und Multidimensional In Situ Cytometry Survey (MICS) validiert wurden. In einem Parallelansatz 
wurde das Expressionsprofil und das Antigen des Anti-ACSA-2 (ACSA: Astrozytenzell-
oberflächenantigen) Antikörpers untersucht. In Zusammenarbeit mit der Arbeitsgruppe von Dr. Harold 
Cremer am Institut de Biologie du Développement de Marseille wurde das Expressionsprofil von 
ACSA-2 über IHC, Immunzytochemie (ICC), MICS sowie per Durchflusszytometrie untersucht. Durch 
die Koexpression von ACSA-2 mit diversen Astrozytenmarkern konnte ACSA-2 als Astrozyten 
spezifischer Marker bestätigt werden, der nicht von Neuronen, Oligodendrozyten oder anderen nicht-
astrozytären Zellen exprimiert wird. Western Blot Analysen, Immunprezipitationen und 
Deglykosylierungs assays deuteten darauf hin, dass der Anti-ACSA-2 Antikörper eine Zuckerstruktur 
auf Astrozyten erkennt. In weiterführenden Untersuchungen wurde das Expressionsprofil von GLAST 
und ACSA-2 auf embryonalem, neonatalem und adultem Maushirn mittels IHC, ICC und per 
Durchflusszytometrie getestet. ACSA-2 und GLAST zeigten ein unterschiedliches Expressionsprofil in 
verschiedenen Hirnregionen, in der Retina und im Rückenmark von neonatalen Mäusen. Es folgten 
weitere Expressionsanalysen von GLAST und ACSA-2 in Stammzellregionen. Die Expression von 
ACSA-2 in der subventrikulären Zone (SVZ) wurde anhand von IHC, in vivo Elektroporation und 
Durchflusszytometrie untersucht. Hierbei konnte gezeigt werden, dass GLAST und ACSA-2 in der 
adulten SVZ koexprimiert vorliegen. Unterschiedliche Expressionsmuster wurden ferner im rostral 
migratory stream und im Hippocampus von adulten Maushirnschnitten detektiert. Jedoch war es nicht 
möglich, die Unterschiede auf Einzelzellebene zu bestätigen. Signifikante Expressionsunterschiede 
zwischen GLAST und ACSA-2 wurden im Cerebellum von adulten Maushirnschnitten identifiziert. In 
anschließenden Untersuchungen wurde die Herkunft dieser Zelltypen in der cerebellaren 
Entwicklungsphase (E13-P12) analysiert. Hierbei wurde eine ACSA-2-/GLAST+ und eine ACSA-
2+/GLAST+/- Zellpopulation identifiziert. Die größten Expressionsunterschiede lagen zwischen E17 und 
P3 vor. Zudem sank die Frequenz an ACSA-2-/GLAST+ Zellen in der weiteren Entwicklung. Beide 
Zellpopulationen wurden per magnetischer Zellsortierung mit hoher Reinheit angereichert und 
anschließend mittels ICC, Neurosphere assay, Genexpressionsanalysen und Zelltransplantation 
untersucht. Zudem wurde ein in vivo Zelldifferenzierungs Assay mit isolierten ACSA-2-/GLAST+ und 
ACSA-2+/GLAST+/- Zellen aus dem Cerebellum von β-actin GFP Mäusen durchgeführt. Diese 
Experimente fanden in Kollaboration mit der Arbeitsgruppe von Dr. Annalisa Buffo am Neuroscienze 
Institute Cavalieri Ottolenghi in Turin statt. Die Analyse zeigte, dass ACSA-2-/GLAST+ Zellen in 
Interneurone, Bergmann glia, Astrozyten and Oligodendrozyten differenzieren konnten. Im Gegenzug, 
konnten ACSA-2+/GLAST+/- Zellen nur in Astrozyten und Oligodendrozyten differenzieren. 
Genexpressionsanalysen beider Zellgruppen zeigten, dass Stammzellfaktoren und Gene für einen 
GABAergen Phänotyp in den ACSA-2-/GLAST+ Proben angereichert waren (Gli1, Wif1, Nestin, Ptf1a, 
Ascl-1). Gene, die Zellinteraktion und Zelladhäsion kodieren (Gjb2, Gjb6, Gja1, Vitronectin), waren in 
den ACSA-2+/GLAST+/- Proben angereichert.   
 
Zusammenfassend zeigt diese Studie eine regionale, funktionale und molekulare Charakterisierung von 
Astrozyten anhand von Zelloberflächernmarkern. Anhand dieser Charakteristika wurde eine neue 
ACSA-2-/GLAST+ multipotente Zellvorläuferpopulation im Cerebellum identifizieren.  
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Abstract: 
Astrocytes, a member of the glial cell family, are the most abundant neural cell type of the central 
nervous system (CNS) and present functional and morphological heterogeneity. Among other 
characteristics, astrocytes provide trophic functions, are essential for the formation of the blood-brain 
barrier, regulate ion homeostasis, synaptogenesis and synaptic plasticity. Despite their diversity 
astrocyte subpopulations are not well characterized mainly due to the lack of markers that could classify 
functional subclasses. This study aimed at the phenotyping of astrocyte subpopulations based on cell 
surface marker expression, their prospective isolation and subsequent molecular and cellular 
characterization of the identified subsets. The glutamate aspartate transporter (GLAST) is a common 
astrocyte marker expressed by astrocytes in the CNS. As the GLAST antibody allows for the isolation 
of astrocytes it was chosen as principal component for the identification of astrocyte subpopulations. 
One approach, which was not successful, was the generation of novel monoclonal astrocyte 
subpopulation specific antibodies using GLAST isolated astrocytes and hybridoma techniques. Another 
approach was the identification of novel astrocyte markers by flow cytometry. 232 cell surface markers 
were tested for their expression on astrocytes. In total, 15 candidates were identified and subsequently 
validated by immunohistochemistry (IHC) and the recently established in house technology: 
Multidimensional In Situ Cytometry Survey (MICS). The expression profile and the nature of the target 
of the novel Anti-ACSA-2 (ACSA: astrocyte cell surface antigen) antibody were addressed. In co-
operation with the group of Dr. Harold Cremer at the Institut de Biologie du Développement de 
Marseille, the expression profile of the ACSA-2 antigen was analyzed systematically using IHC, 
immunocytochemistry (ICC), MICS and flow cytometry. Co-expression of ACSA-2 with common 
astrocyte markers such as GFAP, S100β and GLAST and missing expression on neurons, 
oligodendrocytes validated ACSA-2 as an astrocyte specific marker. Additional Western Blot analysis, 
immunoprecipitation and deglycosylation assays pointed out the ACSA-2 antibody addresses a 
glycosylation structure expressed by astrocytes. In the next step, the expression profile of ACSA-2 and 
GLAST was investigated in comprehensive analyses of embryonal, neonatal and adult mouse brain 
using IHC, ICC, MICS, and flow cytometry. ACSA-2 and GLAST demonstrated differential marker 
expression in distinct brain regions, retina and spinal cord of neonatal mice. Additional studies 
addressed ACSA-2 and GLAST expression on neural stem cells. The expression of ACSA-2 in the 
subventricular zone (SVZ) was analyzed using IHC, in vivo electroporation and flow cytometry. ACSA-
2 was demonstrated to be co-expressed with GLAST in the adult SVZ as shown by IHC and flow 
cytometry. Differences between ACSA-2 and GLAST expression were also identified in the rostral 
migratory stream (RMS) and hippocampus of the adult mouse brain. However, these differences could 
not be confirmed on the single cell level by flow cytometry. Cerebellar glia revealed significant 
differences in GLAST and ACSA-2 expression in the adult mouse brain. To address the origin of these 
potential subpopulations GLAST and ACSA-2 expression was monitored between E13 and P12 in the 
developing cerebellum. Thereby, ACSA-2-/GLAST+ and ACSA-2+/GLAST+/- cells were identified. 
Populations were most discriminative between E17 to P3 and frequencies of ACSA-2-/GLAST+ cells 
decreased with the onset of development. Both fractions were isolated to high purities by magnetic cell 
sorting. Cell characteristics were addressed by ICC, neurosphere assay, gene expression profiling and 
transplantation assay. Cell differentiation in vivo was investigated in collaboration with the group of Dr. 
Annalisa Buffo at the Neuroscienze Institute Cavalieri Ottolenghi in Turin. ACSA-2-/GLAST+ and 
ACSA-2+/GLAST+/- cells were isolated from the cerebellum of P0-P3 β-actin GFP mice and grafted into 
cerebellum of homochronic wild-type mice. ACSA-2-/GLAST+ cells were able to differentiate into 
interneurons (stellate and basket cells), Bergmann glia, astrocytes and oligodendrocytes. In contrast, 
ACSA-2+/GLAST+/- cells only differentiated into astrocytes and oligodendrocytes. Gene expression 
profiling was performed to address differences on the transcriptome level. Genes related to a 
multipotent and GABAergic phenotyp were enriched in the ACSA-2-/GLAST+ sample set (Gli1, Wif1, 
Nestin, Ptf1a, Ascl-1). Genes involved in cell-cell interactions as well as cell matrix proteins (Gjb2, 
Gjb6, Gja1, Vitronectin) were enriched in the ACSA-2+/GLAST+/- sample set.   
 
In conclusion, this study presents a regional, functional and molecular discrimination of astrocyte 
subpopulations based on specific cell surface markers. As a result it describes the identification of a 
novel ACSA-2-/GLAST+ subpopulation of astrocytes which act as multipotent progenitors in the 
cerebellum. 
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Abbreviations: 
ACSA   Astrocyte cell surface antigen 
Aldh1l1   Aldehyde dehydrogenase 
BSA   Bovine serum albumin 
BLBP   Basic lipid binding protein 
BMP   Bone morphogenic protein  
CD   Cluster of differentiation 
CHO   Chinese Hamster Ovary cell line  
CNS   Central nervous system   
DAPI   4′,6-Diamidin-2-phenylindol 
DMEM   Dulbecco's Modified Eagle's Medium 
DMSO   Dimethylsulfoxide 
DPBS   Dulbecco’s Phosphate Buffered Saline  
E   Embryonic day  
EGFP   Enhanced green fluorescent protein 
EGL   External granule layer (Cerebellum) 
EDTA   Ethylen-diamine-tetra-acetate 
EGF   Epidermal growth factor 
FGF   Fibroblast growth factor 
FSC   Forward scatter 
Gcl   Granule cell layer 
GFAP   Glial fibrillary acidic protein 
GLAST (ACSA-1) Na+-dependent L-glutamate/L-aspartate transporter 
GS   Glutamine synthetase 
h   Hour 
ipl   Inner plexiform layer (olfactory bulb) 
HEPES   4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HBSS   Hank’s Balanced Salt Solution 
IBDM   Institut de Biologie du Développement de Marseille  
LB   Luria-Bertani medium  
LRC   Ligand receptor capturing  
MAP2   Microtubule-associated protein 2  
Mcl   Molecular cell layer 
mi   Mitral cell layer (olfactory bulb) 
min   Minutes 
MICS   Multidimensional in situ Cytometry Survey 
mL   Milliliter 
mM   Millimolar 
MOPS   3-(N-morpholino)propanesulfonic acid 
ms   Millisecond 
NPC   Neural precusor cell  
NSC   Neural stem cell  
NTDK (T)  Neural Tissue Dissociation Kit (Trypsin) 
NTDK (P)  Neural Tissue Dissociation Kit (Papain) 
NTDK (PN)  Neural Tissue Dissociation Kit (Postnatal neurons) 
OB   Olfactory bulb  
o/n   Over night 
P   Postnatal day  
PAGE   Polyacrylamid gel elektrophoresis 
PB   PBS buffer supplemented with 5%BSA 
PC   Purkinje cell 
Pcl   Purkinje cell layer 
PBS   Phosphate buffered saline  
Pen/Strep  Penicillin/Streptomycin  
PI   Propidium Iodid  
PNS   Peripheral nervous system 
PSA-NCAM  Polysialyated cell-adhesion molecule 
PVZ   Periventricular Zone 
PWM   Prospective white matter  
SDS   Sodiumdodecylsulfa
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µm   Micrometre 
µM   Micromolar 
RT   Room temperature 
RIN   RNA Integrity number  
RMS   Rostral migratory stream 
RPMI-1640  Medium composed at the Roswell Park Memorial Institute 
SHH   Sonic hedgehog  
SSC   Side scatter 
SVZ    Subventricular zone 
TAE   Tris base; EDTA; acetic acid containing buffer 
TBS   Tris Based Saline  
v/v   Volume concentration (voume/volume) 
VZ   Venricular Zone (4th ventricle) 
WGA   Wheat germ agglutinin 
wt   wild-type 
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1 Introduction 
1.1  Function and heterogeneity of astrocytes 
 During very early embryonic development three primary cell sources, the three germ 
layers are formed: the ectoderm, mesoderm and endoderm. The central nervous system (CNS) 
arises from the ectodermal germ layer. In this step of neural induction, organizers trigger the 
development of the neuro-ectoderm 1. Further differentiation of the neuro-ectoderm forms the 
neural plate. In a subsequent step, called neurulation, the lateral edges of the neural plate fold 
dorsally, fuse and give rise to the neural tube. Through formation of three primary brain 
vesicles, that give rise to five secondary brain vesicles, various structures of the adult brain are 
obtained 2.   
This work focuses on the most abundant cell type of the CNS: the astrocytes, also named 
astroglia. They comprise 25-50% of total brain volume and outnumber neurons by the ratio of 
10:1 in rodents 3,4. Astrocytes are non-neuronal cells that compose the subset of glia together 
with myelin-forming oligodendrocytes and microglia, derivatives of hematopoietic cells also 
named as macrophages of the brain. Further members of the glial cell family are NG2 cells, 
and Schwann cells, the oligodendrocyte equivalents of the peripheral nervous system (PNS). 
Historically, glia have been considered as passive supporters that act like a glue for the brain. 
At time of their discovery, in the 18th century by Rudolf Virchow, astrocytes were classified as 
non-excitable cells. Indeed, in comparison to neurons astrocytes are electrically  
non-excitable 5,6. However, their excitability is executed by the propagation of calcium signals 
as a mediator of bi-translational interactions between neurons and glia at the tripartite  
synapse 7. Astrocytes are coupled to each other by gap junctions 5. These gap junctions are 
permeable for ions, such as potassium, sodium or calcium, small molecules, including 
nucleotides, cAMP, sugars, and peptides 8. The flow of small molecules and ions serves as a 
mean of intercellular communication. Communication between astrocytes is initiated by a 
calcium influx and propagated to neighboring cells through calcium waves 9,10. Hippocampal 
astrocytes were demonstrated to be connected to up to 100,000 synapses 11. Furthermore, 
intracellular signaling in astrocytes is triggered by cell-cell contact with neuronal dendrites and 
synapses 12,13.	   Astrocytes also promote synaptogenesis and are an essential element of the 
tripartite synapse, which is composed of astrocytes, the pre- and the postsynaptic terminal at 
the synaptic cleft 14,15. Furthermore, astrocytes have housekeeping functions and are involved 
in several metabolic pathways. They do not only facilitate the clearance of neurotransmitters at 
the synaptic cleft 16 but also actively secrete metabolites, called gliotransmitters 17,18 such as  
D-serine, ATP 18,19, thrombospondins15 cholesterol20 as well as growths factors such as  
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brain-derived neurotrophic factor (BDNF) or nerve growth factor (NGF) 21. Another important 
metabolic function is the conversion of glutamate into glutamine catalyzed by the enzyme 
glutamine synthetase (GS). Astrocytes release glutamine at the presynaptic terminal. 
Glutamine is subsequently taken up by surrounding neurons and converted into glutamate 22,23. 
In addition, astrocytes regulate the pH level and brain homeostasis 24,25,26 through ion channels 
such as sodium, potassium 27,28 and water channels called aquaporins 11,12. Furthermore, 
astrocytes are the major source of extracellular matrix (ECM) proteins and cell adhesion 
molecules 29. They secrete different matrix metalloproteases (MMPs) which are important for 
the remodeling of the ECM 30. In addition to their functional divergence, astrocytes represent 
morphological and functional heterogeneity linked to different brain regions or developmental 
time-points 31. The most prominent example for morphologically different astrocytes are 
fibrous astrocytes of the white matter and protoplasmic astrocytes of the gray matter 32. The 
functions of astroglia during development were first addressed by Rakic et al. 32. They 
demonstrated that radial glia, primary progenitors of the developing CNS, a subgroup of 
astroglia, are essential for the differentiation and guidance of neurons during development 33. 
Similar observations were made in the developing cortex and the rostral migratory stream 
(RMS) 34,35. In this context it was demonstrated that neuronal guidance is mainly driven by the 
interaction between members of the Slit family, expressed by astrocytes, and Robo receptors, 
expressed by neurons 36,37. Furthermore, astrocytes are an essential element of the blood-brain 
barrier, a physical barrier around blood-vessels formed by astrocyte perivascular endfeet, 
endothelial cells and pericytes 38. In a healthy organism, this barrier separates the blood system 
from the CNS. Only certain gas molecules such as oxygen or carbon dioxide and small 
lipophilic agents can pass this barrier by passive diffusion. Some other small molecules such as 
glucose or amino acids can be selectively transported 38.  
Apart from these general properties of astrocytes their functions in the diseased brain were 
addressed. On the one hand, astrocytes were reported to be mediators of neurodegenerative 
disorders. On the other hand, astrocytes are considered to be targets for translational or 
regenerative medicine. Their self-renewing capacities and the possibility to use them for trans-
differentiation 39,40 are valuable for clinical approaches. In respect to all the distinct functional 
properties of astrocytes, it is apparent that astrocytes are not a uniform subset but rather 
composed of various subpopulations. 
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1.2  Radial glia  
  The CNS of vertebrates consists of neurons and glia that derive from multipotent 
neuroepithelial progenitor cells of the neural tube. During initiation, multipotent 
neuroepithelial cells of the ectoderm undergo rapid symmetric cell division. They fold and 
form the neural plate, which then forms the neural tube via Sonic hedgehog (SHH), bone 
morphogenic protein (BMP) and Wnt signaling 41. In the next step, neuroepithelial cells 
polarize and divide asymmetrically. These cells give rise to radial glia a more restricted 
progenitor population in the early prenatal state 42-44 (Figure (Fig.) 1.1 a). Radial glia are 
characterized by a long, radial, bipolar shape and span from the ventricular zone towards the 
pial surface 45. This cell type was first described by Golgi in 1873. Later, Ramon y Cajal and 
Magini reported about the significance of radial glia during development 46. Radial glia belong 
to the astroglia subset. They express a panel of astrocyte specific markers such as GFAP 
(absent in rodents) 47, Tenascin C, GLAST 48, glycogen granules 49, and BLBP 50. Besides, 
radial glia express neuroepithelial cell markers such as Nestin 51 and the intermediate-filament 
associated protein RC2 52,53. In the first period of development, radial glia serve as scaffold for 
migrating neuroblasts 54 and as a source for new neurons 55 (Fig. 1.1 b,c). At the end of 
developmental neurogenesis radial glia disappear or transform into astroglia 56,57. However, it 
could be demonstrated that some radial glia subtypes persist as the Bergmann glia in the 
cerebellum, as Müller glia in the retina and as neural stem cells in the SVZ and  
hippocampus 58-62.  
 
   
 
Figure 1.1: Radial glia during development.	   	  
               Early in development cells of the neuroepithelium, the mutipotent neuroepithelial cells  
               undergo rapid symmetric cell division. During embryonic development and around birth  
               neuroepithelial cells transform into radial glia cells (a). By asymmetric division, radial glia  
               generate pools of transit amplifying cell types or transform into neurons (b). Radial glia  
               postnatally and transform directly into cortical astrocytes. Some radial glia  
               transform intoneuronal stem cells residing in the SVZ and behave as stem cells that can self- 
               renew and give rise to neurons (c). Modified from Alvarez-Buylla et al. (2001) 45.  
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1.3  Neural stem cells   
Among the features of astrocytes, their stem cell characteristics are of great interest. 
Since their discovery in the 1980s 63, research on NSCs has increased dramatically due to the 
potential of NSCs to cure neurodegenerative diseases. Pioneering studies on neurogenesis were 
conducted by Altman et al. and Kaplan et al 64,91. The classical model of adult neurogenesis is 
restricted to two neurogenic niches. However, recent studies demonstrated that neurogenesis is 
not restricted to these two niches and occurs also in other brain areas as demonstrated for the 
striatum in human brain 65. One classical neurogenic niche is the subventricular zone (SVZ) of 
the lateral ventricle. The other one is the dentate gyrus of the hippocampus. Both areas are 
bilaterally located in the fore- and midbrain. In contrast to other germinal layers, the SVZ of 
the forebrain persists after birth. In the 1990s several groups discovered multipotent neural 
stem cells in the developing mouse brain 63,66,67. In 1999 Doetsch et al.68 characterized these 
multipotent stem cells of the SVZ as astrocytes based on morphology and marker expression. 
In a coronal section, the SVZ is shaped like a triangle composed of three walls as depicted in 
(Fig. 1.2 a). The medial wall contacts the septum. The dorsal wall adjoins the corpus callosum 
and contacts the lateral wall at the dorsal horn. The lateral wall flanks the striatum. Neural 
stem cells are commonly isolated from the lateral wall of the SVZ, which is assembled by 
different cell layers and distinct cell types classified as Type A, B, C, and E cells. The edge of 
the ventricle is composed of ependymal cells that derive from radial glia 69 (Type E cells), as 
seen in Figure 1.2 b,c. The ependymal cell layer is tightly connected with slowly proliferating  
Type B1 cells and a further source of astrocytes 69 the B2 cells that regulate local environment. 
Type B1 cells are the neural stem cells and are characterized by the expression of common 
astrocyte markers 70,71. Since neural stem cells and ependymal cells express mutual astrocyte 
markers such as epidermal growth factor receptor (EGFR) or GFAP 71 there is a demand to 
identify a specific stem cell marker. So far, the isolation of neural stem cells is executed using 
at least two markers in combination, such as GLAST, GFAP, EGFR and Prominin-1 72,73-75. In 
vivo, Type B cells of the lateral wall of the SVZ generate transit amplifying precursors (Type 
C cells), that generate neuroblasts (Type A cells) (Fig. 1.2 b,d). These neuroblasts are 
characterized by the expression of polysialyted-neural cell adhesion molecule (PSA-
NCAM)76,77. In the SVZ, neuroblasts are surrounded by Type B and Type C cells. After their 
generation in the SVZ, neuroblasts follow the RMS along a posterior-anterior axis towards the 
olfactory bulb 78. The RMS is composed of ‘tunneling astrocytes’ that guide the way towards 
the olfactory bulb. Astrocytes support the migration progress by the secretion of soluble 
molecules (e.g. growth factors), the expression of matrix proteins, cell-cell contacts as we
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receptor-ligand interactions (e.g. Slit and Robo) 37,79. In the olfactory bulb neuroblasts migrate 
to their final location and differentiate into olfactory bulb interneurons. 
 
 
Figure 1.2: The lateral ventricle of the adult mouse brain.  
       One neurogenic area in the adult brain is the subventricular zone (SVZ). The SVZ is composed  
       of a dorsal (red) a lateral (green) and a medial wall (blue)(a). Cells of the lateral wall are  
       classified as Type A, B, C and E cells (b,c)80,81. Type B cells are the neural stem cells that give  
       rise to transit amplifying (Type C cells) that generate migratory neuroblasts (Type A cells) (d).  
       Modified from Alvarez-Buylla et al. (2002) and Mizadeh et al. (2008) 80,81. 
 
 
1.4  Identification of astrocyte subpopulation specific markers 
  Astrocytes are phenotypically diverse and their tasks differ in respect to their 
localization. Hence, the marker expression profile of astrocytes is strongly correlated to their 
localization, developmental status and interaction with other cell types. The first sub-
classification study was carried out by immunohistochemistry in 1984 82. This study was based 
on morphology, regional distribution and marker expression. The study identified two major 
astrocyte populations: the protoplasmic astrocytes and the fibrous astrocytes. Protoplasmic 
astrocytes are located in the grey matter, have short processes, many branches typically 
ensheath synapses and express the intermediate filament glial fibrillary acidic protein  
(GFAP) 11,83,84. Fibrous astrocytes are located in the white matter, have long unbranches 
processes and are characterized by a weaker expression of GFAP 32. Besides GFAP, other 
common astrocyte markers such as glycogen granules, glutamate transporter (GLT-1) and GS 
were identified 85-87. In 2008, aldehyde dehydrogenase (Aldh1l1) was identified as a novel 
astrocyte specific marker by comprehensive microarray analysis 88. Aldh11 is a more robust 
marker than GFAP, as GFAP is exclusively found on terminally differentiated astrocytes and 
not expressed by quiescent astrocytes in healthy tissue 89,90. In addition, first subtype specific 
markers like calcium-binding protein, S100β, or potassium channel, Kir4.1,  
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were identified 91-93 using single-cell gene expression profiling 94 or electrophysiological 
studies 95. Another subtype marker, Aquaporin-4, a water channel, was identified by 
transcriptome analysis comparing primary and cultivated astrocytes, neurons and neural stem 
cells (NSCs) from distinct ages and distinct brain regions 96. Aquaporin-4 was demonstrated 
being exclusively expressed on astrocyte endfeet 97. Unfortunately, the majority of the 
mentioned markers are intracellular proteins. Therefore, these markers cannot be used for 
direct isolation and further characterization of living cells. To this aim, several transgenic 
mouse lines were generated. These mouse lines enable for the isolation of potential astrocyte 
subpopulations through expression of a reporter gene under an astrocyte specific promoter  
(e.g. Aldh1L1, BLBP, S100β, GFAP, GLT-1, GLAST 98,99,98,100-103). The first approach to 
isolate astrocytes from primary tissue of wild-type (wt) mice was realized in 2012 by the 
generation of a novel Anti-GLAST antibody 104.   
 
	  
1.5  Reactive Astrocytes  
 Trauma, neurodegeneration or other CNS insults cause tissue damage which influences 
neurons and glia and hampers their interaction 105-108. Upon tissue damage, activated microglia 
migrate to the affected tissue and initiate first immune response 109-112. Microglia also produce 
reactive oxygen species (ROS)113 and nitric oxide (NO) which cause oxidative stress that leads 
to damage and aging of cells 114,115. While NO species can be neutralized by the glutathione 
metabolites produced by astrocytes, ROS and reactive nitrogen species (RNS) lead to the 
phosphorylation of STAT6, a stress sensor. This phosphorylation up-regulates expression of 
cyclooxygenase-2 (COX-2) and induces release of pro-inflammatory cytokines. In addition, 
the STAT6 phosphorylation induces the release of PGE2 and prostacyclin. COX-2 activates 
neighboring cells e.g. astrocytes 116-118.	  Activation of astrocytes is called reactive gliosis 119. 
Upon reactive gliosis astrocytes undergo biochemical, morphological and physiological 
changes. They start to proliferate, modify the expression of cellular markers, become  
hypertrophic 120, increase the production of intermediate filaments 121 and migrate to the side of 
injury to form a glial scar. This is a cellular attempt to prevent further tissue damage and 
spread of the disease as the scar separates healthy tissue from injured tissue 122,123. 
There is currently no exclusive cell-surface marker is described that allows for the 
discrimination of reactive astrocytes from non-activated astrocytes in the diseased brain. 
Furthermore, several markers of reactive astrocyte address intracellular epitopes or 
transcription factors. Therefore, these markers do not allow for further isolation and 
characterization of viable reactive astrocytes. The most common marker to study reactive 
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astrocytes is GFAP 119,121. Other astrocyte markers, that are upregulated on reactive astrocytes 
are S100β, BLBP 122, vimentin 124 or Nestin are also used to discriminate reactive astrocytes. 
	  
 
1.6 Cerebellum 
1.6.1 Development of the cerebellum   
 The brain is composed of three main areas named as Prosencephalon (Forebrain), 
Mesencephalon (Midbrain) and Rhombencephalon (Hindbrain). Each region itself consists of 
region specifc areas. Major part of this study was performed in the cerebellum, which is part of 
the Rhombencephalon (Hindbrain).  
The cerebellum is important for voluntary movement and motor function, as demonstrated in 
the early 19th century by three neurophysiologists: Luigi Roland, Marie-Jean-Pierre Flourens 
and John Call Dalton, Jr. 125. Further reports also showed that the cerebellum has an impact on 
higher cognitive functions, cognitive progression and behavior 126. Besides, the cerebellum is 
affected in several diseases like ataxia, schizophrenia, and autism 127. In addition, uncontrolled 
growth of cerebellar precursors results in medullablastoma the most common malignant brain 
tumor in children 128.   
Although the cerebellum comprises only 10% of the total brain volume, granule neurons 
account for 50% of all brain neurons 129. The cerebellum is one of the best-studied brain region 
in respect to circuitry 130, development 54, anatomy and fiber connectivity 131. During ontogeny 
the cerebellum arises from the met-mesencephalic junction of the neural tube 132 around 
embryonic day 9 (E9) in mice 133. At the initiating phase (E9- E12) the cerebellum conducts a 
90° rotation from the anterior-posterior axis towards the medial-lateral axis. This results in a 
bilateral wing-like morphology 134. Early developmental steps are driven by specific proteins 
such as the transcription factors Hoxa2 (posterior) and Oxt2 (anterior) are further accompanied 
by soluble molecules of the Wnt and FGF families (especially fgf8) 129. 
After several structural modification steps, the cerebellum obtains its foliated structure. 
Anatomically, the mammalian cerebellum is composed of 10 primary lobules (Fig. 1.4 a), first 
characterized by Olof Larsell (1970) 135,136. The cardian lobes are formed at embryonic stage 
while lobules and sub-lobules are formed at postnatal stage 137. Although the foliation process 
starts around E14 in mice 138, the maturation of the architecture lasts until adulthood. 
 
 
 
 
 Introduction  	  
-8- 
1.6.2 Cerebellar progenitors  
  The progenitor pools of the cerebellum derive from two distinct germinal territories: 
the ventricular zone of the fourth ventricle and the rhombic lip, as demonstrated by Alvarado-
Mallart and Le Dourian 132,139. It is suggested that cells of the deep cerebellar nuclei (DCN) 
arise from both germinal matrices. The ventricular zone (VZ) is located at the inner germinal 
layer, where interneurons arise around E12.5. These interneurons can be distinguished by the 
expression of Pax-2 140, and Pft1-a which is exclusively expressed by GABAergic projection 
neurons 141,142.	  Cells of the deep nuclei arise from the cerebellar plate around E10.25 143. These 
cells become post mitotic and form a „mantle“ above the VZ 144,145.	  Between E11 and E14.5 
cortical precursor cells of the VZ exit the cell cycle. These are Purkinje cell precursors that 
start to express calbindin 146 and migrate radially along radial glia processes 147, compare 
Figure 1.3. These precursors pass the „mantle“ of deep cerebellar nuclei and settle down in the 
prospective white matter just beneath the developing granule cell layer (Gcl) 148. In this region, 
Purkinje cell precursors form a multilayer of immature neurons (E14-E17). Then, Purkinje cell 
precursors differentiate and start to interact with parallel fibers 146. By maturation, the 
multilayer disperses and a Purkinje cell monolayer appears (Fig. 1.3 c). Once the Purkinje cell 
monolayer is formed, interneurons such as stellate, basket and Golgi cells are generated from 
precursors of the deep (prospective) white matter 129,149. 
The second major germinal matrix is the rhombic lip, an external layer located close to the roof 
plate of the neuroepithelium. This external germinal layer (EGL) arises around E12.5 and 
gives rise to all types of glutamatergic cells. A pool of migrating cells, which derives from this 
germinal matrix, contributes to the cerebellar nuclei 37. The EGL is a highly proliferative cell 
source, which produces granule neurons 150,151 regulated by SHH and Wnt signaling  
pathways 152,153. Cells of the EGL are characterized by the expression of Math1, a helix-loop-
helix transcription factor 154. EGL cells proliferate rapidly between E13 and P15, highest at  
P8 143. Upon birth until P14, cells at the EGL exit cell cycle and start to migrate inwards along 
Bergmann glia. Migrating granule cells pass through the developing Purkinje cell layer and 
settle down at the developing internal Gcl 54,146,155,156. An important molecule involved in this 
migration process is Reelin 157 and the extracellular protein Astrotactin, which is expressed by 
migrating neurons in the cerebral cortex and the cerebellum 158-160. The migration stops soon 
after the disappearance of the EGL. The final differentiation step of Purkinje cells and granule 
cells is depending on their interplay and results in the arborisation of Purkinje cells 31,32. This 
interaction is also depending on Reelin, BDNF and SHH signaling 161.   
Glial cells of the cerebellum were first described by Ramon y Cajal in 1911. The majority of 
cerebellar glia derives from the ventricular neuroepithelium (VN) 162 and shares a common 
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ancestor with neurons 163. The key regulator for glial versus neuronal fate in the VN 
compartment is considered to be Notch and BMP dependent 164. Two minor fractions of glial 
cells originate from the rhombic lip. One is the unipolar brush cell, which migrates towards the 
white matter 165. The other fraction migrates tangentially over the cerebellar surface. This cell 
type is remained postnatally and expresses GFAP 166. In addition, this cell type expresses 
Math1 and can differentiate into granule cells 167. Upon isolation and SHH treatment these 
progenitors differentiate into astrocytes in vitro showing a multipotent potential 168.  
 
 
Figure 1.3: Bergmann glia in cerebellar corticogenesis.  	  	  	   	  	  	  	  	  	  Purkinje cells (blue) in the embryonic cerebellum (A) are generated by radial glia (red) in the  
       ventricular neuroepithelium (VN) and migrate along radial glia procresses (red). In  
       the external granular layer (EGL) granule cell precursors (green) are generated. Around birth  
       radial glia transform into Bergmann glia (B). Thereby loosing their connection to the cortex (B).  
       Next, Bergmann glia spread their processes towards the pial surface (B). Purkinje cells cluster in  
       the Purkinje cell plate (PCP) beneath the EGL (C). At postnatal development (D), granule cells  
       migrate inwards along Bergmann glia. Purkinje cells acquire a monolayer arrangement. The  
       interaction between granule cells and Bergmann glia leads to the expansion of the molecular  
       layer (ML) and the internal granule cell layer (IGL). Modified from Buffo et al. (2013) 169.   
 
 
 
1.6.3 Composition of the cerebellum at adult state  
  A fully developed cerebellum comprises a four-layer-structure (Fig. 1.4 b) composed 
of distinct cell types 170: The inner cell layer of the adult cerebellum is the white matter, which 
is a myelin-rich area. Above the white matter is the Gcl, where Golgi cells and the most 
numerous kind of neurons of the brain the granule cells reside. Granule cells are major 
excitatory neurons, which transmit glutamate 171. Furthermore, they co-ordinate the afferent 
excitatory input they receive from mossy fibers. Mossy fibers originate from nuclei in brain 
stem and spinal cord 172. These fibers connect granule and Golgi cells and build synaptic 
complexes, called cerebellar glomeruli (also recognizable as rosettes) 173. The next cell layer is 
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the Purkinje cell layer. The cell bodies of the Purkinje cells are surround by Bergmann glia171. 
Purkinje cells are inhibitory and secrete the neurotransmitter GABA. Bergmann glia derive 
from radial glia and are located around the Purkinje cells soma after maturation. Their 
processes spread from the Purkinje cell layer towards the subpial basement membrane 174. 
During early development, radial glia serve as a scaffold for migrating Purkinje cells (Fig. 1.3). 
Postnatally, Bergmann glia serve as a scaffold for granule cells 175. In the superficial layer, the 
molecular layer, dendrites of the Purkinje cells are located. Furthermore, axons of granule cells 
(called parallel fibers) but also stellate and basket cells are found in this layer 171. Parallel 
fibers of the molecular cell layer (Mcl) derive from the granule cells of the Gcl. Parallel fibers 
are in contact with stellate and basket cells as well as dendrites of the Purkinje cells. While 
Purkinje cells are in close contact to Bergmann glia, basket and stellate cells are partially in 
contact with Bergmann glia whereas Golgi and granule cells are not in contact with Bergmann 
glia 176. Cerebellar glia are categorized into different subtypes: glia of the white matter, 
astrocytes of the Gcl 177, unipolar brush cells 165 and Bergmann glia. Several studies suggest 
that cerebellar glia of the developing cerebellum have stem cells or progenitor cells 
characteristics 178,179.  
 
 
Figure 1.4: The architecture of the cerebellum.  
      After foliation the cerebellum is composed of 10 lobules (a). The cerebellum is comprised of  
       four layers (b): the white matter, the Gcl, the Purkinje cell layer and the molecular  
       layer. Granule cells and Golgi cells are located in the Gcl. The soma of  
       Purkinje cells and Bergmann glia are located in the Purkinje cell layer. Inhibitory  
       interneurons, stellate and basket cells, the processes of Bergmann glia and dendrites of  
       Purkinje cells are located in the Mcl. Modified from Kobielak et al. (2004) and  
       Takana et al. (2008) 180,181.  
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1.8  Aim of this study:   
 Astrocytes display heterogeneity in morphology and function. Therefore, astrocytes are 
considered being an inhomogenous cell type that is rather composed of different 
subpopulations. In the past, several approaches have been performed to classify astrocyte 
subsets. However, studies based on cell morphology, regional distribution, gene expression 
profiling, proteomics, electrophysiologic properties or marker expression did not result in 
functional categorization of astrocyte subpopulations based on marker expression.   
 
Cell surface markers are a powerful tool to classify cell subsets and circumvent the use of 
transgenic models. They do not only allow for the prospective isolation of cells but also for 
their subsequent characterization on the single cell level. However, the availability of astrocyte 
subpopulation specific antibodies is currently limited and this retards further studies. In this 
study, the astrocyte cell surface marker GLAST, which shows a widespread expression on 
astrocytes of the CNS, served as basis for the analysis of astrocyte subpopulations. The first 
aim was to generate novel astrocyte subpopulation specific antibodies or to identify novel 
subpopulation specific markers. The generation of astrocyte subtype specific antibodies was 
addressed by immunization approaches. The identification of novel astrocyte markers was 
performed by cell surface marker screenings using an antibody library. Furthermore, the 
expression profile of the novel marker ACSA-2 was analyzed to prove its astrocyte specificity. 
Moreover, the antigen recognized by the ACSA-2 antibody was addressed. Besides, a 
functional characterization of this marker was performed. In addition, in combination with 
GLAST this marker was used to identify astrocyte subpopulations.  
 
A further aim of this study was the identification of neural stem cell markers. On the one hand, 
the subependymal layer of the adult subventricular zone (SVZ) was addressed. One the other 
hand, stem and progenitor cells of the neonatal cerebellum, a less characterized cell population, 
were investigated. Although cerebellar stem cells have been well characterized by other studies, 
the lineage relationship between multipotent stem and lineage restricted precursors in the 
neonatal cerebellum is not well described. The possibility to identify and isolate stem and 
precursor cells from neonatal cerebellum would contribute to our understanding of lineage, 
function and heterogeneity of cerebellar astrocytes.   
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To address the properties of the astrocyte subpopulations in the developing cerebellum 
isolation protocols were established and suitable marker combinations were identified. This 
step was mandatory to proceed with functional studies including cell-based assays, cell 
transplantation and gene expression profiling. Transplantation studies were chosen to address 
cell fates, as an in vivo model is more reliable than an in vitro assay.  
Gene expression profiling combined with pathway analysis was further used to address the 
transcriptome of the multipotent and the precursor cell type. In addition, the lineage 
relationship between the identified subpopulations was addressed by bioinformatic tools.  
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2 Materials 
2.1.1 Antibodies for immunohistochemistry or immunocytochemistry 
Antibody Clone Isotype Provider 
Anti-ACSA-2 IH18A3   Miltenyi Biotec 
Anti-βIII tubulin 5G8 mouse IgG1 Promega 
Anti-Calretinin 
 
rabbit poly. Swant 
Anti-BLBP 
 
rabbit poly abcam 
Anti-EGFR 
 
rabbit poly Thermo 
Anti-GAT-3 
 
rabbit IgG Millipore  
Anti-GFAP 
 
rabbit IgG Dako 
Anti-GFAP Z334 mouse IgG1 Millipore  
Anti-GFP 
 
rabbit poly Dako 
Anti-GLAST ACSA-1 mouse IgG2a Miltenyi Biotec 
Anti-GS   rabbit poly abcam  
Anti-MAP2   mouse IgG Chemicon 
Anti-MBP   mouse IgG2a Millipore  
Anti-NG2   rabbit IgG Chemicon 
Anti-Parvalbumin   mouse IgG1 Swant 
Anti-RC2   mouse IgGM Millipore 
Anti-S100b   rabbit abcam 
Anti-S100b   rabbit poly abcam 
CD24 193- 563 rat IgG Rougon 
CD106 429 rat IgG BD 
Wheat germ agglutinin 
 
 sigma 
 
2.1.2 Secondary antibodies and nuclear stain 
Invitrogen A488 A555 A594 A647 Conc. 
goat anti mouse IgG1 A-21121 - A-21125 - 4 µg/mL 
goat anti mouse IgG A-11001 - A-11032 - 4 µg/mL 
goat anti mouse IgG2a A-21131 - A-21165 - 4 µg/mL 
goat anti mouse IgM A-21042 - A-21044 - 4 µg/mL 
goat anti rabbit A-11008 A-31572 A-11012 A-21244 4 µg/mL 
goat anti rat IgG A-11006 - A-11007 - 4 µg/mL 
goat anti rat IgM A-21212 - A-21213 - 4 µg/mL 
goat anti chicken A-11039 - - - 4 µg/mL 
 
HRP Provider Dilution 
Anti mouse Dako 1:20000 
Anti goat stemgent 1:5000 
Anti rabbit Thermo 1:500 
Anti rat BioLegend 1:5000 
SA GE 1:5000 
Cy3 
  Anti rat Jackson 1:500 
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DAPI Sigma   0.25 µg/mL 
DRAQ5TM - Alexa647 abcam  ab108410 5 µM  
Hoechst 33342 Sigma   1-10 µM 
TOTO-3 -Alexa633 Invitrogen T3604 1.25 µM 
 
 
2.1.3 Antibodies for flow cytometry  
Antibody Isotype Clone Fluorochrome Biotin MicroBeads 
Anti-AN2 rat IgG1 1E6.4 PE, APC x x 
Anti-A2B5 mouse IgM 105-HB2 PE, APC x x 
Anti-ACSA-2 rat IgG2b IH3-18A3 PE, APC, FITC x x 
Anti-GLAST mouse IgG2a ACSA-1 PE, APC x   
Anti-O4 mouse IgM O-4 PE, APC x x 
Anti-Prominin rat IgG1 MB-9-3G8 PE, APC x x 
Anti-PSA-NCAM mouse IgM 2-2B PE, APC x x 
Anti-Ter119 rat IgG2b Ter-119 PE, APC, VioBlue x x 
CD24 rat IgG2bκ M1/69 PE, APC, VioBlue x x 
CD31 rat IgG2a 390.1 PE, APC, VioBlue x x 
CD45 rat IgG2bκ 30F11 PE, APC, VioBlue x x 
CD51 rat IgG1, κ RMV-7 PE, APC x   
CD90.1 rat IgG2bκ 30-H12 PE, APC x x 
CD140a rat IgG2aκ APA5 PE, APC x x 
CD171 rec.hum IgG1 REA163 PE, APC x x 
 
2.1.4 Chemicals  
Agarose Bio Rad; Munich 
Agilent Washing buffer Agilent Techn.; Santa Clara (SA,US) 
Barrier Marker (Dako pen) Dako; Glostrup (Denmark) 
Brij35 (30%) Sigma-Aldrich; St. Louis (MO, US) 
Complete EDTA free Roche; Mannheim 
Coomassie Pierce; Rockford (US) 
Cell Trace-Violet Cell Proliferation Kit Invitrogen; Darmstadt 
Disodiumhydrogenphosphate (Na2HPO4) Merck; Darmstadt 
Deglycosylation mix NEB; Hitchin (UK)  
DPBS (+ calcium and magnesium) Lonza; Cologne 
Ethanol Applichem; Darmstadt 
Etidium-bromide Roth; Karlsruhe 
Ethylendiaminetetraacetate (EDTA) Sigma-Aldrich; St. Louis (MO, US) 
Fast green (at 1% v/v) Applichem; Darmstadt 
Fetal bovine serum  PAA; Pasching (Austria) 
Fetal calf serum- Bichrom Merck; Darmstadt 
Fix and Perm Miltenyi Biotec; Bergisch Gladbach 
Flourescent Mounting Medium Dako; Glostrup (Denmark) 
Glue (Locite 604) Henkel; Düsseldorf 
Glycerin Roth; Karlsruhe 
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Goat serum Dianova; Hamburg 
HEPES, 1M Lonza; Cologne 
HBSS -phenol red; calcium; magnesium Lonza; Cologne 
HBSS -phenol red Lonza; Cologne 
Hybond ECL GE; Fairfield (CT, US) 
Hypoxanthine/Azaserin Sigma-Aldrich; St. Louis (MO, US) 
Imaging plates (24, 96 well) Miltenyi Biotec; Bergisch Gladbach 
Isoboa Roche; Mannheim 
L-Glutamine Invitrogen; Darmstadt 
LB Agar Roth; Karlsruhe 
LB Medium Roth; Karlsruhe 
MACSfectin Miltenyi Biotec; Bergisch Gladbach 
Methanol Applichem; Darmstadt 
Nail polish P2 cosmetics; Neudorf 
NeuroBrew-21 Miltenyi Biotec; Bergisch Gladbach 
Neuro Basal - Phenol red Invitrogen; Darmstadt 
Not fat dry milk powder Applichem; Darmstadt 
NuPAGE® 4-12% Bis-tris-Gel Invitrogen; Darmstadt 
NuPAGE® MOPS SDS Running Buffer (20X) Invitrogen; Darmstadt 
NuPAGE® Sample reducing agent (10X) Invitrogen; Darmstadt 
NuPAGE® LDS Sample buffer (5X) Invitrogen; Darmstadt 
NP-40 (10%) NEB; Frankfurt-Höchst  
Ketamine hydrochloride/Xylazine hydrochloride Sigma-Aldrich; St. Louis (MO, US) 
Paraformaldehyde-powder Sigma-Aldrich; St. Louis (MO, US) 
Paraformaldehyde (32% Stock) Science Services; Munich 
Penicillin/Streptomycin Lonza; Cologne 
Phytohaemagglutinin (PHA-L) Sigma-Aldrich; St. Louis (MO, US) 
Poly-L-Lysine Sigma-Aldrich; St. Louis (MO, US) 
Polyethylenglycol (PEG 1500) Sigma-Aldrich; St. Louis (MO, US) 
Potassiumchloride (KCl) Sigma-Aldrich; St. Louis (MO, US) 
PageRulerPrestained Protein Ladder  Thermo; Waltham (MA, US) 
SDS Running buffer anamed; Gross-Bieberau 
Sodium azide (NaN3) Merck; Darmstadt 
Sodium chloride Merck; Darmstadt 
Surcrose Serva Electrophysics; Heidelberg 
Sulfo-NHS-Biotin EZ linker  Thermo; Waltham (MA, US) 
Tiazovivin Stemgent; Cambridge (MA US) 
Tissue Tack Polysciences; Eppelheim 
Triton-X 100 Sigma-Aldrich; St. Louis (MO, US) 
Trizma® hydrochloride Sigma-Aldrich; St. Louis (MO, US) 
Tween-20 Sigma-Aldrich; St. Louis (MO, US) 
Tweezerelectrodes CUY650P10 Nepa gene; Ichikawa (Japan) 
4′,6-Diamidino-2-phenylindole dihydrochloride Sigma-Aldrich; St. Louis (MO, US) 
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2.1.5 Instruments and equipment 
Agilent Bioanalyzer 2100 Agilent Techn.; Santa Clara (SA,US) 
Brushes Th. Geyer; Renningen 
Centrifuge- Heraeus® Thermo; Waltham (MA, US) 
Cell strainer (70 µm) BD; Franklin Lakes (NJ,US) 
Cell strainer (50 µm) Miltenyi Biotec; Bergisch Gladbach 
Coverslips (12 mm diam.; 25 x 50 mm) Menzel; Braunschweig 
Cryostat (Leica CM1860 UV) Leica; Solms 
Dumont forceps (No.5) F.S.T; Heidelberg 
Electroporation device CUY21 Nepa gene; Ichikawa (Japan) 
Falcon tubes (15 mL, 50 mL) BD; Franklin Lakes (NJ,US) 
Filter tips (10, 200, 1000 µL) Thermo; Waltham (MA, US) 
gentleMACSTM Octo Dissociator Miltenyi Biotec; Bergisch Gladbach 
Hamilton Syrige Hamilton; Bonaduz (CH) 
Incubator-Heracell Thermo; Waltham (MA, US) 
LD, LS columns Miltenyi Biotec; Bergisch Gladbach 
Low attachment plates NOF; New York (US) 
MACSMix- Tube Rotator Miltenyi Biotec; Bergisch Gladbach 
MACSQuant Miltenyi Biotec; Bergisch Gladbach 
Microscope  Leica; Solms 
Microscope LSM-710 Zeiss; Jena 
Microscope slides Thermo; Waltham (MA, US) 
Multiwell plates (96 well; 24 well) BD; Franklin Lakes (NJ, US) 
MS columns Miltenyi Biotec; Bergisch Gladbach 
NanoDrop PEQLAB; Erlangen 
OctoMACS Miltenyi Biotec; Bergisch Gladbach 
Orbital shaker Heidolph; Schwabach  
Pipette (Glas) VWR; Darmstadt 
Pipette Eppendorf; Hamburg 
Pipetboy Eppendorf; Hamburg 
Razor Wilkinson; Solingen 
QuadroMACS Miltenyi Biotec; Bergisch Gladbach 
Razor Wilkinson; Solingen 
Scalpel B.Braun; Melsungen 
Scalpel (22.5°) F.S.T; Heidelberg 
Scissors F.S.T; Heidelberg 
SDS gel chamber Invitrogen; Darmstadt 
Semi Dry Blotter Biometra; Goettingen 
Stripette (5, 10, 25 ,50 mL) Sarstedt; Nümbrecht 
Super Frost Slides Roth, Karlsruhe 
TipOne (10, 100, 1000 µL) Starlab; Hamburg 
TubeOne (0.5, 1.5, 2 mL) Starlab; Hamburg 
Tissue Flasks (T75,T175) BD; Franklin Lakes (NJ, US) 
Tris-Glycerin Gels anamed; Gross-Bieberau 
Tisch centriguge- Heraeus® Thermo; Waltham (MA, US) 
Tris-Glycerin Gels anamed; Gross-Bieberau 
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Tweezerelectrodes CUY650P10 Nepa gene; Ichikawa (Japan) 
Vibratome (Microm HM 650 V) Thermo; Waltham (MA, US) 
Water bath Julabo; Seelbach 
Whatman paper Bio Rad; Munich 
26 G x 1' canula B.Braun; Melsungen 
30 G x 1/2' canula B.Braun; Melsungen 
 
Dissociation reagents 
Neural Tissue Dissociation Kit (Trypsin) - NTDK(T) Miltenyi Biotec, Bergisch Gladbach 
Neural Tissue Dissociation Kit (Papain) - NTDK(T) Miltenyi Biotec, Bergisch Gladbach  
Neural Tissue Dissociation Kit Postnatal Neurons - NTDK (PN) Miltenyi Biotec, Bergisch Gladbach 
 
Molecular biological Kits 
Agilent Low Input Quick Amp Labeling Kit Agilent T.; Santa Clara (SA,US) 
NucleoBond® PC 500 Kit Machery-Nagel; Düren 
NucleoSpin® plasmid Kit  Machery-Nagel; Düren  
Retinal Ganglion Isolation Kit (RGC) Miltenyi Biotec, Bergisch Gladbach 
RNeasy Mini Kit  Quiagen, Hilden 
 
Separation reagents 
Anti-ACSA-2 MicroBead Kit  Miltenyi Biotec, Bergisch Gladbach 
Anti-GLAST (ACSA-1) MicroBead Kit Miltenyi Biotec, Bergisch Gladbach 
Protein A/G MicroBead Kit  Miltenyi Biotec, Bergisch Gladbach 
 
2.1.6  Reagents  
 10X PBS pH 7.4  Transferbuffer  TBS buffer pH 7.6 
 NaCl  138mM Tris-Base 48mM  NaCl  150mM 
 Na2HPO4 8.2mM  Glycerin 39mM  Tris/HCl   50mM 
 KCl  2.4mM  SDS  1.3mM   
 KH2PO4 1.3mM  Methanol 10%(v/v) 
 
 Lysis buffer 
 Triton-X-100 1%(v/v) 
 NaCl  150 mM 
 Tris HCl 50 mM (pH 8) 
 
2.1.7  Software 
Adobe Reader Abobe; Munich 
Axiovision Zeiss; Jena 
Endnote Thomson Reuter; New York City (NY, US) 
FlowJo Miltenyi; Bergisch Gladbach  
MetaCore Thomson Reuter; New York City (NY, US) 
MACSQuantify Miltenyi; Bergisch Gladbach  
Multiple experiment viewer (TM4) Dana-Farber Cancer Institute; Boston (MA, US) 
Prism6 Graph Pad; La Jolla, CA USA 
Zen2011 Zeiss; Jena 
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2.1.8  Animal strains, bacteria strains and cell lines 
Cell line Origin 
HM-1 Mouse embryonic stem cell line Mouse  
CM7/1 Mouse embryonic stem cell line Mouse  
OP-9 Mouse embryonic stem cell line Mouse  
L929 Fibroblasts Mouse  
H4 (HTB-148) Neuroblastoma cell line Human 
LS Neuroblastoma cell line Human 
1881 B cell lymphoma cell line Human 
BW B cell line Human 
RPE-1 Retina pigment epithelium Human 
4T-1 Mamacarcinom cell line Mouse (Xenograft) 
HEK (293 T) Human embyonic kidney cell line Human 
CHO Chinese hamster ovary cell line Hamster 
Sp2/0-Ag14 Murine myeloma cell line Mouse 
 
Animals Background Supplier 
Rat Wistar Wild-type Harlan 
Mouse CD1 Wild-type Animal facility 
Mouse BALB/c Wild-type Harlan 
Mouse C57BL/6 Wild-type Harlan 
Mouse β-Actin-GFP  Transgene Animal facility 
Mouse GAD67-GFP Transgene Animal facility 
    Escherichia coli  Supplier 
 DH5alpha Competent Cells Invitrogen 
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2’ Methods 
2.2 Cell and biochemical methods 
2.2.1 Ethical guidelines for animal research 
Animals were maintained under specific pathogen-free conditions according to the 
recommendations of the Federation of European Laboratory Animal Science Association. All 
experiments were performed in compliance with the European Communities Council Directive 
of 24 November 1986 (86/609/EEC) 
 
2.2.2 Tissue dissociation 
  A single cell suspension from solid tissue is obtained by combination of mechanical 
and enzymatic treatment. Dissociation protocols are optimized according to tissue type, species 
and age of the animal. Different parameters such as: Temperature, incubation time and 
enzymes are carefully chosen to obtain high amounts of vital cells. 
 
2.2.2.1 Dissociation of embryonic brain tissue 
Embryonic mouse brain tissue was used to study astrocyte marker expression at early 
developmental stages. Pregnant CD1 mice purchased from Harlan Laboratories (Rossdorf; 
Germany) were sacrificed by CO2 application. Embryonic brains were dissected, collected and 
dissociated using the Neural Tissue Dissociation Kit – Postnatal Neurons (NTDK (PN)) in 
combination with trypsin (T) or papain (P). Trypsin is a serine protease that harbors a catalytic 
triade 182,183 and papain is a cysteine protease. Tissue was incubated in a water bath (37°C) for 
5 minutes (min) mixed discontinuously. Tissue was dissociated mechanically using a 
1 milliliter (mL) pipette and incubated for another 5 min in a water bath. The cell solution was 
passed through a 70 µm cell strainer and pelleted by 10 min centrifugation at 300 g at room 
temperature (RT). The cell pellet was resuspended in Hank’s Balanced Salt Solution (HBSS) 
and processed immediately.  
 
2.2.2.2 Dissociation of neonatal (also referred as postnatal) brain tissue 
Neonatal CD1 wt mice aged P0 to P7 were obtained by in-house breeding (Miltenyi 
Biotec (2.1.8)). Mice were sacrificed by decapitation. Brains were removed and dissociated 
using the NTDK/ NTDK (PN) plus (T) or (P) in combination with the gentleMACSTM Octo 
Dissociator according to the manufacturer’s instructions (Program: NTDK_1_37°C). For 
analysis of distinct brain regions olfactory bulb, cortical hemispheres, hippocampus, 
midbrain/diencephalon and cerebellum were dissected, dissociated and stained separately.  
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2.2.2.3 Dissociation of adult mouse brain tissue 
In contrast to neonatal brain, the adult mouse brain is composed of myelin rich (white 
matter) and myelin rare areas (grey matter). The isolation of neural cells from the adult brain 
requires a myelin-removal step, which can either be performed by the depletion of myelin 
using Myelin Removal Beads or by density gradient centrifugation. Brains from adult CD1 
mice (P40) were sliced manually into 8 pieces and dissociated on the gentleMACS Octo 
Dissociator (Program: ABDK) in the presence of Adult Mouse Brain Dissociation Kit with 
papain following the manufactuer’s protocol. By density gradient centrifugation (10 min,  
3.000 g, 4°C), viable cells were separated from myelin, as myelin has a lower density. Neural 
cells were harvested from the interphase and further processed. 
 
2.2.2.4 Dissociation of SVZ tissue 
  Adult mice (> P40) (BALB/c, CD1, C57BL/6 (2.1.8)) or neonatal CD1 mice (P2-P5) 
were sacrificed. Brains were dissected and cut into coronal floating sections (400 µm) using a 
vibratome. The lateral wall of the SVZ was dissected manually with an ophthalmic scalpel 
(22.5°). Tissue was collected and incubated at 37°C in pre-heated NTDK(PN) solution 1 and 2 
for 15 min under continuous rotation on the MACSmix Tube Rotator. Solution 3 and 4 of the 
NTDK(PN) were added and tissue was dissociated using a fire polished glass pipette (diameter 
approx. 0.8 mm), then incubated for another 15 min.  
 
2.2.2.5 Dissociation of retinal tissue 
 The retina is part of the central nervous system, which develops from the neural tube. 
Neural retina was harvested from CD1 mice at postnatal day 2 and 6. Mice were decapitated 
and the eyes were collected. The intra-ocular pressure was reduced by picking the eye with a 
needle. The lens was cropped using vannas spring scissors, thereby the vitreous humour was 
exposed and enabled the removal of the retina. The tissue was collected in a 15 mL FalconTM 
and processed according to the Retinal Ganglion Cell Isolation Kit, rat (RGC) using 0.05% 
trypsin for enzymatic treatment. Solutions were applied at RT; centrifugation steps were 
carried out at 130 g, RT. After sedimentation the supernatant was removed carefully.  
Solution 1 (RGC) and trypsin were added. Cells were incubated for 15 min at 37°C in the 
MACSMix, before 30 µL of enzyme mix 2 (RGC) were added. Tissue was then dissociated 
with a wet 5 mL pipette and incubated for another 10 min at 37°C. Tissue was further 
dissociated using a fire-polished Pasteur pipette (appr. 0.8 mm diameter). Cells were applied 
on a cell strainer (70 µm) and resuspended in D-PBS supplemented with BSA.  
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2.2.2.6 Dissociation of spinal cord 
 For analyses of spinal cord tissue, CD1 wt mice (P6) were sacrificed by decapitation. 
The back was opened and the spinal cord was dissected using forceps (Dumont No.5). Tissue 
was dissociated using NTDK(PN) in combination with trypsin for enzymatic treatment and the 
gentleMACS Octo Dissociator for mechanical treatment (Program: NTDK_1_37°C).  
 
 
2.2.3  Cultivation of neural cells 
2.2.3.1 Cultivation of primary neural cells   
  Mixed mouse brain tissue cultures were prepared from the cerebral hemispheres or the 
midbrain of CD1 wt mice (P0 to P2). The meninges were removed to prevent overgrowth of 
fibroblasts in the culture. Tissue was dissociated with the NTDK/NTDK(PN)(T) and cells were 
seeded at a density of 4 x 104 to 1 x 105 cells on poly-L-lysine coated 1 cm cover slips. The 
cover slips were incubated with poly-L-lysine for 30 min to o/n, washed with destilled water 
and dried prior to use. Cells were cultured in MACS Neuro Medium supplemented with 1% 
NeuroBrew-21, 1% Penicillin/Streptomycin (Pen/Strep) and L-Glutamine (2 mM) for  
1 to 14 days.  
 
2.2.3.2 Cultivation of isolated astrocytes   
  MACS isolated astrocytes (2.6) were seeded at a density of 4 x 104 to 1 x 105 cells on 
poly-L-lysine coated 1 cm cover slips or 24-well imaging plates (poly-L-lysine coating 
according to 2.2.6). Cells were cultured in MACS Neuro Medium supplemented with  
1% NeuroBrew-21, 1% Pen/Strep and L-Glutamine (2 mM) for 1 to 14 days. 
  
2.2.3.3 Neurosphere assay 
 The neurosphere assay addresses the fundamental features of neural stem cells (NSCs). 
Its principles were first reported by Reynolds and Weiss in 1992 63. Self-renewing multipotent 
stem cells are able to form free-floating spheres in the presence of epidermal growth factor 
(EGF) and basic fibroblast growth factor (FGF). Upon dissociation and plating in the absence 
of EGF and FGF these cells differentiate into neurons, astrocytes and oligodendrocytes. The 
dissociation of primary spheres and further cultivation in FGF and EGF containing medium 
leads to the generation of secondary neurospheres. By the generation of secondary and tertiary 
spheres, the self-renewing characteristics of stem cells are examined, as non-stem cells are not 
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self-renewing and lost during passaging. Cells were seeded at a density of 1,000 cells/µL 
(500,000 cells/500 µL) in a 24 well low-attachment plate. Cells were grown in MACS Neuro 
Medium supplemented with 1% NeuroBrew-21, 1% Pen/Strep, 20 ng/mL human FGF and  
20 ng/mL human EGF. The medium was prepared fresh and replaced every three days by 
centrifugation (150 g, 6 min, RT) (Fig. 2.1). If secondary spheres were generated cells were 
dissociated using trypsin and replaced in a low-attachment dish in the presence of growth 
factors. Depending on the sphere diameter after 6 or 12 days, cells were seeded on poly-L lysin 
coated cover slips for final differentiation (coating as decribed in 2.2.3.1) (Fig. 2.1).   
 
Figure 2.1: A schematic overview of the neurosphere assay   
       Dissociated cells were cultivated in low attachment plates at a high cell density. For generation of  
       neurospheres human EGF and human FGF were added to the medium. After 6-12 days cells were  
       either dissociated and seeded for final differentiation or re-plated in a low attachment plate for  
       the generation of secondary/tertiary neurospheres.  
 
2.2.4  Cell lines  
  Frozen cell lines were thawed in pre-warmed medium to dilute the DMSO in the 
freezing solution. Cells were pelleted by 10 min centrifugation at 300 g, at RT and seeded with 
fresh medium in a T25 flask. To freeze cells, the cells were harvested from culture at  
70% confluence, pelleted using centrifugation and resuspended in FCS. After the addition of 
DMSO (10% v/v) cells were shock-frozen at -80°C in a freezing container and transferred into 
liquid nitrogen for long-term storage.  
  
2.2.4.1 Murine myeloma cell line (Sp2/0)  
 The murine cell line Sp2/0-Ag14 is a myeloma cell line. Myeloma cells are able to fuse 
with antibody-producing B cells, which result in immortalized hybridoma cells and used for 
monoclonal antibody production,184 as demonstrated by Köhler and Milstein in  
1975 185, later awarded Nobel Prize. Sp2/0-Ag14 cells were cultivated in  
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DMEM (Dulbecco's Modified Eagle's Medium) supplemented with 20 mM HEPES and 2 mM 
L-Glutamine. After fusion with antibody producing B cells the medium was supplemented 
with 0.1 mM Hypoxanthine, which induces selection pressure.   
 
2.2.4.2 CHO cells  
  Chinese Hamster Ovary cells (CHO) are an immortalized adherent growing cell line 
generated in 1957 186. CHO are commonly used for recombinant antibody production 187.  
CHO cells were cultivated in CHOMACS CD medium supplemented with 8 mM L-Glutamine 
in the presence of 1% (v/v) Pen/Strep.  
 
2.2.4.3 HEK 293 cells  
  This human embryonic kidney cell line is an adherent growing epithelial cell line. It 
was generated in 1970 by the transformation of human embryonic kidney cells treated with 
adenovirus 5 DNA 188. The adherent cell line was cultivated in DMEM supplemented with 
10% FCS in the presence of 1% (v/v) Pen/Strep.  
 
2.2.4.4 1881 cells  
  The 1881 cell line is a mouse B cell line derived from BALB/c bone marrow that was 
transformed with Abelson murine leukemia virus 189. The suspension cell line was grown in 
RPMI-1640 in the presence of 10% FCS and 1% (v/v) Pen/Strep. 
 
2.2.5 Flow cytometric analysis  
 Single cell suspensions of one million cells from dissociated mouse whole brain tissue 
or isolated astrocytes were incubated with mouse Fc Receptor (mFcR) blocking reagent ((1:10) 
Miltenyi Biotec) to block unspecific antibody binding to Fc receptor expressing cells. Cells 
were subsequently stained with antibodies directed against cell surface marker(s) of interest at 
a defined titer in PB (Phosphate buffered saline (PBS) supplemented with 5% bovine serum 
albumin (BSA)) for 10 min at 4°C. After washing and centrifugation (200 g, 5 min, RT), data 
was acquired on a flow cytometer (MACSQuant) and analyzed using MACSQuantity software.
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2.2.5.1 Flow cytometry - Gating strategy 
Single suspension cells can be analyzed by flow cytometry. The most common graphs 
are histograms (one-dimension) or dot plots (two-dimensions). In a dot plot, each event is 
represented by a dot correlating to the signal intensity of two channels concurrently;  
see Fig. 2.2 (4,5). A gating strategy allows analyzing subpopulations of cells, independent 
from the entire sample. The gates are set according to an unstained sample (negative staining 
control). The first gate excludes all doublets, cells that cluster or stick to each other  
(Fig. 2.2 (1)). In the next gate, the forward scatter (FSC) is applied against the side scarrer 
(SSC) to mask the population of interest. In this study neuronal cells were gated, as presented 
in Fig. 2.2 (2). In the third gate, viable cells are discriminated from dead cells using the cell 
death marker Propidium-iodide (PI) against PE (Fig. 2.2 (3)). By plotting the FSC against a 
given fluorescence channel, the frequencies of a marker expressed on a cell population can be 
determined (Fig. 2.2 (4)). In addition, the percentage of double positive cells can be analyzed if 
co-stainings were performed. Therefore, two distinct fluorescence channels are assigned 
against each other (Fig. 2.2 (5)). On the MACSQuant, the spillover was compensated using a 
matrix that displays all available channels.  
 
  
Figure 2.2: Gating strategy for flow cytometry analysis  
       The first gating step excludes doublets (1). Thereafter the cells of interest are gated (2)  
       and living cells are discriminated by PI labeling (3). The expression of a marker or  
       marker co-expression is further analyzed using dot plots (4,5). 
 
 
2.2.6 Magnetic cell separation  
 Magnetic cell separation (MACS) can be used to enrich or deplete cells. Cells are 
labeled either directly using antibody MicroBead conjugates or indirectly by fluorochrome or 
biotin conjugates in combination with Anti-fluorochrome or Anti-Biotin MicroBeads. Cells are 
pre-incubated with mFcR before the antibodies are added according to the manufacturer’s 
instructions. After labeling, cells were washed (Table 1) and applied onto a suitable column: 
For enrichment an MS or an LS column were used. For depletion, LD columns were used. 
Columns were placed in a permanent magnet (OctoMACS, QuadroMACS), which induces a 
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high-gradient magnetic field. The MicroBead labeled cells are retained by the magnetic field 
within the column. Unlabeled cells run through the column and are collected in the negative 
fraction (Table 1). In case of a positive enrichment, the target cells are labeled. The column is 
taken out of the magnet and the labeled fraction can be eluted. In a depletion strategy, non-
magnetic cells are magenetically labeled and retained within the magnetic field, whereas target 
cells are collected in the flow through. For cultivation the separation was performed under a 
laminar flow with sterile equipment, solutions and filtered buffer. Cells were cultivated as 
described in 2.2.3.2. 
 
Table 1: MACS separation  
Column Cell amount Rinse column Cellsolution Washing step Elution 
MS 2 x 107 500 µL 500 µL 3 x 500 µL 1 mL 
LS 4 x 107 3 mL 500 µL 3 x 3 mL 5 mL 
LD 4 x 107 3 mL 500 µL 2 x 1 mL 3 mL 
 
 
2.2.7 Cell surface marker screen  
 To perform the cell surface marker screening, single cell suspensions obtained by 
tissue dissociation were analyzed by flow cytometry. Isolated astrocytes, cells of whole mouse 
brain tissue or from different brain regions were stained in a 96 well plate with the antibody 
concentration given in Appendix I. The final antibody titer on the cells was 0.5 µg/mL, as 
recommended in the protocol of the Mouse Cell surface Marker Screening Panel (BD Lyoplate 
mouse, BD). Forebrain, midbrain and cerebellum were dissociated separately and labeled with 
following concentrations of CellTraceTM Violet Cell Proliferation Kit – accoding to the 
manufactuer’s instructions: Forebrain (1.75 µM), midbrain (0.2 µM) and cerebellum (0 µM). 
Positive markers (>5% on astrocytes) were re-screened (Table 2). For visualization a heat map 
was generated using the MultiExperiment Viewer (TM4:MeV) using Pearson’s Correlation.  
For analysis the relative expression was calculated as follows: 
 𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒  𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛     𝑜𝑛  GLAST!𝑐𝑒𝑙𝑙𝑠 = %  !"  !"#$%#  !"  !"#$!!    !!!!!! ÷ %  !"  !"#$!!!"##$   !!!!!!    (1)     𝑟𝑒𝑙𝑎𝑡𝑖𝑣𝑒  𝑒𝑥𝑝𝑟𝑒𝑠𝑠𝑖𝑜𝑛   𝑜𝑛  ACSA − 2!𝑐𝑒𝑙𝑙𝑠 = %  !"  !"#$%#  !"  !"#!!!!!"##$   !!!!!! ÷ %  !"  !"#!!!!!"##$   !!!!!!   (2)   
Abbreviations: F: Forebrain, M: Midbrain, C: Cerebellum 
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          Table 2: Antibody clones used for rescreening  
Marker Clone Conc. 
CD3e 145-2C11 1:11 
CD24 M1/69 1:11 
CD26 H194-112 0.5 µg/mL 
CD29 HMß1-1  1:11 
CD38 90 1 µg/mL 
CD47 DX5 1:11 
CD49e 5H10-27 1:11 
CD106 429 0.25 µg/mL 
CD119 2 E 2 0.5 µg/mL 
CD147 RL73 0.25 µg/mL 
CD200 OX-90 1:100 
 
2.2.8  Immunization 
Lewis rats were immunized by contralateral footpad immunization for the generation 
of astrocyte subpopulation specific monoclonal antibodies. MACS enriched astrocytes from 
mice served as immunogen. Another cells pool of murine cells depleted from astrocytes was 
applied as decoy. Per fraction 0.5 - 2 x 106 cells were injected into the hind footpad. The 
injection was repeated six times, at day 0, 4, 7, 11 and 14. At day -3 only the decoy fraction 
was injected. In different immunization attempts different immunization strategies were tested: 
- Immunogen: Enrichment of GLAST+cells/Decoy: Depletion of GLAST+ cells   
- Immunogen: Enrichment of GLAST+cells/Decoy: Depletion of ACSA-2+ cells  
Furthermore, different adjuvants such as Phytoheamagglutinin (PHA-L) a lectin derived from 
Phaseolus vulgaris (at a final concentration of 10 µg/mL per boost) or CpG a dinucleotide 
which addresses Toll-like receptor 9 (at a final concentration of 50 µg per boost) were tested in 
both settings to increase the immunogenic potential by the activation of the innate immune 
response. At day 15 the popliteal lymph nodes from the hind footpad of the immunized rats 
were harvested by dissection. The lymph nodes were minced to obtain the antibody producing 
B cells. B cells were subsequently fused with murine Sp2/0 hybridoma cells in the presence of 
Polyethylenglycol (PEG), which enables the fusion of cell membranes. Cells were plated in a 
96 well plate in the presence of mouse peritoneal macrophages isolated one day before. Cells 
were grown in the presence of azaserin and hypoxanthine, based on the HAT system 190. 
Azaserine blocks the purine metabolism in unfused cells. In addition, unfused Sp2/0 cells lack 
the enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT) and die. Cells were 
cultivated in the presence of 9% CO2 at 37 °C for 5-7 days then fed to enhance cell growth. 
The hybridoma supernatants were screened on dissociated primary mouse brain tissue (P4-P6) 
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on a flow cytometer. The supernatant was incubated with 1 x 104 cells for 10 min at 4°C. After 
washing and centrifugation (300 g, 5 min, RT) cells were incubated with a secondary 
fluorochrome coupled antibody directed against the rat kappa light chain. After washing, cells 
were stained with the Anti-GLAST or Anti-ACSA-2 antibody to discriminate astrocyte 
subpopulation specific clones.   
 
2.2.9 In vivo electroporation  
Electroporation is an effective method to channel small charged molecules like DNA or 
messenger RNA (mRNA) through the lipid bilayer of cellular membranes, which cannot enter 
the cell by osmosis. Physically, electroporation induces a shift in the lipid rafts and enables the 
passage of small molecules 191. First experiments of in vivo electroporation were carried out on 
mouse muscle tissue 192 and could be translated onto CNS derived tissue including retina 193, 
embryonic 194 and postnatal brain 195. The technique is a powerful tool to study developmental 
processes, cell differentiation and migration processes. In vivo electroporation of the 
periventricular zone of the postnatal brain allows studying the SVZ/RMS/olfactory bulb 
system. In this study the electroporation technique was used to target stem cells and radial glia 
in the periventricular zone (PVZ).   
Animals were treated according to the guidelines of the French ethics committee. Neonatal 
mice (P1, P2) were anesthetized by hypothermia and fixed for injection. The injection point 
was tapped by an ophthalmic scalpel. The injection was performed manually using a glass 
capillary (200 µm) connected to a Hamilton syringe. The capillary was filled with 2 µL of 
plasmid solution (5 µg/mL) labeled with 1% (v/v) fast green. For injection the needle was 
placed to the midpoint between the eye and the lambda, lowered between 2.5 and 3 mm and 
the DNA was injected. In case of successful injection a labeled ventricle was visible under a 
light source. By the usage of tweezerelectrodes and conductive gel five electrical pulses (100V, 
50 ms, separated by 950 ms intervals) were applied. The electric field was applied horizontally 
to obtain the electroporation of the dorsal wall and vertically to electroporate the lateral 
compartment. Animals were resuscitated in an incubator at 37°C and returned to the mother.	   
 
 
2.2.10  Cell transplantation of ACSA-2+/GLAST+/-, ACSA-2-/GLAST+ cells into the 
 neonatal cerebellum  
  The progeny of ACSA-2+/ GLAST+/- and ACSA-2-/ GLAST+ cells was investigated in 
an in vivo model by cell transplatation. For both transplantation groups cerebelli of β-actin 
GFP mice (P0-P3) were dissected, dissociated and labeled with mFcR Blocking Reagent. 
ACSA-2+/ GLAST+/- cells were isolated using the Anti-ACSA-2 MicroBead Kit. For the 
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enrichment of ACSA-2- / GLAST+ cells a two-step separation strategy was applied. Therefore, 
cells were first labeled with Anti-L1CAM-PE (titer 1:2.5), then labeled with Anti-ACSA-2 
MicroBeads (1:2.5), Anti-PE MicroBeads (1:2.5), Anti-CD45 (1:10), Anti-PSA-NCAM (1:10) 
and Anti-Ter119 MicroBeads and processed over an LD column. Afterwards, ACSA-2-
/GLAST+ were incubated with Anti-GLAST Biotin (1:5) and Anti-Biotin MicroBeads (1:5) 
and enriched using an MS column. ACSA-2+/GLAST+/- and ACSA-2-/GLAST+ cells were 
injected into the lateral part of the vermis of P1-P3 hosts (n=9, n=11). Pups were anesthetized 
by hypothermia. 50,000 cells/µL were injected using a glass micropipette and the pups were 
returned to the mother. Per condition a cohort of 9 and 11 animals was transplanted. Mice were 
perfused intracardially with 4% PFA in PBS 30 days after injection and processed as described  
in 2.3.1/2.3.2. For statistical analysis integrated cells per animal were counted using a 
representative selection of fractions per animal (15-20 sections). Statistics were calculated with 
the Prism software using two-tailed unpaired Student’s t-test, error bars represent the standard 
deviation (SD). 
 
2.2.6  Histochemical methods 
2.3.1 Preparation of brain tissue 
  Adult mice were anesthetized with an overdose of xylazin/ketamin (> 10 mg/kg body 
weight). Neonatal mice were either anesthetized by xylazin/ketamin or by hypothermia (4 min). 
Mice were perfused intracardically with 2% or 4% paraformaldehyde (PFA) (32% PFA Stock 
solution diluted with PBS). Brains were post fixed in 2% or 4% PFA for 6 hours (h) or over 
night (o/n) and then transferred into PBS o/n. For cryoprotection brains were incubated in  
30% sucrose o/n.  
 
2.3.2 Immunohistochemistry 
  For vibratome sectioning, brains were embedded in 3.5% agarose plus 8% sucrose, 
sectioned into 40-60 µm slices and stained as floating sections. The agarose was removed for 
staining and unspecific binding sites were blocked for 1 h at RT with 4% goat serum. The 
primary antibodies were incubated in PBS supplemented with 1% goat serum and  
0.0-0.3% Triton-X-100 o/n at 4°C or RT. After washing (3 times, 10 min in PBS), the 
secondary antibodies were incubated for 1 h at RT. After washing (3 times, 10 min in PBS), 
cell nuclei were stained by Hoechst 33258 or DAPI. After a final PBS washing step, the 
sections were mounted (Mowiol or Mounting medium) and monitored by confocal imaging 
(Zeiss, Leica).  
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2.3.3 Immunohistochemistry of Afg31l1 d/d Afg3l2 fl/fl GFAP cre mice 
Floating sections (30 µm) were dehydrated in PBS containing 4% sucrose (30 min), 
treated with methanol (30 min) and washed (3 times, 10 min in PBS). Sections were blocked 
for 45 minutes with 10% goat serum (life technologies). The primary antibodies were 
incubated over night at 4°C in PBS supplemented with 0.4% Triton-X-100 and 4% goat serum. 
After washing (3 times, 10 min in PBS), the secondary antibody was applied for 1 h at RT. In 
the final washing step the nuclei were stained with DAPI and the sections were mounted for 
visualization. 
 
2.3.4 Immunocytochemistry 
Cells were cultivated in a 24 well plate as described before (2.2.3.1/2.2.3.2). Primary 
neural cells were washed with PBS, fixed with 4% PFA (20 min, RT). After fixation cells were 
washed again three times with PBS and stored at 4°C in PBS supplemented with 4% sodium 
azide (NaN3), which enables long-time storage. For staining, cells were blocked with 5-10% 
goat serum for 45 minutes. The primary antibodies were incubated over night at 4°C in PBS 
supplemented with 0.0-0.3% Triton-X-100 and 5% goat serum. After washing (3 times, 10 min 
in PBS), the secondary antibody was applied for 1 h at RT. After washing (3 times, 10 min  
in PBS), cell nuclei were stained by Hoechst 33258, DRAQ5 or DAPI. Cover slips were 
mounted and cells were monitored by confocal imaging.  
 
2.3.5 Live cell staining 
Cells were cultivated in a 24 well plate as described before (2.2.3.1/2.2.3.2). Live cell 
staining was performed to visualize ACSA-2 staining on living astrocytes in mixed mouse 
brain tissue culture or on isolated astrocytes. The Anti-ACSA-2 antibody was given into the 
medium of the primary mixed neural cells in a final concentration of 10 µg/mL and incubated 
o/n at 37°C. After a washing step with medium the secondary antibody [0.4 µg/mL] was 
incubated for 1 hour at 37°C. Cells were fixed with 4% PFA and stained for further markers as 
described before (2.3.4).  
 
2.3.6 Multidimensional in situ Cytometry Survey (MICS)  
 Whole mouse brain tissue cells were cultivated in a 24 well imaging plate as described 
before (2.2.3.1). The Multidimensional in situ Cytometry Survey (MICS) allows investigating 
the expression profile and proteome of 100 markers on the cultivated cells. This is performed 
by repetitive antibody staining and bleaching cycles 196. For MICS PE-conjugated antibodies 
were used. The antibodies were diluted in PB buffer plus 0.2% Triton-X-100 if required. Cells 
were blocked in an initial step. Each staining cycle starts with 10 min antibody incubation, 
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then a photo is taken and thereafter the spot is bleached.   
 
2.3.7 Imaging 
 Sections or cover slips were monitored on Zeiss or Leica confocal microscopes. At the 
laser-scanning microscope (LSM (Zeiss)) pictures were taken with option ‘best compromise’. 
‘Mosaic pictures’ were taken at the Zeiss Z1 Apotome. For the analysis of the transplantation 
experiments, z-stacks were patially visualized as maximum intensity projections (MIPs) using 
the AxioVision Software.  
 
 
2.4  Protein biochemical Methods 
2.4.1 Ligand receptor capturing 
 One approach to identify the ACSA-2 antigen was performed by a so-called ligand 
receptor capturing (LRC) in co-operation with the ETH Zurich. 100 µm sections of P1 mice 
brains were obtained by vibratome sectioning. The tissue was shock-frozen in liquid nitrogen 
and shipped to Zurich. The LRC is a mass-spectrometric approach for the ligand-based 
identification of antigens 197. The LRC technology is based on trifunctional linker (TRICEPS), 
which can be coupled to a ligand of interest and enables the ligand-based capture of receptors. 
After purification the samples are analyzed by mass spectrometry analysis (MS). In 
quantitative comparison the identified peptides are compared against a control probe 198.  
 
2.4.2  Western Blot Analysis  
 Whole mouse brain tissue from adult and neonatal mice (P1, P2) was minced by Ultra-
Turrax. Triton-X-100 buffer plus protease inhibition cocktail (P 8340 (Sigma)) was added and 
incubated for 30 minutes on ice. After centrifugation (4.000 g, 12 min, 4°C), the supernatant 
was collected. The protein concentration was determined by Bradford assay. 10 µg of protein 
lysate per sample were incubated with 1x SDS sample buffer on a heating block (70°C, 5 min). 
Samples and PageRulerPrestained Protein Ladder were loaded onto a 4%-20% Tris-glycin 
gradient gel. The electrophoresis was run (140 V, 30 mA, 30 Watt for 90 minutes) with 
electrophoresis or MOPS buffer. Proteins were transferred onto a Hybond ECL membrane® 
using a semi dry blotter (40 minutes with 23 V, 150 mA, 10 Watt). Prior to primary antibody 
incubation the membrane was blocked in Tris Based Saline (TBS) plus 0.2% Tween20 and  
5% dry milk powder over night at 4°C. The primary antibody Anti-ACSA-2 [10 µg/mL] was 
applied for 1 hour at RT. The membrane was washed with TBS plus 0.2% Tween20 before the 
secondary antibody (goat anti rat HRP (Stemgent (1:1000)) was added and incubated for 
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1 hour at RT. After a washing step with TBS plus 0.2% Tween20 and distilled water, the 
membrane was treated with Immobilon Western Chemiluminescent HRP Substrat and the 
photofilm (Hyperfilm ECL) was exposed until a band appeared.  
 
2.4.3 Immunoprecipitation 
 Cells from postnatal mice were obtained by tissue dissociation of whole mouse brains 
using the NTDK(P). 1 x 107 cells were pelleted by centrifugation and washed with PBS. Cells 
were lysed in lysis buffer supplemented with protease inhibition cocktail (P 8340 (Sigma)) 
using a syringe. Cells were incubated on ice for 10-30 minutes and mixed in between. Cells 
were pelleted by centrifugation (10,000 g, 4°C, 10 min) and the supernatant was collected. For 
pre-clearing the lysate was incubated with Protein G MicroBeads and incubated for 30 minutes 
on ice to reduce unspecific signals. The pre-cleared fraction was passed through an µ column 
and subsequently incubated with 15 µg of the Anti-ACSA-2 pure antibody or the ratIgG2b 
isotype control antibody. 50 µL of Protein G Beads were added were to both samples and 
incubated for 30 minutes on ice. The lysate was applied onto µ columns, washed 3 times with 
low salt buffer and once with high salt buffer. For elution pre-heated 1x SDS sample buffer 
was used. Samples were analyzed by SDS PAGE and Western Blotting.   
 
2.4.4 Immunoprecipitation upon surface biotinylation 
 The protocol was kindly provided by Tobias Haas (University of Rome). In brief, the 
surface of the cell was labeled with a Sulfo-N-Hydroxysulfosuccinimid ester (NHS)-Biotin 
reagent. The Sulfo-NHS-Biotin is negatively charged and cannot permeate the cell membrane. 
Instead, it reacts with primary amines and N-termini of polypeptides expressed on the cell 
surface. In that way, the biotinylation discriminates surface molecules from cellular proteins. 
The biotinylation step lasted for 30 minutes at 4°C under slightly alkaline conditions (pH 7.4). 
The reaction was quenched by washing with PBS supplemented with 100 mM glycine. 
Afterwards the cells were lysed and incubated with pre-clearing Beads (Sepharose + isotype 
antibody or MicroBeads + isotype antibody) in PBS plus 2.5% BSA to block unspecific 
binding sides. The pre-clear step was repeated 3 times (3 h, 1 h and 30 minutes). Beads or 
Sepharose were pelleted after each incubation step. The supernatant was transferred onto the 
next pre-clearing sample and the pellet was incubated with 1x SDS sample buffer and frozen 
until anayses. Afterwards, an incubation step with empty Beads was performed. After pelleting 
the supernatant was incubated with the target antibody (2.5 µg Anti-ACSA-2) over night under 
continuous rotation. All samples were boiled and loaded onto a MOPS gel. The Western Blot 
analysis was performed as described before (2.4.2). For detection a Streptavidin HPR antibody 
was used. 
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2.4.5 Deglycosylation Assay 
 The glycosylation pattern of the ACSA-2 antigen was investigated by a 
deglycosylation assay using the Protein Deglycosylation MIX (NEB). Glycosylation is one of 
the most common post-translational modifications. Glycosylation pattern can be removed by 
catalysing enzymes like PNGaseF, O-Glycosidase, Neuramidase, Galactosidase and N-
Acetylglucoamidase, which are provided in the mixture. 5 µL enzyme mix were applied to 
8.3 x 104 cells which corresponds to 100 µg glycoprotein. Cells were incubated for 2, 4 and 6 h 
at 37°C, measured by flow cytometry. Additionally, sorted astrocytes were incubated with the 
enzyme mix for 4 h, fixed with 2% PFA and stained against ACSA-2 in combination with 
GFAP, CD81 [5 µg/mL; clone Eat2] as negative control and wheat germ agglutinin (1:300) as 
positive control. Plated cells were analyzed by immunocytochemistry (2.3.4).  
 
 
2.5  Molecular Biological Methods 
2.5.1 Transformation in E.coli 
 Transformation is used to introduce a DNA-plasmid into a competent recipient (bacteria, 
yeast, plants) for amplification. Competent cells are obtained by a chemical treatment step 
using calcium-chloride, which increases the permeability of the cell membrane. The 
transformation can be performed by heat-shock or by an electric pulse. In this study, the heat 
competent Escherichia coli (DH5alpha) were used. Aliquots were stored at -80°C and thawed 
on ice prior to use. The DNA-plasmid was pre-diluted to obtain a concentration of  
1-10 ng/µL, applied to the bacteria and mixed by soft shaking. Cells were incubated on ice for 
5 min. A heat-shock (42°C, 30sec) was applied using a water bath. Cells were resuspended in 
250 µL Luria-Bertani (LB) Medium, plated on agar plate with 100 µg/mL ampicillin and 
cultivated at 37°C for 16 h. 
	  
2.5.2 Plasmid preparation  
 Colonies were picked with a toothpick. Cultures were grown in LB-suspension 
medium (2 mL) containing 100 µg/mL ampicillin on a shaker (300 rpm) for 16 h at 37°C. 
Plasmids were either isolated by the NucleoSpin® plasmid Kit or used to inoculate a 200 mL 
culture. Cells were grown under the given conditions. Plasmids were isolated using the 
NucleoBond® PC 500-Kit.	   DNA yield was measured on the NanoDrop. Pure DNA has a 
quotient E260/E280 between 1.8 and 2.0. 
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2.5.3 Control restriction 
 Quantitative quality check of the plasmid DNA was performed by control restriction. 
Restriction enzymes were chosen according to restriction sites indicated on the vector map. 
The length of vector and insert were calculated using CloneManager. According to the 
manufacturer’s instruction the restriction reaction was incubated for 1 hour at RT.  
 
µL   
 
TEA buffer   
X 1 µg DNA   
 
40 mM  Tris 
1 Restriction enzyme (10 U/µL)  
 
20 mM Acetic acid 
2 Buffer 10X  
 
1 mM EDTA 
20 ad aqua dest. 
 
pH 8.0   
 
Fragments were analyzed on a 1% agarose gel. For the electrophoresis and gel preparation 
TAE buffer was used. The agarose was dissolved by heating, followed by a cooling-down step 
in a water bath and supplemented with ethidiumbromide. This reagent binds to nucleic acids 
and thereby visualizes the DNA fragments under the UV light.  
 
2.5.4 Transfection of mammalian cells 
 CHO and HEK cells were seeded 24 h before transfection at a density of  
50,000 cell/well into a 24 well plate. 6 µL MACSfectin were mixed with 100 µL of medium.  
2 µg plasmid DNA were added and incubated for 20 min at RT. The mixture was applied onto 
the cells. After 24 h the cells were harvested and analyzed by flow cytometry.   
 
2.5.5  Gene expression profiling (Microarray)  
  ACSA-2+/GLAST-, ACSA-2+/GLAST+/- and ACSA-2-/GLAST+ cells were isolated as 
described in 2.2.10. Each sample group was composed of three to four samples. For each 
sample 50,000 cells were harvested. RNA was isolated with the RNeasy Mini Kit. Quality was 
anaylsed on the Agilent 2100 Bioanalyzer platform. The results were visualized as 
electropherogram and gel image. In addition, the RNA Integrity number (RIN) was calculated 
to check integrity and over all RNA quality. This value is calculated using a proprietary 
algorithm, which includes several quality control values, like 28S RNA/18S RNA peak area 
ratios and unexpected peaks in the 5S region. High RIN values (up to 10) indicate a high 
quality. Low RIN values (down to 1) indicate low RNA quality. For subsequent gene 
expression profiling experiments a RIN > 6 is sufficient 199. In this experiment RIN values 
were between 3.2 and 10. In the next step 50 ng total RNA was used for the linear T-7 based 
amplification step. For the production of Cy3-labeled RNA the samples were amplified and 
labeled according to the manufactuer’s protocol (Agilent Low Input Quick Amp Labeling Kit). 
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Dye-incorporation and yield of cRNA were measured on the NanoDrop. In the subsequent step 
600 ng Cy3-labeled fragmented cRNA were hybridized overnight (17h, 65°C) to Agilent 
Whole Mouse Genome Oligo Microarrays 8 x 60K (Agilent’s recommended hybridization 
chamber and oven). Following samples were processed with less Cy-3 labeled RNA:  
1 sample of ACSA-2-/GLAST+ with 470 ng, 1 sample ACSA-2-/GLAST+ with 570 ng and  
1 sample ACSA-2+/GLAST- with 510 ng. The microarrays were washed twice for one minute: 
First with the Agilent Gene Expression Wash Buffer 1 at RT and second with the Agilent Gene 
Expression Wash Buffer 2 at 37°C. The detection of hybridized Agilent Microarrays was 
accomplished using Agilent’s Microarray Scanner System. Analyses were performed using 
MetaCore. Visualization was done in MeV and Prism.  
 
2.5.5.1 Stategies to analyse gene expression profiling data (Microarray)  
 The raw expression data was pre-processed at the bioinformatics department at 
Miltenyi Biotec. Statistical properties were equalized by quantile normalization using an R tool. 
Normalization facilitates comparison between arrays. Data was transformed into log_2. 
Discriminatory genes analysis was performed testing ACSA-2+/GLAST-, ACSA-2+/GLAST+ 
and ACSA-2-/GLAST+ genes against each other by analysis of variants (ANOVA). For 
statistical analysis significance values were calculated using Tukey’s range test. For 
visulatisation heat maps were chosen.  
In subsequent analysis, p-values less than 0.05 (Tukey’s range test) were considered. In 
addition, only sample probes with one outlier or less, regarding signal intensity, were 
considered within the sample set of interest by the applicaton of Flags. Flags prevent usage of 
genes that are expressed around background level.  
In a following step, changes in fold change were included. Fold changes describe the change in 
the quantile normalization. It is simply calculated as ratio between raw value and final value. 
Fold changes or log_2 ratios are of value to measure changes in gene expression levels. The 
log_2 ratios are more stringent as the log_2 ratio of 2/-2 corresponds to a fold change of 4/-4. 
In subsequent pathway analysis, gene lists were used to identify bias towards biological 
processes or pathway. Probabilities of biological processes and pathways were calculated as  
p-values including multiple testing correction. Categories with p-values lower than 0.05 were 
considered.  
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3.  Results 
3.1 Identification of novel astrocyte cell surface markers by cell surface  
   marker screening   
  The major bottleneck for the isolation and characterization of astrocyte subpopulations 
is the limited amount of astrocyte cell surface markers. To overcome this problem, a panel of 
232 fluorochrome-coupled antibodies was tested to identify novel astrocyte specific cell 
surface markers. Flow cytometry and antibody panels are classical immunological tools 
commonly used to identify and study hematopoietic cells and their subpopulations 200. The 
majority of surface markers tested in this approach were annotated according to the 
nomenclature for clusters of differentiation (CD) 201. The surface marker screen was performed 
on single suspensions cells derived from whole mouse brain. These cells were obtained by a 
combined mechanical and enzymatic treatment as described before (2.2.2) 202. The proteolytic 
activity of both enzymes, papain and trypsin, can potentially harm cell surface epitopes. 
Therefore, markers tested negative in this screen were maybe false negatives due to enzyme 
sensitivity. In this screen, astrocytes were discriminated from non-astrocytes based on the 
expression of the astrocyte specific markers ACSA-2 and GLAST (ACSA-1). The screen was 
performed twice. In total 232 antibodies, including 150 CD annotated antibodies, were tested. 
All tested antibodies are listed in Appendix I. Markers with a frequency over 5% on astrocytes 
were further validated in re-screening experiments using whole mouse brain tissue and GLAST 
sorted astrocytes. In the first screening no novel astrocyte cell surface marker was identified. In 
a second screening approach the CellSurfaceMarker Panel Mouse (BD) was chosen. Marker 
expression in different brain regions was addressed by violet staining (CellTraceTM 
(Invitrogen)). CellTraceTM is internalized by viable cells and cleaved by cellular esterases. 
Based on different VioDye concentrations cells of forebrain, midbrain and cerebellum were 
discriminated (2.2.7). Each region was investigated for the co-expression of GLAST/ACSA-2 
with markers of the CellSurfaceMarker Panel. The data from this screen was visualized as heat 
map (Fig. 3.1 a). It represents the frequencies of all tested markers on GLAST and ACSA-2 
positive astrocytes in forebrain, midbrain and cerebellum. Markers were clustered by two-
dimensional hierarchical clustering using distance matrix of Pearson's correlation (Fig. 3.1). 
Markers with frequencies higher than 5% on GLAST or ACSA-2 positive astrocytes 
(regarding whole mouse brain tissue) were considered for subsequent re-screening (Fig. 3.1). 
Markers known to be commonly expressed by neural cells (CD90.2, CD81, CD9) were not 
rescreened.  
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Figure 3.1: Visualization of the cell surface marker screen as heat map.  
        Mouse brain tissue of forebrain, midbrain and cerebellum was dissociated and discriminated by  
         CellTraceTM labeling. Marker expression on astrocytes was determined by co-labeling with Anti- 
         ACSA-2 and Anti-GLAST (ACSA-1). Markers tested positive on ACSA-2/GLAST expressing  
        astrocytes of forebrain, midbrain and cerebellum were visualized as heat map (a). Markers  
        considered for re-screening are given in (b). Level of co-expression of a given markers on  
        GLAST and ACSA-2 positive astrocytes is indicated by color key: Green (0-40%), black  
        (41-60%) and red (61-100%). Hierarchical clustering using distance matrix of Pearson's  
        correlation was performed using MeV software.  
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  In the re-screening approach some markers could not be validated. These markers were 
removed from the marker list. In total, 10 markers were identified, which were further 
validated by individual re-screening approaches. The data from the rescreen on the flow 
cytometer (n=3) was also visualized by a heat map (Fig. 3.2 a). Hierarchical clustering grouped 
ACSA-2 and GLAST positive astrocytes of forebrain (F), midbrain (M) and cerebellum (C). 
This illustrated that GLAST positive astrocytes of a given brain region are closer related to 
ACSA-2 positive astrocytes in this brain region than to GLAST positive astrocytes of another 
brain region (Fig. 3.2 a). In addition, the relative expression of each marker on GLAST+ (1) 
and ACSA-2+ (2) astrocytes was compared, as calculated in 2.2.7. The relative expression 
frequencies of each marker were comparable between ACSA-2 and GLAST positive astrocytes 
(Fig. 3.2 b). Marker expression on astrocytes in forebrain (F), midbrain (M) and cerebellum 
(C) were additionally visualized as bar diagrams (Supplementary Fig. 1). As seen in heat map 
and bar diagrams (Fig. 3.2 and Supplementary Fig. 1), the integrin beta-1 (CD29), the integrin 
associated Protein (CD47), and the a membrane glycoprotein (CD200), were co-expressed on 
85 to 100% of GLAST and ACSA-2 positive astrocytes. In addition, CD29, CD47 and CD200 
were detected on neurons (data not shown) indicating that these markers are commonly 
expressed by neural cells. Part of the T cell receptor named as CD3e and the dipeptidyl 
peptidase-4 ((DPP4) CD26), presented very low frequencies on astrocytes (arround 5% or less). 
It is likely that this expression is background staining caused by unspecific binding of the 
antibody or an inappropriate titer. Basigin (CD147) and vascular cell adhesion protein 1 
((VCAM-1) CD106) presented a similar expression patter. Both markers showed highest 
expression in forebrain, lower expression in midbrain and weak expression in cerebellum  
(Fig. 3.2 a, Supplementary Fig. 1). CD147 expression on astrocytes is not well characterized 
whereas CD106 is described e.g. to be expressed on astrocyte endfeet in the SVZ 203. 
Interferon gamma receptor (CD119) and integrin α5 (CD49e) presented comparable 
frequencies in fore- and midbrain and were weaker expressed in the cerebellum. In contrast, 
the heat stable antigen (CD24) was expressed on 60% of cerebellar astrocytes and on 30-50% 
astrocytes from fore- and midbrain. In a further approach all 10 markers were tested on 
neuronal cells of the retina derived from P6 mice (Fig. 3.2 c). As in brain, the relative 
expression of each marker on GLAST and ACSA-2 positive astrocytes was calculated (2.2.7). 
In comparison to the tested brain samples CD49e (<5%), CD106 (<10%) and CD119 (<5%) 
showed a weak expression in the retina. Only CD24 (80-100%) and ACSA-2+/CD147+ cells 
(90%) showed a higher expression in the retina compared to brain samples.  
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Figure 3.2:  Re-screening of potential astrocyte subpopulation markers.  
       A surface marker screen was conducted to identify novel astrocyte subpopulation markers. Brain  
        tissue derived from forebrain, midbrain and cerebellum was dissociated and co-labeled with the  
        marker of interest and Anti-ACSA-2 and Anti-GLAST to discriminate marker co-expression on  
        astrocytes. 10 markers were identified using re-screenings. The level of co-expression is  
        indicated by color key: Green (0-40%), black (41-60%) and red (61-100%). Hierarchical  
        clustering using distance matrix of Pearson's correlation was performed using MeV software (a).  
        Relative expression frequency of the marker was calculated for brain tissue derived from  
        P4 mice (b) and retina samples  derived from P6 mice (c). Historgams show relative marker  
        expression ± SD (n=3). 
 
  In the next step, pure or PE coupled antibodies directed against the identified markers 
were used for immunohistochemistry (IHC) or Multidimensional in situ Cytometry Survey 
(MICS) analyses. Unfortunately, only antibodies against CD24 (clone: 194-4.3)	   and CD119 
could be used for IHC approaches. All other tested antibodies (2.2.7 Table 2) did not result in 
any staining. In addition, all PE coupled antibodies were tested by MICS on cultivated mixed 
mouse brain cells derived from P1 dissociated mouse brain. In the immunocytochemical (ICC) 
analysis most of the antibodies labeled different kind of neuronal cells, including astrocytes 
and neurons. Marker expression on astrocytes was validated by co-stainings with Anti-GLAST, 
Anti-GFAP and Anti-ACSA-2 specific antibodies. In the ICC, the antibody did either not 
result in any staining (CD49d, CD2) or the antibody recognized all astrocytes as indicated by 
co-labeling with the astrocyte specific antibody Anti-GLAST, as demonstrated for CD26 
(Supplementary Fig. 2 a-c) and CD119 (Supplementary Fig. 2 d-f). According to these results, 
significant differences seen in marker expression on the flow cytometer are considered being 
caused by enzymatic treatment in the dissociation step. Since the epitope is able to recover 
during cultivation, this could explain why tested markers were expressed by all GLAST 
expressing astrocytes when analyzed by ICC.  
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3.2 Generation of astrocyte subpopulation specific antibodies  
  by immunization 
 Astrocytes fulfill various tasks in different parts of the brain. Because of their 
ambiguous heterogeneity it is suggested that the astrocyte cell compartment is composed of 
different subpopulations 204,205. Some specific subpopulation markers such as Aquaporin-4 and 
Kir4.1 were already identified 95,96. For the identification and characterization of astrocyte 
subpopulations novel monoclonal antibodies directed against cell surface molecules would be 
of great benefit. To address this, one approach of this study aimed at the generation of novel 
antibodies directed against astrocyte subpopulations. In contrast to a ‘defined-target 
immunization’, which is conducted using transfectants and usually based on an optimized 
sequence of one single target gene, an ‘undefined-target immunization’ approach was 
performed using dissociated primary mouse brain tissue. The advantage to use primary cells is 
that the whole cell serves as immunogen. Thus, this strategy favors the generation of highly 
diverse antibodies. In this study, the production of monoclonal antibodies was induced by 
contralateral footpad immunization in rats (2.2.8) 206. Primary GLAST positive astrocytes 
obtained from postnatal mice by MACS (2.2.6) served as immunogen. Cells were enriched to 
high purity (Fig. 3.3 a) and coated with adjuvants (2.2.8) to increase the immunological 
potential. The immunogen was injected subcutaneously into the left hind footpad. Unspecific 
immune response of the target lymph node was prevented by administration of a decoy, a 
neuronal cell cocktail consisting of non-astrocytes, obtained by astrocyte depletion (Fig. 3.3 b). 
After fusion to Sp2/0 hybridoma cells, antibody-containing supernatant of each clone was 
screened on dissociated primary brain tissue derived from neonatal mouse brains. Within the 
screening approach, the specificity of the generated monoclonal antibodies towards astrocyte 
cell surface epitopes was tested using co-stainings with astrocyte markers (GLAST, ACSA-2). 
The majority of monoclonal antibody clones obtained in these approaches recognized either all 
astrocytes (Fig. 3.3 c) or did not reveal specific staining (Fig. 3.3 d). In total, the generation of 
subpopulation specific antibodies was performed four times. Unfortunately, no subpopulation 
specific antibody clones were obtained by immunization.   
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Figure 3.3: Generation of subpopulation specific antibodies by immunization.  
            Lewis rats were immunized by contralateral footpad immunization over a time period of 18  
        days. Pure astrocytes (> 95%) enriched by MACS (Anti-GLAST Biotin + Anti-Biotin  
        MicroBeads) served as immunogen (a). For the decoy fraction, astrocytes were depleted to high  
        purity (>95%) (b). Purities were determined on a flow cytometer. 0.5- 2 x 106 cells per fraction  
        were coated with adjuvants and injected subcutaneously. Clones did either recognize all  
        GLAST expressing astrocytes (27%) (c) or did not reveal specific staining (d).  
 
3.3 ACSA-2 - An astrocyte specific cell surface marker 
3.3.1 General expression profile of the ACSA-2 antigen   
 ACSA-2 antigen expression was partially investigated in collaboration with the group 
of Dr. Harold Cremer at the Institut de Biologie du Développement de Marseille (IBDM). The 
Anti-ACSA-2 antibody was titrated on adult mouse brain coronal sections of the cerebellum to 
determine the optimal titer. Bright specific staining in the Gcl of the cerebellum was observed 
at a concentration of 0.4 µg/mL. This concentration was used for all subsequent IHC 
experiments of adult mouse brain sections. Thereafter, the expression profile of the ACSA-2 
antigen was analyzed by single stainings of the Anti-ACSA-2 antibody on sagittal and coronal 
adult mouse brain sections. Brightest expression of ACSA-2 was observed in brainstem  
(Fig. 3.4 a), the glomeruli of the olfactory bulb (Fig. 3.4 b), the globus pallidus in the 
telencephalon (Fig. 3.4 c) and the Gcl of cerebellum (Fig. 3.4 d). Corpus callosum, cortex and 
SVZ presented weaker ACSA-2 expression. Very low ACSA-2 expression was detected in the 
white matter of the cerebellum and the dentate gyrus of the hippocampus (Table 3, Fig. 3.4 a). 
  
 
 
Figure 3.4: Expression profile of ACSA-2 in adult mouse brain sections.  
       Expression of ACSA-2 was investigated on coronal and sagittal sections. Intensity of ACSA-2  
        expression varies between brain regions, as illustrated in the sagittal mouse brain section (a).  
        Highest intensities of ACSA-2 expression were detected in the glomeruli of the olfactory bulb  
        (b), the globus pallidus (c) and the Gcl of the cerebellum (d). Scale bar represents 50 µm (b-d). 
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Table 3: Expression profile of ACSA-2 in adult mouse brain 
Brain area Expression level 
	  
Brain area Expression level 
Glomeruli (OB) ++ 
	  
Dorsal wall of the SVZ + 
Mitral cell layer (OB) + 
	  
Striatum + 
Inner plexiform layer (OB) + 
	  
Globus pallidus ++ 
Olfactory nerve layer (OB) + 
	  
Thalamus + 
RMS - 
	  
Granule cell layer (Cerebellum) ++ 
Cerebral hemispheres + 
	  
Molecular cell layer (Cerebellum) - 
Hippocampus (DG) - 
	  
White Matter (Cerebellum) - 
Hippocampus CA1/CA3 + 
	  
Pons ++ 
Corpus callosum + 
	  
Medulla ++ 
Lateral wall of the SVZ + 
	   	   	   
Legend: Staining intensities: - very low,  + low to moderate, ++ moderate to strong 
 
 
3.3.2 ACSA-2 expression on different neuronal cell populations  
 The Anti-ACSA-2 antibody resulted from a previous immunization of rats immunized 
with astrocytes isolated from GFAP-eGFP mice100. Anti-ACSA-2 recognizes a currently 
uncharacterized cell surface antigen. In the following approaches, the target of the antibody, 
the antigen expression profile and its specificity were investigated. The expression profile of 
ACSA-2 was validated by different approaches: IHC analysis of adult mouse brain sections (in 
co-operation with the IBDM in Marseille), ICC analysis of primary mouse brain cells, 
including MICS of cultivated and flow cytometry analysis of dissociated neonatal mouse brain 
samples. Using these techniques, the co-expression of ACSA-2 with common astrocyte 
markers (S100β, GFAP, GLAST), oligodendrocyte markers (NG2, MBP, CD140a, O4) and 
neuronal markers (MAP-2, calretinin, GAD67, PSA-NCAM) was investigated. In the first step, 
co-expression of ACSA-2 with astrocyte specific markers such as GFAP, the calcium binding 
protein S100β and the astrocyte cell surface marker GLAST was tested by IHC. Therefore, the 
co-expression with astrocyte specific markers was investigated in the corpus callosum of adult 
mouse brain coronal sections. The corpus callosum is a myelin rich area that is involved in 
interhemispheric communication.	  Although the corpus callosum harbors a high frequency of 
glia cells, it comprises a low frequency of astrocytes 207. This allows studying marker 
expression on single astrocytes. In the corpus callosum co-expression of ACSA-2 (Fig. 3.5 
b,e,h) with all three tested astrocyte markers (GFAP (Fig. 3.5 a), S100β (Fig. 3.5 d) and 
GLAST (Fig. 3.5 g)) could be demonstrated (Fig. 3.5 c,f,i). Co-expression of ACSA-2 (Fig. 
3.5 k) with GFAP (Fig. 3.5 j) was further confirmed by ICC on cultivated whole mouse brain 
tissue cell cultures using live cell staining (2.3.5) (Fig. 3.5 j-l). In a flow cytometric approach, 
co-expression of GLAST and ACSA-2 was investigated and revealed approximately 12% co-
expressing cells derived from P3 mouse brain (Fig. 3.5 m). ICC analysis performed by MICS 
 
 Results  
 
-42- 
showed that all GFAP+ cells expressed ACSA-2. In addition, ACSA-2+/GFAP- negative cells 
were detected (Fig. 3.5 p). Furthermore, all GLAST+ cells depicted ACSA-2 expression. 
However, GLASTbright/ACSA–2dim and ACSA-2bright/GLASTdim cells were also identified (Fig. 
3.5 s).   
 
           Figure 3.5:   
           ACSA-2 is co-expressed with  
           common astrocyte markers. 
            Co-expression of ACSA-2  
           with GFAP (a-c), S100β (d-f)  
           and GLAST (g-i) was  
           characterized by IHC in the  
           corpus callosum of adult  
           mouse brain coronal sections.  
           Co-expressed of ACSA-2 with  
           GFAP and S100β is indicated  
           by arrowheads. In addition, co- 
           expression with GFAP was  
           analyzed using live staining  
           (2.3.5) on cultivated primary  
           brain cells derived from  
           dissociated P1 mouse brain  
           tissue (j-l). Flow cytometric  
           analysis showed co- 
           expression of GLAST and  
         ACSA-2 (m). MICS revealed  
    co-expression of ACSA-2 with  
           GFAP and GLAST on  
          cultivated brain cells.  
          Differences in the expression 
          levels are indicated by  
          arrowheads (n-s).  
          Scale bars represent 5 µm (a-i)  
    and 20 µm (j-l). 
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  Next, the expression of ACSA-2 on oligodendrocyte precursors and mature 
oligodendrocytes was investigated. Oligodendrocyte progenitors were identified by the 
expression of proteoglycan NG2 208. The corpus callosum was tested, which is mainly 
composed of mature oligodendrocytes but also harbors some oligodendrocyte precursors. In 
general, the cell surface marker NG2 showed a weak expression in the adult mouse brain. But, 
some NG2 positive cells were detected in the corpus callosum. These cells were not labeled by 
the ACSA-2 antibody (Fig. 3.6 a-c). In addition, co-expression of ACSA-2 with the myelin 
basic protein (MBP), a protein expressed by mature oligodendrocytes 209, was investigated in 
the olfactory bulb. Here, MBP was predominantly expressed in the internal plexiform layer 
(ipl), in the Gcl and weakly expressed in the mitral cell layer (mi). None of these layers 
presented co-expression of MBP and ACSA-2 (Fig. 3.6 d-f). The same result was obtained by 
co-stainings of MBP and ACSA-2 on mixed mouse brain tissue cultures using live staining  
(Fig. 3.6 g-i). In an additional approach, the co-expression of O4 (Fig. 3.6 j) and ACSA-2 was 
tested by MICS (Fig. 3.6 j-l). The cultivated cells did not show any co-expression of O4 and 
ACSA-2. These results were further supported by flow cytometric data. Therefore, mouse 
brain tissue cells derived from P4 mice were co-labeled with Anti-ACSA-2 and 
oligodendrocyte specific cell surface markers (O4, CD140a). As shown in Figure 3.6 m,n, the 
oligodendrocyte precursor marker CD140a and the mature oligodendrocyte marker O4 were 
not co-expressed with ACSA2.  
 
 
  
Figure 3.6:   
ACSA-2 is not co-expressed 
with oligo-dendrocyte markers. 
Co-expression of ACSA-2 with 
oligodendrocyte specific 
markers was tested by IHC on 
adult mouse brain sections, by 
ICC on mixed brain tissue cells 
derived from P1 mice using live 
cell staining and MICS. Flow 
cytometry was performed with 
dissociated brain samples from 
P4 mice. ACSA-2 was not co-
localized with NG2 in the 
corpus callosum (a-c). ACSA-2 
was neither expressed on MBP 
positive oligo-dendrocytes in the 
corpus callosum (d-f) nor on 
MBP expressing cells in miced 
mouse brain tissue cultures 
derived from P3 mice (g-i). 
Scale bars represent 10 µm (a-c), 
20 µm (d-f), 73 µm (g-i). 
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Figure 3.6:   
ACSA-2 is not co-
expressed with oligo-
dendrocyte markers. 
ACSA-2 expression 
was further not 
identified on O4 
positive cells in 
cultivated mixed brain 
tissue samples derived 
from P1 brain tissue, as 
tested by MICS (2.6.4). 
Co-expression of 
ACSA-2 on CD140a 
and O4 positive oligo-
dendrocytes (j,k) was 
further excluded by 
flow cytomtric analysis. 
Abbreviations: internal 
plexiform layer (ipl)  
   
  
              mitral cell layer (mi) 
 
 
 In a further experiment the co-expression of ACSA-2 with neuronal markers was tested. 
To determine if ACSA-2 is expressed by interneurons of the olfactory bulb, calretinin, a 
calcium binding protein was chosen, which is expressed by interneurons in the periglomerular 
olfactory bulb 210. As depicted in Fig. 3.7 a-c, calretinin was not co-expressed with ACSA-2. 
Additionally, expression of microtubule-associated protein MAP-2, which is a neuronal marker 
expressed in the dendrites of postmitotic neurons, was tested 211. The co-expression of MAP-2 
(Fig. 3.7 d,g) with ACSA-2 (Fig. 3.7 e,h) was investigated in the glomeruli of the olfactory 
bulb by IHC on adult mouse brain sections and by ICC on cultivated mixed neuronal brain 
samples using live cell staining (2.3.5) (Fig. 3.7 g-i). Both methods did not reveal ACSA-2 
expression on MAP-2 positive neurons. Co-expression of ACSA-2 with the neuronal precursor 
marker PSA-NCAM was further tested by MICS. As shown in Figure 3.7 j-l, PSA-NCAM 
positive cells did not show ACSA-2 co-expression. On the single cell level, expression of 
ACSA-2 on GABAergic neurons and neuronal precursor cells was investigated by flow 
cytometry. Neuronal precursors were again discriminated by PSA-NCAM expression, as 
described before. Single cell suspensions were derived from P3 wt and P4 GAD67-eGFP 
transgenic mice. Both neuronal populations marked by GAD67-eGFP or PSA-NCAM did not 
present co-expression with ACSA-2 (Fig. 3.7 m,n). Thus, ACSA-2 is not expressed by neurons, 
neuronal subpopulations or neuronal precursors (Fig. 3.7). In addition, expression of ACSA-2 
on hematopoietic cells and microglia was investigated by flow cytometry and MICS 
(Supplementary Fig. 3). Co-expression of ACSA-2 with CD45, a marker of hematopoietic 
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cells and CD11b, a marker for microglia was below 1.5% and can be considered as 
background staining. Besides, MICS analysis did not show co-expression of ACSA-2 and 
CD11b (Supplementary Fig. 3). In summary, this data shows that ACSA-2 is exclusively 
expressed by astrocytes and not by neurons, oligodendrocytes and microglia. 
 
Figure 3.7:   
ACSA-2 is not expressed 
by neurons.  
Co-expression studies of 
Anti-ACSA-2 with 
different neuronal markers 
were performed using IHC, 
ICC and flow cytometry. 
Co-staining with the 
neuronal marker calretinin 
(a-c) and MAP-2 (d-i) did 
not reveal ACSA-2 
expression on neurons. 
The expression of ACSA-
2/MAP-2 was tested on 
cultivated brain cells by 
live cell staining (2.6.4). 
MICS experiments of 
ACSA-2 and PSA-NCAM 
were performed on 
cultivated mouse brain 
samples derived from P1 
brain tissue samples (j-l). 
Flow cytometric data of 
neonatal mouse brain 
tissue labeled with the 
Anti-ACSA-2 antibody, 
the neuronal progenitor 
marker PSA-NCAM and 
the GABAergic marker 
GAD67 (m,n) did not 
show ACSA-2 co-
expression on neuronal 
cells. Scale bar: 10 µm (a-
c), 5 µm (d-f), 20 µm (g-i) 
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3.3.3 Identification of the ACSA-2 antigen  
 Different approaches were followed to identify the antigen which is detected by the 
Anti-ACSA-2 antibody. The first goal was to identify ACSA-2 expression on a cell line, which 
could be expanded and used for the discovery of the epitope. However, none of the cell lines 
showed reproducible ACSA-2 expression (tested cell lines see 2.1.8). Therefore, the following 
approaches had to be conducted using mouse brain tissue cells as primary cell source. 
 
3.3.3.1 Identification of ACSA-2 antigen candidates by ligand receptor capturing  
  In one approach, the identification of the ACSA-2 antigen was performed by ligand 
receptor capturing (LRC) in co-operation with the group of Prof. Dr. Bernd Wollscheid at the 
ETH Zurich. The LRC is a mass-spectrometric approach for ligand-based identification of 
antigens 197. As no suitable cell line was identified, nitrogen frozen mouse brain sections 
obtained from P1 mice were used. Sections were cut on the vibratome, shock frozen in liquid 
nitrogen and analyzed in Zurich. The LRC revealed two different candidates for the ACSA-2 
antigen: GABA transporter-3 (GAT-3), with a molecular mass of around 70 kDa and Neural 
cell adhesion molecule (NrCAM), with a molecular mass of 131 kDa (Supplementary Fig. 4). 
Both markers were described being expressed by astrocytes. GAT-3 is expressed by  
astrocytes 231 and NrCAM is expressed by astroglioma 212. The expression profile of ACSA-2 
(3.3.1) was compared with the in situ hybridization pattern of both candidates (ALLEN 
BRAIN ALTAS 213). Based on these findings and literature, GAT-3 was the more promising 
candidate 214,215.   
 
3.3.3.2 Identification of the ACSA-2 epitope by Western Blot analyses and   
    immunoprecipitation  
Western blot analyses and immunoprecipitation were performed to verify the 
candidates obtained by LRC. In the first step, different cell lysis techniques were tested and 
validated by their signal intensity in Western Blot analysis. Western Blot analyses were 
performed with brain tissue lysates from early postnatal and adult brains. Mechanical cell 
disruption by ultra turrax and by gentleMACS was tested. Furthermore, different lysis buffers, 
with different ion concentrations and pH were tested (Table 4). Samples treated with the ultra 
turrax and RIPA buffer presented the strongest signal (a band around 40 kDa (Supplementary 
Fig. 5)). In the next step, reducing, non-reducing, denaturing and non-denaturing conditions 
were tested. Minor differences between the reducing and non-reducing, the denaturing and 
non-denaturing conditions were detected by Western Blotting. Afterwards, incubation time and 
temperature of the heating block were tested. Optimal condition were an incubation at 75°C for 
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8 min. For further analyses of the 40 kDa band an SDS Page was performed, the gel was 
stained with Coommassie and the 40 kDa band was cut out and analyzed by mass spectroscopy. 
The peptide identified by mass spectroscopy was α-Actin, an intermediate filament 
ubiquitously expressed in all cells. Accordingly, the Western Blot analysis could not address 
the epitope detected by the Anti-ACSA-2 antibody. To exclude technical problems, the same 
lysate sample was tested under the same conditions with an Anti-GAT-3 specific antibody. 
This positive control presented band at 70 kDa, which corresponds to the described mass of 
GAT-3. Therefore, technical problems could be excluded.   
The next step was the establishment of an immunoprecipitation protocol, as this technique is 
more stringent than a Western Blot experiment. Distinct immunoprecipitation protocols were 
tested (Table 4). First experiments were performed using a Protein G MicroBead Kit, as 
described in 2.4.3. In addition, lysing isolated ACSA-2 positive cells directly on a µ column 
was tested. Using these methods, peptides of 40 kDa, 55 kDa and 70 kDa were identified and 
analyzed by mass spectroscopy. However, only ubiquitiously expressed intracellular proteins 
(ATPases, intermediate filaments and heat shock proteins) were identified in the mass 
spectroscopy approach. In co-operation with Tobias Haas from the University of Rome, a 
protocol for the immunoprecipitation upon surface biotinylation was established for neural 
tissue samples. In this method, single suspension cells are biotinylated prior to cell lysis. This 
protocol enables the discrimination of surface molecules including sugars from intracellular 
molecules. The analysis was conducted by an Anti-Streptavidin HPR labeling step, which 
specifically detects biotinylated molecules. The protocol was tested with different chaotropic 
and bionic detergents (Triton-X-100, NP-40, Brij35, Tween20). In addition, different cell 
numbers were tested (0.5 x 106 – 1 x 108). Unfortunately, it was not possible to address the 
epitope of the ACSA-2 antibody by immunoprecipitation upon biotinylation. In summary, it 
was not possible to address the ACSA-2 antigen by Western Blot or immunprecipitation.  
 
Table 4: Tested conditions for Western Blot analysis and immunoprecipitation 
                            Western Blot analysis 
 
   Neonatal tissue Adult tissue 
Lysis buffer based on: Tris-HCl, TritonX100 x x 
 
Igepal, EDTA x x 
 
RIPA x x 
Tissue preparation methods: Ultra turrax x x 
 
Gentle MACS x x 
SDS-PAGE conditions Denaturing x x 
 
Non-denaturing x x 
 
Reducing x x 
 
Non-reducing x x 
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Secondary antibodies: Anti-rat HRP (stemgent) 
 
 
Anti-rat HRP (dianova) 
 
 
Anti-rat Fab HRP 
 
   
   Immunoprecipitation 
0.5 x 106 - 1 x 108 cells 
 
 Dissociated tissue Whole brain tissue  
 
 
Sorted astrocytes 
 Cell treatment Biotinylation 
 IP Upon surface biotinylation 
 
 
With sorted astrocytes 
 
 
Protein G Sepharose 
 
 
Protein G Microbeads 
 Detergents TritonX100 
 
 
Brij-35 
 
 
Tween20 
 
 
Np-40 
  
 
3.3.3.3 Transfection of Slc6a11 in HEK cells  
 Western Blot analysis and immunoprecipitation were not able to identify the ACSA-2 
antigen. Expression analyses of the ACSA-2 antigen (3.3.1) demonstrated a low expression of 
ACSA-2 in hippocampus and high expression in cerebellum and globus pallidus (Fig. 3.4 c). In 
addition, immunohistochemical stainings of ACSA-2 and GAT-3 revealed a high level on co-
expression as depicted by sagittal sections (Supplementary Fig. 6). Moreover, ICC on isolated 
astrocytes revealed co-expression of GAT-3 and ACSA-2 on astrocytes (Supplementary Fig. 7). 
To reveal if GAT-3 is the target of the Anti-ACSA-2 antibody, a DNA-plasmid encoding 
GAT-3 coupled to a GFP reporter was used (Slc6a11-GFP (Vector map see Supplementary Fig. 
8)). This DNA-plasmid was amplified in E-coli using standard protocols (2.8.1-2.8.3). The 
plasmid was transfected into 1881, CHO and HEK cells using a cationic lipopolyamine 
transfection reagent (MACSfectin) (2.5.2-2.5.4). None of the cell lines expressed ACSA-2 
prior to transfection. Best transfection efficiency was obtained in HEK cells with around 35% 
transfection efficiency (Supplementary Fig. 9). HEK cells were seeded at 60% confluence one 
day before transfection and transfected as described before (2.8.4). 50,000 cells were treated 
with 2 µg DNA-plasmid. For positive control, transfected HEK cells were fixed with 4% PFA 
24 h after transfection, permeabilized, stained against the intracellular domaine of GAT-3 
using an Anti-GAT-3 specific antibody and analyzed by microscopy. The transfected cells 
showed co-expression of reporter gene and Anti-GAT-3 antibody labeling (Fig. 3.8 a-d). 
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Samples stained with the Anti-ACSA-2 antibody did not present any co-staining on the 
transfected cells (Fig. 3.8 e-h). For flow cytometry, samples were harvested using 
Trypsin/EDTA. Cells were fixed, permeabilized for intracellular staining using fix and perm 
and stained with Anti-GAT-3 and Anti-ACSA-2. The flow cytometry data did neither show 
any ACSA-2 expression on transfected cells (Fig. 3.9 a) nor co-expression of ACSA-2 and 
GAT-3 (Fig. 3.9 c) was detected. In contrast, the transgene was recognized by the Anti-GAT-3 
antibody as demonstrated by intracellular staining (Fig. 3.9 b). From this data it can be 
concluded that Anti-ACSA-2 does not recognize GAT-3.  
 
              
 
Figure 3.8: Transfection of HEK cells with the Slc6a11 plasmid.   
      HEK cells were seeded at 60% confluence one day before transfection. Cells were fixed with 4%  
        PFA 24 h post transfection. The plasmid harbors a GFP reporter. Cells were stained with Anti- 
        ACSA-2 (1 µg/mL), Anti-GAT-3 (0.4 µg/mL) and Anti-Toto-3 for nuclei staining.  
        Analysis revealed co-expression of GFP with Anti-GAT-3 (a-d) but no co-expression of GFP  
        with Anti-ACSA-2 (e-h). Scale bar represents 50 µm.   
 
    
Figure 3.9: Transfection of HEK cells with the Slc6a11 plasmid.  
       HEK cells were seeded at 60% confluence and transfected with the DNA-Plasmid (Slc6a11)  
       24h later. Cells were fixed 24 h after transfection and stained against ACSA-2 (a), GAT-3 (b) and  
       a combination of both markers (c). Cells were analyzed by flow cytometry. The expression of the  
       reporter (GFP) was detected in the FITC channel.  
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3.3.3.4 Deglycolsylation assay  
 A deglycosylation assay was established to address whether the Anti-ACSA-2 antibody 
recognizes a glycosylation pattern on astrocytes. In the first test, whole mouse brain single cell 
suspension cells were used. Cells were incubated with a deglycosylation mix for 2, 4 and 6 h at 
37°C (2.5.5). Thereafter, cells were stained with the Anti-ACSA-2 antibody and the 
deglycosylation efficiency was measured by flow cytometry. No effect was seen after 2 h. 
After 6 h cells were dead as indicated by PI labeling. In correspondence to the protocol, the 
optimal incubation time to obtain a deglycosylation effect on astrocytes was 4 h. The mean 
fluorescence intensity (MFI) and also the cell number of viable ACSA-2 positive cells was 
moderately decreased after the deglycosylation treatment, whereas control samples presented a 
higher MFI (data not shown). For validation, the experiment was repeated by ICC on plated 
cells after 3 days in vitro. This treatment was performed under equal conditions, cells were 
treated with the enzyme mix for 4 h at 37°C. In this experiment, the deglycosylation reaction 
revealed a decrease in the signal intensity of the Anti-ACSA-2 labeling, which was measured 
by the decrease of the mean signal intensity as calculated using ImageJ (Fig. 3.10 a). In 
addition, immunocytochemical stainings revealed a strong decrease in the signal intensity of 
the Anti-ACSA-2 labeling in the presence of the deglycosylation enzyme (Fig. 3.10 c). As 
control, equal cell amouts were treated under buffer only conditions (Fig. 3.10 b). As positive 
control, wheat germ agglutinin (WGA) was chosen, which is an ubiquitiously expressed  
lectin 216. It selectively binds to N‐acetylglucosamine and N‐acetylneuraminic acid (sialic acid) 
residues 217. The WGA specific antibody revealed co-expression with the Anti-ACSA-2 
specific antibody (not shown). Upon deglycosylation, the signal intensity of the WGA labeling 
was decreased (Fig. 3.10 d,e). As negative controls, GFAP and CD81 were chosen. GFAP 
served as survival control of treated astrocytes and was not affected by the deglcyosylation 
treatment (Fig. 3.10 f,g). CD81 is a not post-transcripionally glycosylated and was therefore 
chosen as negative control 218. In this assay, the signal of the labeling of the CD81 antibody did 
not show an alteration in the signal intensity after deglycoslyation (Fig. 3.10 h,i). In conclusion, 
this data presents that the Anti-ACSA-2 antibody most likely recognizes a sugar moiety or a 
glycosylation related pattern on the astrocyte cell surface.  
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Figure 3.10: Addressing the ACSA-2 antigen by deglycosylation assay.  
        The deglycosylation assay was conducted on isolated ACSA-2 positive cells derived from P2  
         mice after 4 days in vitro. Deglycosylation has a significant effect on the signal intensity of the  
         Anti-ACSA-2 labeling, as measured by the decrease of the mean signal intensity (Calculated in  
         ImageJ) (a). ICC revealed a decreased in the signal intensity of the Anti- 
         ACSA-2 and the WGA labeling upon declycosylation (b-e). Labeling of Anti-GFAP and  
         the CD81 specific antibody were not affected by the treatment (f-i). Scale bar represents 10 µm. 
 
 
3.4 Comparison of GLAST and ACSA-2 expression  
3.4.1 Expression of GLAST and ACSA-2 in the embryonic mouse brain   
Approaches to generate and identify novel astrocyte subpopulation specific antibodies 
were performed to enlarge the antibody panel for the isolation and subsequent analyses of 
astrocyte subpopulations. Unfortunately, both approaches were not successful. Therefore, 
ACSA-2 and GLAST were used in a comprehensive analysis to analyse whether ACSA-2 and 
GLAST allow for the discrimination of astrocyte subpopulations. Distinct regions of central 
nervous tissue were tested at several developmental stages using different methods. In the first 
step, the expression of ACSA-2 and GLAST was analyzed on embryonic whole mouse brain 
tissue by flow cytometry. This study addressed whether ACSA-2 and GLAST reveal 
differences in the expression at embryonal age and allow for the disctimination of astrocyte 
subpopulations at this stage. As reported in literature, in mice, precursors differentiate into 
astrocytes around E14 219. To address this, the ACSA-2 and GLAST expression was analyzed 
on dissociated embryonic brain tissue samples derived from E12, E14, E16 and E18 mouse 
brains by flow cytometry (2.2.5.1). To address glial precursors, a co-staining with the cell 
surface ganglioside A2B5 was performed. Expression of A2B5 is upregulated during 
embryonic development 220,221. In this analysis, A2B5 was detected on E12 mouse brain tissue  
(Fig. 3.11 a,e) 222. In contrast, the frequencies of GLAST and ACSA-2 positive astrocytes 
detected between E12 and E16 were less than 5% (Fig. 3.11 b,c,e,f). Frequencies of GLAST+ 
and ACSA-2+ astrocytes increased rapidly around E18 (Fig. 3.11 d,h). In parallel, the co-
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expression of A2B5 with GLAST and ACSA-2 increased to 10% (Fig. 3.11 d,h). At late 
embryonic stage (E18) arround 10% GLAST+/A2B5+, ACSA-2+/A2B5+ double positive and 
approximately 5% GLAST+/A2B5-, ACSA-2+/A2B5- cells negative for A2B5 expression were 
detected (Fig. 3.11 d,h).  
 
Figure 3.11: Expression profile of GLAST, ACSA-2 and A2B5 in embryonic mouse brain.  
        Dissociated embryonic mouse brain tissue samples derived from different developmental stages  
         (E12/E14/E16/E18) were dissociated and analyzed by flow cytometry for GLAST, ACSA-2 and  
         A2B5 expression.  
 
  In the next step, frequencies of GLAST+/-/ACSA-2+/- cells were investigated at 
embryonic age. As seen in Figure 3.12, between E12 and E16 GLAST or ACSA-2 positive 
cells were not detected (< 5%). A population of around 10% GLAST+/ACSA-2+ cells was first 
detected at E18 (Fig. 3.12 d). Furthermore, approximately 6% ACSA-2+/GLAST- and  
4% ACSA-2-/GLAST+ cells were identified at E18 (Fig. 3.12 d). In summary, this approach 
shows that ACSA-2 and GLAST expression on embryonic mouse brain tissue was seen as 
early as E18. ACSA-2 and GLAST are co-expressed but minor frequencies of  
ACSA-2+/GLAST- and ACSA-2-/GLAST+ are detectable in the embryonic brain. 
 
        
Figure 3.12: Expression profile of GLAST and ACSA-2 in embryonic mouse brain.  
        Embryonic mouse brain tissue samples (E12/E14/E16/E18) were further investigated for their  
         co-expression profile of GLAST and ACSA-2. 
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3.4.2 Expression of GLAST and ACSA-2 in neonatal mouse brain tissue  
 In comparison to embryonic mouse brain, the percentage of astrocytes in postnatal 
(also referred as neonatal brain) and adult brain increased substantially. Therefore, the 
expression profile of GLAST and ACSA-2 was investigated at neonatal age. As depicted in 
Figure 3.13, a total frequency of 15% GLAST+ astrocytes was detected in postnatal mouse 
brain (P3). ACSA-2+ astrocytes revealed total frequencies of approximately 20% in P3 mouse 
brain samples. Although GLAST and ACSA-2 are co-expressed by the majority of astrocytes 
(11.94%) a low frequency of ACSA-2-/GLAST+ cells (3%) and a higher frequency of  
ACSA-2+/GLAST- cells (7,14%) was detectable. 
 
         Figure 3.13:   
         Expression of GLAST and ACSA-2 in   
              early postnatal mouse brain  
              Expression of GLAST and ACSA-2 was investigated by flow  
          cytometry using P3 mouse brain tissue. Minor frequencies of  
         single positive populations were seen although in the major  
         fraction both markers are co-expressed. 
 
 
 
 
 
 
 
Frequencies of ACSA-2-/GLAST+, ACSA-2+/GLAST+ and ACSA-2+/GLAST- were 
further addressed in an age-dependent manner. Therefore, whole brain tissue at developmental 
stages (between P1 and P7) was chosen. In biological replicates (n=3), frequencies of  
ACSA-2-/GLAST+ (Fig. 3.14 a), ACSA-2+/GLAST+ (Fig. 3.14 b) and ACSA-2+/GLAST-  
(Fig. 3.14 c) were analyzed. This analyses revealed differences between the three populations 
(Fig. 3.14). Thus, subsequent investigations aimed at the prospective characterization of the 
ACSA-2-/GLAST+ and the ACSA-2+/GLAST- cell subset, as differences in marker expression 
were considered to display astrocyte subpopulations.  
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Figure 3.14: Comparison of GLAST and ACSA-2 expression on whole mouse dissociated brain tissue.    
             Whole mouse brain tissue of P1, P3, P5 and P7 mice was dissociated and stained against  
        GLAST and ACSA-2. Frequencies of ACSA-2+/GLAST- (a), ACSA-2+/GLAST+ (b) and  
        GLAST+/ACSA-2- cells (c) were identified using flow cytometry (n=3). Shown are  
        frequencies ± SD. 
 
  To address the cellular origin of the single positive populations the expression profile 
of ACSA-2 and GLAST was investigated in different areas of the brain by flow cytometry and 
IHC. At first, the expression of GLAST and ACSA-2 in postnatal mouse brain tissue was 
analyzed between P1 and P7 on the single cell level by flow cytometry. Single cell suspensions 
of olfactory bulb, midbrain and diencephalon, cerebral hemispheres, hippocampus and 
cerebellum were analyzed. These regional expression profiles revealed characteristic 
expression patterns of GLAST and ACSA-2 for each brain region (Fig. 3.15 and 
Supplementary Fig. 10). Besides, the area specific analyses enabled for the identification of 
minor cell populations that are under-represented in the whole mouse brain (compare Fig. 3.14, 
Fig. 3.15). In the olfactory bulb a high percentage of ACSA-2+/GLAST- (20%) and a low 
percentage of ACSA-2-/GLAST+ (<5%) and ACSA-2+/GLAST+ cells (<8%) was identified 
(Fig. 3.15 Supplementary Fig. 10). For further analysis, ACSA-2+/GLAST- cells of the 
olfactory bulb were isolated, plated and stained against GLAST and ACSA-2. However, after 
isolation the plated cells were immunopositive for GLAST as analyzed by ICC (data not 
shown). This effect can be caused either by an application dependent sensitivity of the GLAST 
antibody, which is more sensitive in ICC and IHC than in flow cytometry, or by a slight 
trypsin sensitivity of the GLAST epitope. In comparison to the olfactory bulb, the frequency of 
GLAST+/ACSA-2+ cells was higher in the other tested brain regions between P1 and P7: In 
cerebral hemispheres the majority of astrocytes co-expressed both markers (11-25%).  
ACSA-2-/GLAST+ or ACSA-2+/GLAST- astrocytes were detected with frequencies less than 
7% at P7 (on average). In midbrain and hippocampus high frequencies of ACSA-2+/GLAST- 
(8-25%) and ACSA-2+/GLAST+ cells (7-18%) were detected. Frequencies of  
ACSA-2-/GLAST+ cells in midbrain and hippocampus were lower than 5%. In summary, 
ACSA-2-/GLAST+ presented low percentages (<5%) in cortical hemispheres, midbrain and 
hippocampus. In contrast, in cerebellum, a high frequency of ACSA-2-/GLAST+ cells was 
detected (2-8%). Based on these analyses the highest expression was detected at P1 (8%). 
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Figure 3.15: Expression of GLAST and ACSA-2 in distinct regions of neonatal mouse brain (P1-P7).  
          Tissue samples were dissociated, stained with GLAST and ACSA-2 specific antibodies and  
           analyzed by flow cytometry. Whole brain tissue and brain areas olfactory bulb, cortex,  
           hippocampus, midbrain/diencephalon and cerebellum were investigated at P1, P3, P5 and P7.  
           Frequencies of ACSA-2+/GLAST-, ACSA-2+/GLAST+ cells ACSA-2+/GLAST- cells were  
           analyzed by flow cytometry. Shown is one representative dot plot per age and region. 
 
 
3.4.3  Comparison of GLAST and ACSA-2 expression in olfactory bulb, RMS and 
cortical hemispheres 
Aim of this approach was to address the differences between GLAST and ACSA-2 
expression in the adult mouse brain by IHC, similar to those observed in neonatal brain. 
However, it was not possible to obtain a specific staining of the ACSA-2 antibody on neonatal 
brain tissue. Different treatments, increasing antibody concentration and decreasing PFA 
concentration could finally reveal a weak labeling of the ACSA-2 antibody in brain reagions, 
which show a high ACSA-2 expression (e.g. the cerebellum). Therefore, following analysis of 
GLAST and ACSA-2 expression were performed on adult mouse brain coronal sections. 
Immunohistochemical analysis of adult mouse brain sections revealed co-expression of 
GLAST and ACSA-2 in most areas of the adult brain. Co-expression of GLAST and ACSA-2 
in the corpus callosum was described earlier in chapter 3.3.2 (Fig. 3.5 g-i). As demonstrated in 
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Figure 3.16, co-expression between ACSA-2 and GLAST was detected in different cortical 
layers. GLAST expression was restricted to defined layers in the cortex, whereas ACSA-2 
presented a homogenous expression pattern in the cortex.   
 
 
Figure 3.16: Expression of GLAST and ACSA-2 in the cortex of adult mice brains.  
          Expression of GLAST and ACSA-2 in the cortex of adult mouse brain coronal sections.  
          Floating sections (40 µm) were stained with Anti-ACSA-2 (a) and Anti-GLAST (b). Not all  
          layers present ACSA-2/GLAST co-expression as shown by overlay and arrowheads (c).   
 
A difference in the expression pattern between GLAST and ACSA-2 was seen at lower 
magnification in the olfactory bulb (Fig. 3.17 a-c). As depicted, GLAST presented 
homogenous expression profile in all layers of the olfactory bulb (Fig. 3.17 b). Expression of 
ACSA-2 was predominant in the glomeruli of the olfactory bulb and weaker in the inner layers 
of the olfactory bulb (Fig. 3.17 a). Higher magnification images of the olfactory bulb revealed 
co-expression of both markers in the glomeruli of the olfactory bulb (Fig. 3.17 d-f). 
Differences in the expression pattern of GLAST and ACSA-2 were seen for the ‘tunneling 
astrocytes’ in the RMS (Fig. 3.17 g-i). As reported by Jungblut et al. GLAST is expressed on 
astrocytes in the RMS. In contrast to GLAST, ACSA-2 was weakly expressed on ‘tunneling 
astrocytes’ (Fig. 3.17 g (arrowheads)). In the olfactory bulb at the level of the rostral margin of 
the accessory olfactory bulb in the area of the anterior olfactory nucleus high expression of 
ACSA-2 and low expression of GLAST was detected (Fig. 3.17 g-i (*)).  
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Figure 3.17: Area specific expression pattern of ACSA-2 and GLAST.  
        Adult mouse brain coronal sections (40 µm) were stained as floating sections. Brain  
         sections revealed differences in the expression pattern between ACSA-2 and GLAST in the  
         olfactory bulb (a-c, d-f) and RMS (g-i). Arrowheads indicate strong GLAST expression in the  
         RMS. (*) indicates ACSA-2 expression in the anterior olfactory nucleus.   
         Scale bars: 500 µm, (a-c), 20 µm (d-i). 
 
Tunneling astrocytes are a specialized subtype of astrocytes, which serves as scaffold 
for migrating neuroblasts in the RMS. The interaction between astrocytes and neurons of the 
RMS is mediated by soluble molecules and by cell-cell contacts, mainly through interaction of 
receptors and ligands. Apart from their interaction with migrating neuroblasts and their 
migration supporting function, little is known about the properties of this specialized subset of 
astrocytes. The following experiment aimed at the characterization of ACSA-2 and GLAST 
expressing ‘tunneling astrocytes’ by flow cytometry. Therefore, RMS tissue was dissected 
from adult mice (10 weeks (n=3)) and analyzed on the single cell level using a flow cytometer  
(Fig. 3.18 a). For regional control striatal tissue was dissociated and stained in parallel (Fig. 
3.18 d). Migrating neuroblasts were detected by the expression of PSA-NCAM. As 
demonstrated in Figure 3.18 b, the frequency of migrating neuroblasts in the RMS tissue was 
13.10%. In contrast, PSA-NCAM positive cells were not detected in striatum (1% (Fig. 3.18 
e)). Frequencies of astrocytes in striatum and RMS were measured based on equal cell 
amounts. A high frequency of astrocytes was detected in the striatum with approx. 40%  
(Fig. 3.18 f). 14% of the cells were GLAST+/ACSA-2- and 27% GLAST-/ACSA-2+. Low 
percentages of astrocytes were detected in the area around the RMS (<5%) (Fig. 3.18 c). In 
contrast to the IHC data GLAST+/ACSA-2+ and also GLAST-/ACSA-2+ cells were detected by 
flow cytometry. According to the flow cytometric data the identification of GLAST+/ACSA-2- 
cells in the RMS could not be validated.  
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Figure 3.18: Flow cytometric analyses of astrocytes in the RMS and striatum.  
        RMS and Striatum were dissected from adult mouse brain, dissociated, stained and analyzed by  
         flow cytometry. Tissue samples from RMS (a) and striatum (b) were stained against GLAST  
         and ACSA-2. Migrating neuroblasts were discriminated by PSA-NCAM labeling (b,e).   
 
3.4.4 Comparison of GLAST and ACSA-2 expression in neurogenic regions of adult 
and neonatal mice 
A further question addressed in this work was whether GLAST and ACSA-2 allow for 
the identification and prospective isolation of neural stem cells. The dentate gyrus of the 
hippocampus is one neurogenic niche, which was already investigated in the neonatal mouse 
brain by flow cytometry. In the neonatal hippocampus high frequencies of GLAST+/ACSA-2+ 
cells was detected (3.4.2). In this study, the expression of GLAST and ACSA-2 in the 
hippocampus of the adult mouse brain was investigated by IHC. As known from literature, the 
dentate gyrus of the hippocampus is a glutamate rich area and reveals a high expression of the 
glutamate transporter GLAST 104. Interestingly, a very weak expression of ACSA-2 was 
detected in the hippocampus of adult mouse brain (Fig. 3.19 a). To further address these 
differences, the adult hippocampus was dissected and analyzed. Therefore, the dissociation 
protocol was optimized to obtain viable cells. However, it was not possible to obtain enough 
vital cells from this brain region to perform further analyses. 
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Figure 3.19: Expression of GLAST and ACSA-2 in adult hippocampus.   
          Coronal sections of adult mouse brain (40 µm) were stained as floating sections against  
          ACSA-2 (a) and GLAST (b). Very weak staining of ACSA-2 was detected in the hippocampus. 
          In contrast a high expression of GLAST was detected. Scale bar represents 20 µm. 
 
  One aim of current stem cell research is the identification of a cell surface marker that 
allows for the isolation of adult SVZ stem cells. However, the major problem is the 
identification of a marker, which is neither expressed by ependymal cells nor by surrounding 
astrocytes in the SVZ. For GLAST it was already shown that it is expressed by stem cells of 
the SVZ using in vivo electroporation and IHC 104. However, GLAST is further expressed by 
surrounding astrocytes in the lateral ventricle. Therefore, GLAST alone is not sufficient for the 
enrichment of SVZ derived stem cells. This approach addressed whether ACSA-2 is expressed 
by SVZ stem cells or by surrounding astrocytes in the SVZ. If ACSA-2 is not expressed by 
SVZ derived stem cells a combination of ACSA-2 and GLAST could be used to isolate SVZ 
stem cells. Therefore, the expression profile of ACSA-2 and GLAST was investigated in the 
dorsal and lateral wall and the dorsal horn of the SVZ on adult mouse brain coronal sections. 
The dorsal part of the SVZ adjoins the corpus callosum and the lateral wall adjoins the striatum 
(Fig. 3.20 a). The dorsal horn (Fig. 3.20 a-c) forms ventrally and dorsally and connects dorsal 
and lateral wall (Fig. 3.20 g-i). All stem cell areas presented a bright expression of GLAST 
(Fig. 3.20 b,e,h) and a comparatively weak expression of ACSA-2 (Fig. 3.20 a,d,g). The 
expression of ACSA-2 was weakest in the dorsal wall (Fig. 3.20 d) and brighter in the dorsal 
horn and the lateral wall (Fig. 3.20 a,g). In all stem cell regions of the SVZ the expression of 
ACSA-2 was brighter than in the surrounding tissue of striatum and corpus callosum  
(Fig. 3.20 a). In summary, the IHC analyses showed GLAST and ACSA-2 co-expression in all 
three compartments of the SVZ (Fig. 3.20 c,f,i).  
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Figure 3.20:   
ACSA-2/GLAST (ACSA-1) 
co-staining in the SVZ.   
Coronal sections of the adult 
mouse brain were stained as 
floating sections (40 µm). 
The SVZ was co-stained with 
ACSA-2 and GLAST 
(ACSA-1) specific antibodies. 
Marker expression was 
investigated on the dorsal 
horn (a-c), the dorsal wall (d-
f) and the lateral wall (g-i) of 
the SVZ. Scale bar represents 
10 µm. Abbreviations: CC: 
Corpus callosum, Str: 
Striatum. 
 
 
 
 
 
 
In a further step, the expression of ACSA-2 on electroporated neonatal tissue was 
investigated in collaboration with the IBDM in Marseille. In vivo electroporation of the dorsal 
and a lateral wall of the SVZ was performed with a GFP plasmid to efficiently target neural 
precursor (NPCs) in the SVZ 212. The animals were perfused on day one post electroporation 
(1dpe). At this time, the GFP-encoding plasmid is detectable in radial glia, the neural stem 
cells of the postnatal SVZ 195,223 (Fig. 3.21 b).	  The better staining of the ACSA-2 antibody was 
observed in the dorsally electroporated mice (Fig. 3.21 a). As described previously, ACSA-2 
presents a weak labeling in the neonatal tissue. Nevertheless, a weak co-expression of ACSA-2 
on the cell membrane and GFP staining in the cytoplasm could be detected in the dorsal horn 
at 1dpe (Fig. 3.21 c). This result supports that ACSA-2 is expressed by stem cells of the SVZ. 
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Figure 3.21: ACSA-2 expression on NPCs using in vivo electroporation.  
         P1 pups were electroporated dorsally using a GFP plasmid 195. The animals were perfused and  
         dissected one day after electroporation and cut as floating sections at 50 µm. The dorsal part of  
         the SVZ was investigated using coronal sections. Sections were stained with the astrocyte  
         specific antibody Anti-ACSA-2 and Anti-GFP. Scale bar represents 5 µm.  
 
  In a subsequent experiment, expression of GLAST and ACSA-2 in the lateral wall of 
the SVZ was analyzed by flow cytometry. Therefore, the lateral wall of the SVZ was dissected 
from coronal sections of early neonatal (P4,P5) and adult mice (6 weeks) (Fig. 3.22 a). SVZ 
tissue was dissociated and stained against GLAST, ACSA-2 and CD24. CD24 is reported to be 
strongly expressed by ependymal cells 68,75. However, lower expression of CD24 was also seen 
on neuroblasts 224. Considering that CD24 allows for the discrimination of ependymal cells, the 
antibody against CD24 was used in the following experiment to discriminate ependymal cells 
and astrocytes, including stem cells, by flow cytometry. In adult SVZ tissue (Fig. 3.22 b), 
CD24 was expressed on 50% of all viable cells. The flow cytometric data showed a low 
percentage of CD24+/GLAST+ (4%) and CD24+/ACSA-2+ cells (5%) (Fig. 3.22 b). A higher 
percentage of ACSA-2+ and GLAST+ did not show CD24 expression (15-23%). Therefore, 
CD24 can be used to discriminate ACSA-2+ and GLAST+ astrocytes from ependymal cells or 
neuroblasts. In a co-staining with the GLAST and the ACSA-2 specific antibodies it was 
addressed if the marker combination of GLAST and ACSA-2 can be used to discriminate 
subpopulations of SVZ astrocytes. The majority of adult SVZ astrocytes co-expressed ACSA-2 
and GLAST, as seen by co-stainings, Figure 3.22 e. The expression profile was further 
investigated on different mouse strains: BALB/c, C57BL/6 and CD1 (Fig. 3.22 c-e). This 
analyses revealed only minor differences in the expression profile between the selected mouse 
strains. Further analyses of SVZ derived astrocytes were performed using neonatal mice. At P5, 
the ependymal cell layer and the periventricular zone (PVZ) are tightly connected to each other. 
A distinct ependymal cell layer is not given, yet. Therefore, CD24+/
 
GLAST+ cells and 
CD24+/ACSA-2+ cells present higher co-expression compared to adult tissue (11-16%) (Fig. 
3.22 f). Moreover, in correspondence to the architecture of the PVZ the frequency of CD24
 
positive cells was higher at P5 compared to adult tissue samples. Nevertheless, at P5, GLAST 
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and ACSA-2 were co-expressed on the majority of PVZ derived astrocytes (11.6%)  
(Fig. 3.22 f).  
 
Figure 3.22:   
Expression of GLAST and ACSA-
2 on neonatal and adult SVZ tissue. 
The lateral wall of the SVZ (a) was 
dissociated and stained against 
ACSA-2, GLAST and CD24 on 
adult mice (b) and neonatal mice 
(P5) (f). The staining pattern of 
GLAST and ACSA-2 on adult mice 
was further investigated on BALB/c 
and C57BL/6 mice (c-e). 
 
 
 
 
 
 
 
 
 
 
 
 
In summary, the astrocyte markers GLAST and ACSA-2 were co-expressed by SVZ 
derived astrocytes. Therefore, it is not possible to discriminate stem cells of the SVZ by the 
expression of the cell surface markers ACSA-2 and GLAST neither in the neonatal nor in the 
adult SVZ. In addition to these analyses, several antibodies directed against ependymal cells 
and surrounding astrocytes of the SVZ were tested: S100β, Notch-1 and CD24 (Table 5). 
Furthermore, markers that were considered to discriminate stem cells, such as EGF receptor, 
CD106 and LGR5 (Table 5) were tested by IHC or flow cytometry. However, in this study, no 
suitable marker combination could be identified that allows for the prosective isolation of SVZ 
stem cells.  
 
Table 5: Markers tested on SVZ tissue  
Marker Expressed by Reference 
CD24 Ependymal cells CV Pfenninger et al.  ( 2011)  
Notch-1 Ependymal cells G Stump et al. ( 2002) 
S100ß Ependymal cells, SVZ astrocytes M Carlén et al. ( 2009)  
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α-tubulin Ependymal cells Vukojevic et al. 2014 
EGFR Stem cells of the SVZ  Y Suh et al.  2009 and others 
CD106 Stem cells - Endfeed NSC Kokovay et al. 2012 
LGR5 Stem cells Barker et al. 2007 
 
3.4.5 Comparison of GLAST and ACSA-2 expression in neural retina and spinal 
cord 
 The expression profile of the astrocyte cell surface markers GLAST and ACSA-2, 
which was carefully analyzed on different brain regions, was further analyzed in retina and 
spinal cord. Spinal cord was harvested from P6 mice. The retina is the inner layer of the eye, as 
demonstrated in Figure 3.23. It was harvested from P2 and P6 mice. All samples were 
dissociated (2.2.2.5/2.2.2.6) and labeled with the astrocyte specific antibodies Anti-GLAST 
and Anti-ACSA-2. Single cell suspensions were analyzed by flow cytometry (n=3). Expression 
of GLAST on retinal cells was demonstrated in previous studies 225,226. Expression of ACSA-2 
was not tested on neural retina before. In brain, frequencies of ACSA-2 expression varied 
between 5% and 30% depending on age and brain region. Expression of GLAST spaned from 
5% to 20%, also depending on the aforementioned parameters. In the retina of P2 and P6 mice 
ACSA-2 presented a frequency of 25-35% and GLAST expression accounted for 20-25% 
(n=6). Very interestingly, a high percentage of ACSA-2-/GLAST+ single positive cells was 
detected in P2 and P6 retina (Fig. 3.23 b,c). This expression pattern was comparable to ACSA-
2-/GLAST+ detected in neonatal cerebelli (11-14% (Fig. 3.15)). This can be explained as 
Müller glia of the retina and Bergmann glia of the cerebellum have been reported to be similar 
in morphology and phenotype 227. Results of this study indicate that neural cells of the retina 
and the cerebellum share similar marker expression of GLAST and ACSA-2 during 
development.  
 
 
Figure 3.23: Expression of GLAST and ACSA-2 in the retina.  
          Retinal tissue was harvested from the eyes (a) of P2 and P6 mice. A single cell suspension was  
          obtained by dissociation, cells were stained against GLAST and ACSA-2 (b). The frequencies  
          of ACSA-2-/GLAST+, ACSA-2+/GLAST-, ACSA-2+/GLAST+ (n=3) were measured and  
          visualized as bar diagrams (c). ACSA-2+/GLAST- and ACSA-2-/GLAST+ show a higher  
          frequency than ACSA-2+/GLAST+ cells. 
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  Next, spinal cord tissue derived from P6 mice was analyzed for the expression of 
ACSA-2 and GLAST. In comparison to neural retina and mouse brain regions the staining 
pattern of dissociated spinal cord did not present ACSA-2-/GLAST+ cells (< 1% (n=3)  
Fig. 3.24). Spinal cord tissue samples contained 5% ACSA-2+/GLAST+ cells. The majority 
(15%) was ACSA-2+/GLAST-. Like other brain regions tested before (compare Figure 3.15) 
and retina (Fig. 3.23) spinal cord tissue samples (Fig. 3.24) demonstrated a region dependent 
expression pattern of ACSA-2 and GLAST. 
Figure 3.24:   
Expression of GLAST and ACSA-2 on dissociated 
spinal cord tissue.  
Dissociated spinal cord samples derived from P6 
mice were analyzed by flow cytometry (a). Bar 
diagrams illustrate the frequencies of  
ACSA-2+/GLAST-, ACSA-2+/GLAST+ and  
ACSA-2-/GLAST+ cells (b) (n=3). 
 
 
 
3.5 Analysis of GLAST and ACSA-2 expression on reactive astrocytes 
  In this study genetic mouse models with a deficiency in the m-AAA protease of 
mitochondria were used to study GLAST and ACSA-2 expression on reactive astrocytes. 
Mitochondria’s major function is to support oxidative respiration. Point mutations in 
mitochondrial DNA lead to protein misfolding. These misfolded proteins cause defects in 
respiratory chain and lead to a variety of ageing related diseases, as for example 
neuromuscular or neurodegenerative diseases 228. Sections of Afg3l2PC–KO mice228 and  
Afg31l1 d/d Afg3l2 fl/fl GFAP cre+ as well as control animals were kindly provided by Eva 
Almajan (former PhD student in the group of Professor Rugarli at the university of cologne). 
Sections were stained against ACSA-2, GLAST and GFAP, which is highly expressed by 
reactive astrocytes. In section of wt animals low GFAP expression was detected in the Mcl and 
moderate expression was seen in the Gcl (Fig. 3.24 a). As demonstrated by MIP, GFAP was 
co-expressed with ACSA-2 in the Gcl of wt mice (Fig. 3.24 c). The Afg3l2PC–KO mice is a Cre 
inducible system under the L7 promotor that affects Purkinje cells. As reported by Almajan et 
al., in this mouse model secondary inflammation can be monitored by infiltration of microglia 
and astrocyte activation. In Afg3l2PC–KO mice the activation of reactive astrocytes was 
monitored by the upregulation of GFAP (Fig. 3.24 e). The expression of ACSA-2 was not 
altered in Afg3l2PC–KO mice (Fig. 3.24 d) and ACSA-2 was further not co-expressed with 
GFAP (Fig. 3.24 f). The Afg31l1 d/d Afg3l2 fl/fl GFAP cre+ system is an inducible cell line 
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under the human GFAP promoter. Therefore, the deletion directly addresses astrocytes and 
results in a strong activation of reactive astrocytes (unpublished observation of Eva Almajan). 
Upon tamoxifen application cre recombination is induced and leads to the deletion of Afg3l2 
in GFAP positive cells.   
 
                  
Figure 3.24: Staining of GLAST and ACSA-2 on wt and Afg3l2PC-KO mice.   
         Afg31l1 d/d Afg3l2 fl/fl GFAP cre- sections (wt) and Afg3l2PC-KO sections were kindly  
         provided by Prof. Rugarli. Sections were cut at 40 µm sagittal floating sections. Sections  
         of Afg31l1 d/d Afg3l2 fl/fl GFAP cre- mice (wt) serve as control for  
         Afg31l1 d/d Afg3l2 fl/fl GFAP cre+ (Fig. 3.25) and depict a bright expresssion of ACSA-2 in  
         the Gcl (a) and a moderate expression of GFAP (b). The Afg3l2PC-KO model harbors an  
         inducible form of the Cre recombinase under the L7 promoter. This system specifically  
          addresses Purkinje cells. Upon cre recombination this model reveals a loss of Purkinje cells and  
         in parallel leads to secondary inflammation indicated by the activation of astrocytes. This was  
         monitored by GFAP staining (e). In wt mice, the astrocyte cell surface markers ACSA-2 (d) and  
         GLAST (not shown) were not affected. Scale bar represents 20 µm. Abbreviations: granule cell  
         layer (Gcl), molecular cell layer (Mcl). 
 
Sections of the Afg31l1 d/d Afg3l2 fl/fl GFAP cre+ mice revealed stronger astrocyte 
activation (Fig. 3.25 d) in comparison to wt controls (Fig. 3.24 b) and Afg3l2PC-KO mice  
(Fig. 3.24 e). Besides, strong signal decrease of GLAST expression was detected in the Mcl. 
This is most likely caused by cell death of GLAST expressing astrocytes (Fig. 3.25 a,b). In 
comparison to wt mice, ACSA-2 expression was also decreased in mutant mice as seen for the 
cells in the Gcl (Fig. 3.25 c compared to Fig. 3.24 d). This study reveals that ACSA-2 and 
GFAP expression are not correlated on reactive astrocytes (Fig. 3.24 e). Therefore, ACSA-2 
might be a versatile for the discrimination and sorting of non-reactive astrocytes in a reactive 
or diseased mouse model.  
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Figure 3.25: Staining of GLAST and ACSA-2 on Afg31l1 d/d Afg3l2 fl/fl GFAP cre mice.  
         Sagittal floating sections (40 µm) of Afg31l1 d/d Afg3l2 fl/fl GFAP cre mice were kindly  
         provided by the Rugarli lab. This conditional model harbors an inducible form of the Cre  
         recombinase under the human GFAP promoter. This system specifically addresses astrocytes.  
         Upon cre recombination this model reveals a strong activation of astrocytes as monitored by  
         GFAP staining (d,e). In contrast to wt mice, GLAST (a,b) and ACSA-2 expression (c) were  
         rapidly decreased in the conditional knock-out. ACSA-2 was not co-expressed by GFAP  
         positive reactive astrocytes (e) which allow the usage of ACSA-2 for the discrimination of non- 
         reactive astrocytes. Scale bar represents 20 µm. Abbreviations: granule cell layer (Gcl),  
         molecular cell layer (Mcl). 
  
 
3.6 Analyses of GLAST and ACSA-2 in cerebellum 
3.6.1  Immunohistochemical analyses of GLAST and ACSA-2 in adult cerebellum  
  In the next approach, differences seen in cerebellum of neonatal mice were further 
addressed in the adult brain. Therefore, the expression of ACSA-2 and GLAST was 
investigated in the cerebellum using adult mouse brain sections. After maturation, the adult 
cerebellum comprises a distinct layer structure. The innermost layer is rich in myelin and 
called white matter (WM). GLAST and ACSA-2 were weakly expressed in this part of the 
cerebellum (data not shown). The white matter follows the Gcl, an area with a very high cell 
density composed of granule neurons and Gcl glia 229. The subsequent layer is composed of 
Purkinje cells and named Purkinje cell layer (Pcl). The Pcl separates the Gcl from the Mcl 104. 
Numerous dendrite arbors reside in this layer. GLAST is predominantly expressed in the Mcl 
and weaker in the Gcl (Fig. 3.26 a) 104. This results from distribution and local concentration of 
glutamate in the different cerebellar layers 230. The co-expression studies of GLAST and 
ACSA-2 demonstrated a different expression pattern for ACSA-2 in adult cerebellum	  	  
(Fig. 3.26 b). ACSA-2 presented a bright expression in the Gcl but in contrast to GLAST, 
ACSA-2 shows a weak expression in the Mcl. Nevertheless, co-expression of GLAST and 
ACSA-2 was detected in both layers (Fig. 3.26 c).  
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Figure 3.26: ACSA-2 and GLAST expression in the adult cerebellum   
         Expression of ACSA-2 and GLAST was investigated on adult mouse brain coronal sections  
         using IHC. Analysis revealed different expression pattern between ACSA-2 and GLAST in the  
         Mcl and the Gcl of the cerebellum. Scale bar: 100 µm. 
 
At higher magnification, the expression of GLAST and ACSA-2 in Mcl, Gcl and on 
Bergmann glia cells was investigated (Fig. 3.27 a-c). Thereby, co-staining of GLAST and 
ACSA-2 in the Gcl was demonstrated (Fig. 3.27 d-f). However, ACSA-2 was expressed on a 
broader population than GLAST (Fig. 3.27 d-f (indicated by arrowheads)). A high expression 
of GLAST was detected on Bergmann glia cells in the Mcl (Fig. 3.27 g). Purkinje cell nuclei 
were labeled using DRAQ5 antibody (Fig. 3.27 h). Bergmann glia cells project through the 
Mcl towards the pial surface. Their somata are located in the Pcl 231. Expression of ACSA-2 
was weak on Bergmann glia cell bodies, which are located around the Purkinje cells (Fig. 3.27 
h). Bergmann glia processes, which express GLAST, did not or weakly express ACSA-2  
(Fig. 3.27 h,i). This data supports that GLAST and expression level of ACSA-2 mark different 
populations of astrocytes in the cerebellum.  
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Figure 3.27:   
Expression of ACSA-2 
and GLAST in adult 
cerebellum. 
Expression of ACSA-2 and 
GLAST on Bergmann glia 
cells were investigated in 
the Gcl (1) and Pcl of the 
adult cerebellum (2) using 
coronal floating sections at 
40 µm. The expression of 
GLAST is very bright in 
the molecular cell layer 
(Mcl). Therefore, in this 
picture the bright signal of 
GLAST in the Mcl was 
decreased. Accordingly, 
GLAST expression in the 
Gcl appears very weak in 
this picture (a-c). ACSA-2 
was expressed on a broader 
cell population in the Gcl 
than GLAST (d-f (indicated 
by arrowheads)). GLAST 
presents a bright expression 
on Bergmann glia cells. 
Purkinje cell nuclei were 
labeled by DRAQ5. 
ACSA-2 was not expressed 
on Bergmann glia  
             processes (g-i (arrowheads).  
           Scale bar represents 5 µm  
           (d-i). Abbreviations:  
           granule cell layer (gcl), 
           molecular cell layer (Mcl). 
 
 
3.6.2  Immunohistochemical analyses of GLAST and ACSA-2 in the neonatal 
cerebellum  
  Flow cytometric analysis of GLAST and ACSA-2 in neonatal mice identified an 
ACSA-2-/GLAST+ population in the neonatal cerebellum (compare 3.4.2). The expression of 
ACSA-2-/GLAST+ was most prominent at P1 and decreased around P7 (compare Fig. 3.15). It 
is known that GLAST is expressed by radial glia during development and further expressed by 
radial glia in the developing cerebellum 48. This was demonstrated by co-stainings of Anti-
GLAST with the radial glia marker RC2 52,53 (Fig. 3.28). As the GLAST antibody detects a 
surface antigen and radial glia marker RC2 addresses an intracellular epitope the picture does 
not show a 100% overlap of the two markers (Fig. 3.28 c,f).  
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Figure 3.28: Expression profile of RC2 and GLAST in developing cerebellum.  
         Coronal floating sections (50 µm) derived from neonatal mouse brain cerebellum (P1, P5) were  
         analyzed for the expression of the cell surface marker GLAST and the intracellular marker RC2.  
         Radial processes co-express GLAST and ACSA-2. Scale bar represents 20 µm (a-f). 
 
Little is known about the origin of cerebellar glia and their precursors 169. Based on the 
expression profile (3.4.2) and differences in marker expression on Bermann glia (Fig. 3.27) the 
expression profile of ACSA-2 and GLAST was investigated in the developing cerebellum. The 
aim was to address whether GLAST and ACSA-2 mark different progenitors of the developing 
cerebellum. First, the expression pattern of GLAST and ACSA-2 was investigated in the 
cerebellum on coronal sections derived from early postnatal developmental stages P1 and P3 
(Fig. 3.29). At this age, foliation of the cerebellum, which lasts until adult stage, is still in 
progress. As mentioned previously, staining of the ACSA-2 antibody was in general weakly 
and revealed high background staining. On radial glia ACSA-2 was rather weakly expressed as 
compared to GLAST (Fig. 3.29). Nevertheless, co-expression of GLAST and ACSA-2 was 
seen at P1 and at P3 (Fig. 3.29 c,f).  
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Figure 3.29: Expression profile of ACSA-2 and GLAST in developing cerebellum.  
         Coronal brain sections derived from neonatal mouse brain cerebellum (P1, P3) were analyzed  
         for co-expression of ACSA-2 and GLAST. GLAST is very prominent on radial glia. Staining of  
         the ACSA-2 antibody was rather weak on neonatal tissue. Scale bars: 20 µm (a-c) 10 µm (d-f). 
 
 
3.6.3  Analyses of GLAST and ACSA-2 in embryonic and neonatal cerebellum by 
flow cytometry  
  GLAST and ACSA-2 expression on cerebellar precursors was further characterized 
during cerebellar development. For investigation, cerebellar samples from E12-P12 mice were 
collected and analyzed using flow cytometry (Fig. 3.30). At embryonic stage (E13, E15, E17) 
the cerebellar anlage, the lateral cerebellar primordium 144 the main cell source of the 
developing cerebellum 232, was dissected. As early as E19 the developing cerebellum spreads 
medially and is detectable as monolayer. Analyses at embryonic age revealed that ACSA-2 and 
GLAST expression are hardly detectable at E13 (Fig. 3.30 a). ACSA-2-/GLAST+ and  
ACSA-2+/GLAST+ cells were first detected around E15 (Fig. 3.30 b). Highest frequencies of 
ACSA-2+/GLAST- cells were detected at E17 (Fig. 3.30 c), whereas highest frequencies of 
GLAST+/ACSA-2- cells was visible around birth between E19 and P1 (Fig. 3.30 d,e). 
Postnatally the frequency of GLAST+/ACSA-2- cells decreased with the onset of development 
and was not detectable after P12 (Fig. 3.30 i). In samples of P12 and adult cerebellum (not 
shown) ACSA-2-/GLAST+ cells were not detected.  
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Figure 3.30: Expression of GLAST and ACSA-2 in embryonal and neonatal cerebellum  
         Tissue of E12-P12 cerebellum was dissociated, stained and analyzed by flow cytometry.  
         ACSA-2 and GLAST staining were assigned against each other and visualized as a dot plot.  
          The ACSA-2- /GLAST+ population is marked in red for better visualization. 50,000 cells are  
         depicted. 
 
In the following step, frequencies of A2B5, Prominin-1 and CD15 on  
ACSA-2+/GLAST-, ACSA-2+/GLAST+ and ACSA-2-/GLAST+ cells were determined using 
samples of P1/P2 and P6/P7 cerebelli (Fig. 3.31). A2B5 is a glial precursor marker expressed 
during development, as already described previously (Fig. 3.11). Prominin-1 is described as a 
stem cell marker for different regions of the murine brain including the cerebellum 179. CD15 
was recently described as an indicator for gliogenenic fate by Fleming et al. in 2013. A2B5 
expression was investigated on ACSA-2+/GLAST-, ACSA-2+/GLAST+ and ACSA-2-/GLAST+ 
cells using flow cytometry (Fig. 3.31). The expression of A2B5 in P1 cerebellar samples was 
significantly higher (p<0.05) in the ACSA-2+/GLAST+ compartment than in  
ACSA-2-/GLAST+ and ACSA-2+/GLAST- samples (Fig. 3.31 a). At P7 the frequency of A2B5 
positive astrocytes was reduced and differences between subsets were not significant. In 
addition, CD15 expression was analyzed. CD15 was significantly higher expressed (p<0.001) 
by ACSA-2+/GLAST+ cells of the P2 cerebellum than by ACSA-2-/GLAST+ and  
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ACSA-2+/GLAST- cells at the same age. The differences in CD15 expression were maintained 
until P6 (Fig. 3.3.1 b). However, Prominin-1 expression did not reveal significant differences 
between the sample sets (data not shown). These analyses indicate that ACSA-2+/GLAST-, 
ACSA-2+/GLAST+ and ACSA-2-/GLAST+ astrocyte potentially have different phenotypes. 
Taken from this anlysis, ACSA-2+/GLAST+ cells marker expression correlated with a glial cell 
fate.  
 
 
Figure 3.31: Co-expression of A2B5 and CD15 on ACSA-2+ and GLAST+ cerebellar astrocytes.   
         Cerebelli of P1/P2 and P6/7 mice were dissociated and stained against ACSA-2 and GLAST in  
         combination with A2B5 (a) and CD15 (b). Frequencies of ACSA-2+/GLAST-,  
         ACSA-2+/GLAST+ and ACSA-2-/GLAST+ cells are shown as bar diagrams. Significance levels  
         were determined by Student’s t test (*** p<0.001)(** p<0.01) (* p<0.05).  
 
 
3.6.4  Analyses of ACSA-2+/GLAST+/- and ACSA-2-/GLAST+ cells by neurosphere 
assay and cell transplantation  
  To address multipotent characteristics of ACSA-2+/GLAST+/- and ACSA-2-/GLAST+ 
cells a magnetic isolation protocol was developed. This step was needed to conduct single cell 
analyses such as gene expression profiling and Neurosphere assay. ACSA-2+/GLAST- cells 
were obtained through depletion of GLAST+ astrocytes, PSA-NCAM+ and L1CAM+ neurons, 
CD45+ and Ter119+ hematopoietic cells and subsequent ACSA-2 enrichment. Cells were 
obtained at purities of around 60% (n=5). Unfortunately, very low cell counts were obtained 
using this strategy. For this reason, further analyses were performed with ACSA-2+/GLAST+/- 
cells, which were directly isolated using Anti-ACSA-2 MicroBeads. This population is 
composed of ACSA-2+/GLAST- and ACSA-2+/GLAST+ cells and could be enriched to high 
purities (85%- 95% (n=15)). Additionally, higher cell numbers could be obtained using this 
ACSA-2 enrichment protocol. Isolation of ACSA-2-/GLAST+ was performed by depletion of 
ACSA-2+ astrocytes, PSA-NCAM+ and L1CAM+ neurons, CD45+ and Ter119+ hematopoietic 
cells and a subsequent enrichment step of GLAST positive cells. A purity of 70-85% was 
obtained when P0-P2 cerebelli were used (Isolation of ACSA-2+/GLAST-, ACSA-2+/GLAST+/-,  
ACSA-2-/GLAST+: Supplementary Fig. 11). In general it was possible to isolate  
 
 Results  
 
-73- 
ACSA-2+/GLAST- from P0 to P9 cerebelli. Starting frequencies of ACSA-2+/GLAST- 
decreased from 10% (P0) to 3% (P7 (Fig. 3.30). However, at P9 very low cell numbers were 
obtained and the purity decreased to 50%. Nevertheless, it was possible to plate and analyse 
these cells by ICC. Cells of original (before separation), negative (non-target cells) and 
positive (target cells) fraction were plated at equal cell numbers and analyzed for BLBP and 
GLAST co-expression (Supplementary Fig. 12). Despite low purities in the target fraction it 
was possible to obtain a 3-fold enrichment for ACSA-2-/GLAST+ cells from P9 cerebelli 
(Supplementary Fig. 12). Furthermore, ACSA-2-/GLAST+ isolated cells presented RC2 
expression as analyzed by ICC (Fig. 3.32).   
 
 
Figure 3.32: Immunocytochemistry of isolated ACSA-2-/GLAST+ cells from P9 cerebelli.  
        Cerebelli of P9 mice were dissociated and plated on poly-L-lysine coated cover slips. After  
         5 days in complete medium cells were fixed and permeabilized for intracellular stainings. Co- 
         labeling of GLAST and RCs was seen on the isolated cells as monitored by confocal  
         microscopy.    
     
  Co-expression of GLAST and RC2 suggested that it is possible to enrich  
ACSA-2-/GLAST+ progenitor cells with a radial glia phenotype using the above mentioned 
isolation protocol. A neurosphere assay was established to address the multipotency of  
ACSA-2-/GLAST+ and ACSA-2+/GLAST- cells. At a cell denity of 1,000 cells per µL isolated 
ACSA-2-/GLAST+ cells and ACSA-2+/GLAST+/- cells were treated as described in 2.2.3.3. The 
principle of the neuroshere assay is to obtain multipotent self-replicating stem cells in culture 
and lose non-replicating cells through several passaging steps. It was possible to obtain 
secondary neurospheres from ACSA-2-/GLAST+ cells and ACSA-2+/GLAST+/- cells. Tertiary 
neurospheres could not be obtained although tested several times (n=5). Based on the sphere 
diameter ACSA-2-/GLAST+ cells formed larger neurospheres than ACSA-2+/GLAST+/- 
(Supplementary Fig. 13 a,b). However, upon plating and differentiation, neurospheres of both 
cell populations were able to differentiate into astrocyte and neurons (Supplementary Fig. 13 c). 
In addition, few oligodendrocytes were obtained after a 6 day differentiation step (data not 
shown). As the differentiation potentials of the cell populations could not be addressed by 
neurosphere assay a transplantation experiment was performed. Thereby, the differentiation 
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potential of ACSA-2+/GLAST+/- and ACSA-2-/GLAST+ cells was compared and analyzed in 
an in vivo setting. This experiment was conducted at the Neuroscienze Institute Cavalieri 
Ottolenghi in Turin in collaboration with the group of Dr. Annalisa Buffo. Target cells were 
isolated from β-actin GFP positive mice and the cerebelli of P0 to P3 donors were dissected 
(2.2.10). 50,000 cells per fraction of each fraction were injected into the lateral part of the 
vermis of recipient mice, as depicted in Figure 3.35 a. Grafted mice were dissected after  
30 days. The brains were cut into sagittal sections at 40 µm. The integration capacity, the 
localization and the differentiation potential of the grafted populations were analyzed. 
Integrated cells were discriminated as neurons or glia based on morphology and marker 
expression. Parvalbumin was used as marker for GABAergic interneurons (Fig. 3.33 c,d,g,h). 
Astrocytes were discriminated by S100β or GFAP (Fig. 3.33 b,f, 3.34 b,g,k). For 
discrimination of oligodendrocytes O4 and transcription factor Olig2 were used (Fig. 3.34 f,j). 
For each host a representative amount of tissue sections (15-25) was analyzed and integrated 
cells were counted. ACSA-2-/GLAST+ transplants were able to differentiate into neuronal cells 
(45%) and glia cells (55%) (Fig. 3.35 b). Grafts presented integration of different GABAergic 
interneurons: stellate cells and basket cells. In addition, Bergmann glia, glia cells of the Gcl, 
the Mcl and the white matter were identified (Fig. 3.35 c). In ACSA-2+/GLAST+/- grafts less 
than 2.5% neuronal cells were found (Fig. 3.35 b). This compartment differentiated 
preferentially into glia (Fig. 3.35 b).  
 
Figure 3.33: Cell types identified in the transplants.  
         Host animals were perfused after 30 days, brains were cut as sagittal cryo sections at 40 µm and  
         analyzed by IHC. Integrated cells were analyzed by cell morphology and marker co- 
         expression. Transplanted cells were GFP positive. Co-expression of parvalbumin and the  
         absence of GFAP) identified interneurons (Basket or Stellate cells). Scale bar represents 10 µm. 
        Abbreviations: Mcl: Molecular cell layer.   
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Figure 3.34: Cell types identified in the transplanted animals. 
         Host animals were perfused after 30 days, brains were cut as sagittal cryo sections at 40 µm and  
         analyzed by IHC. Integrated cells were analyzed by cell morphology and marker co- 
         expression. Transplanted cells were GFP positive. The co-expression of GFAP and S100ß  
         identified astrocytes (a-h). Bergmann glia cells were further classified by cell morphology (a-d)  
         and oligodendrocytes by the expression of transcription factor Olig2 (i-l). Scale bar: 10 µm.  
         Abbreviations: Gcl: Granule cell layer, Mcl: Molecular cell layer. 
 
 
Figure 3.35: Cell transplantation of ACSA-2+/GLAST+/- and ACSA-2-/GLAST+ cells.  
          ACSA-2+/GLAST+/- and ACSA-2-/GLAST+ cells of P0 to P3 were isolated from β-actin GFP  
         positive cerebelli. 50,000 cells were injected into P1 and P3 hosts. Injection was performed  
         into both sides of the lateral part of the vermis (a). Cells were classified as neurons or glia by  
         morphology and marker expression as depicted as stacked bar plots (b). Transplanted cells were 
         able to differentiate into stellate and basket cells, Bergmann glia and glia cells of the Gcl, Mcl  
         and WM.    
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ACSA-2-/GLAST+ transplants presented a significantly higher frequency of stellate 
cells and basket cells (Fig. 3.36 a,b). Additionally, it was shown that stellate cells and basket 
cells integrated significantly better in a P1 hosts than in a P3 hosts (Supplementary Fig. 15). 
Furthermore, Bergmann glia were exclusively identified in the ACSA-2-/GLAST+ grafts  
(Fig. 3.36 c). On the other side, Gcl glia cells were significantly higher in ACSA-2+/GLAST+/- 
grafts compared to ACSA-2-/GLAST+ transplants. For ACSA-2+/GLAST+/- cells a slightly 
higher integration potential was observed in P3 hosts (Supplementary Fig. 14). 
 
 
Figure 3.36: Differentiation potential of transplanted cells.  
        ACSA-2+/GLAST+/- and ACSA-2-/GLAST+ cells of P0 to P3 were isolated from β-actin GFP  
         positive cerebelli. Integration as determined on a representative amount of tissue sections (15- 
         25) of each host. Integrated cells of each group were classified according to cell morphology  
         and marker expression as stellate cells (a), basket cells (b), Bergmann glia (c), Glia of the Gcl,  
         Mcl and WM. Significance levels were determined by Student’s t test (*** p<0.001) 
         (** p<0.01) (* p<0.05). 
 
 
In a further validation step, frequencies of oligodendrocytes and astrocytes in Gcl, Mcl 
and WM were determined. For ACSA-2+/GLAST+/- and ACSA-2-/GLAST+ grafts the majority 
of the integrated glia cells were astrocytes as analyzed by GFAP and Olig2 staining 
(Supplementary Fig. 15). 
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3.6.5 Analyses of GLAST and ACSA-2 astrocytes of the neonatal cerebellum by 
gene expression profiling 
 Gene expression profiling of ACSA-2 and GLAST positive astrocytes of the neonatal 
cerebellum was performed to investigate the transcriptome of the identified subpopulations. 
Therefore, ACSA-2+/GLAST-, ACSA-2+/GLAST+/- and ACSA-2-/GLAST+ cells were isolated 
based on the established protocols by magnetic cell separation (Supplementary Fig. 11). The 
purities between the biological triplicates were comparable as analyzed by marker co-stainings. 
ACSA-2+/GLAST- cells were enriched to 70% (± 5%), ACSA-2+/GLAST+/- to 87% (± 7%) 
and ACSA-2-/GLAST+ cells to 75% (± 5%). The cDNA microarray was processed as described 
in chapter 2.5.5. In the first step, the gene expression profile over all genes was investigated for 
all sample groups. In an unsupervised hierarchical clustering the gene expression of each group 
was compared with the gene expression of another group using correlation matrix (Fig. 3.37). 
This analysis was chosen to quantify the similarity between the three populations of the 
cerebellum. In the correlation matrix, low gene expression levels are indicated by black color 
and high gene expression levels is indicated by red color. As seen in Figure 3.37 gene 
expression levels were similar between sample groups. In addition, the pairwise distance 
analysis revealed that ACSA-2+/GLAST+ samples presented an intermediate group between 
ACSA-2+/GLAST- and ACSA-2-/GLAST+ samples. However, ACSA-2+/GLAST+ samples 
were closer related to ACSA-2+/GLAST- samples than to ACSA-2-/GLAST+ as shown in 
Figure 3.37. 
 
Figure 3.37:  
Sample clustering.  
In the first step, the unprocessed data set 
was clustered according to the samples 
groups. This clustering was visualized 
using MeV. Correlation coefficients are 
indicated by their color from black (0) to 
red (1.0). Replicates for each sample 
group clustered together, indicating a 
specific expression profile within one 
group. Sample labeling according to 
Supplementary Fig. 12. 
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  As mentioned before, ACSA-2+/GLAST- cells contribute to the ACSA-2+/GLAST+/- 
sample set. Therefore, in subsequent analysis the ACSA-2+/GLAST- sample set and the 
ACSA-2+/GLAST- sample set were compaired against each other to identify the highest 
discriminatory regulated genes. The total number of genes addressed by the microarray were 
55681. As visualized by a Volcano plot the data set was reduced to 91 candidates 
overexpressed in the ACSA-2-/GLAST+ group and 380 candidates overexpressed in the 
ACSA-2+/GLAST- using stringent filtering ((Fig. 3.38 a) Gene lists are given in AppendixII).  
 
Figure 3.38: Volcano plot of preselected genes.  
         The Volcano plot is a tool to visualize fold change and p-values of genes as scatter plot. 
         In total 5581 genes were addressed by the array (a). Normalized gene samples with a p-value  
         less than 0.05 (Tukey’s range test) and less than one outlier per sample group are shown in b.  
         By furtherprocessing the data set was grouped into genes with a fold change of 2/-2 and 4/-4  
         corresponding to a log_2 ratio of 2/-2 (b,c). Genes with log_2 ratios of 2/-2 were considered in  
         subsequent analysis All Volcano plots were generated in Prism.  
 
  In subsequent steps both gene lists were used to identify bias towards biological 
processes and pathways (Table 6). Genes were categorized to gene ontology families by their 
gene identifier. However, gene ontology listing is not redundant and genes can therefore be 
categorized into different gene ontology families. Functional classes such as ‘receptor 
signaling’, ‘cellular import and export’ as well as ‘intracellular trafficking’ and ‘proliferation’ 
were significantly upregulated in the ACSA-2+/GLAST- sample sets and were not identified in 
the ACSA-2-/GLAST+ samples (Table 6). The ‘receptor signaling’ cluster comprised several 
solute carrier transporter which are important for the uptake of biologically active compounds 
and metabolites 233. This suggests that ACSA-2+/GLAST- cells already acquired a certain 
function and show less plasticity. Families such as ‘development’, ‘cell 
differentiation/migration’ or ‘extracellular matrix proteins’ were found in both gene groups. 
However, single genes were never identified in both sample groups as shown by Venn 
diagrams.  
 
 Results  
 
-79- 
 
Table 6: Pathway families 
 
 
  In the ACSA-2-/GLAST+ sample set CXCR4, which was shown to control migration 
of the cerebellar development at embryonic stage was identified 233. Besides, different genes of 
the Wnt pathway such as Frizzled-1 or Wif1 but also fgf8 were identified (Fig. 3.39). Fgf8 is 
important for the development of the cerebellum 234. The members of the Wnt family are also 
important for development but furthermore for the regulation of cell fate and proliferation as 
well as for migration 235. In addition, members of the sonic hedgehog family including Gli1 the 
hedgehog interacting protein (hhip) and patched homologue 2 (Ptch2) were significantly 
upregulated. Also Hes5, reflecting Notch signaling activity in the progenitor pool was 
identified 236. However, Hes5 was rather weak expressed in 2 from 3 samples of the  
ACSA-2-/GLAST+ sample set. All three pathways, SHH, Wnt and Notch are described to 
influence cell fate specification 237. The enrichment of these genes suggests that ACSA-2-
/GLAST+ are at an early developmental state. To address this further, stem cell factors such as 
Nestin (Nes) 70 were investigated and revealed to be significantly upregulated in the  
ACSA-2-/GLAST+ sample set. In addition, upregulation of the Lgr5 gene was detected. The 
Lgr5 protein is reported to be expressed by distinct stem or progenitor cells in various  
tissues 238,239. Common stem cell factors known to be expressed by embryonic stem cells (Klf-
4, Nanog, Sox-2 240) were suppressed in the ACSA-2-/GLAST+ samples. This indicates that 
ACSA-2-/GLAST+ are restricted stem cells. 
The sample set was further investigated for the expression of Parvalbumin, a marker for 
interneurons, 241 which was seen to be expressed by the ACSA-2-/GLAST+ transplants, as 
shown in chapter 3.6.4. In correlation to the transplantation experiment the expression of Pvlb 
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was significantly upregulated in the ACSA-2-/GLAST+ sample set. In addition, pancreas 
transcription factor 1 subunit alpha (Ptf1a), which is specifically expressed on VZ derived cells 
and important for the generation of interneurons was upregulated on ACSA-2-/GLAST+  
cells 242. Furthermore, Ascl1 (Mash1), which is predominat expressed by cells of the 
prospective white matter cells was upregulated in the ACSA-2-/GLAST+ sample set 243  
(Fig. 3.39 b). As reported by Leto et al. prospective white matter cells compose a defined 
neurogenic niche in the cerebellum 244. In contrast, the ACSA-2-/GLAST+ sample set did not 
show an enrichment for serotonergic or domaminergic neurons marked by Nk2-2, PTEN, or 
OTX-2, Lmx1a 240,245 (Fig. 3.39 c). Furthermore, the GAD1 gene encoding the GAD67 
transporter and doublecortin (Dcx) a microtubule-associated protein expressed by interneurons 
of the SVZ/RMS were suppressed in the ACSA-2-/GLAST+ sample set. This indicates that 
ACSA-2-/GLAST+ cells are primed to differentiate into GABAergic interneurons. The 
oligodendrocyte specific gene Mbp was further identified and differentiation into 
oligodendrocytes was seen in the transplantation experiment (Supplementary Fig. 15). In 
addition, the glial marker Tenascin C, which is reported to be expressed by radial glia and 
Bergmann glia of the cerebellum was enriched in the ACSA-2-/GLAST+ sample set 246. GFAP 
was weak expressed in the ACSA-2-/GLAST+ sample set. In summary, this analysis indicates 
that a specification of t he ACSA-2-/GLAST+ cells towards a GABAergic cell type as well as 
to a glia cell type is favoured. Based on the transplantation experiment and the gene expression 
profiling it is likely that prospectic white matter cells can be characterized by the absence of 
ACSA-2 expression and the prescence of GLAST expression.  
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Figure 3.39: Clustering of genes upregulated in the ACSA-2-/GLAST+ sample set.  
Data set was preprocessed using quantil normalization. Samples were compared using  
ANOVA. Samples with a p-value less than 0.05 (Tukey’s range test), less than one outlier 
per sample group, a log_2 ratio of (2/-2) were considered for this analyses. Samples of 
ACSA-2+/GLAST- (A+/G-), ACSA-2+ /GLAST+ (A+/G+), ACSA-2-/GLAST+ (A-/G+) were 
visualized using MeV. Correlation co-efficients are indicated by their color from blue (-6) 
to yellow (+3) (a). Data was further illustrated as bar diagrams. Triplicates of normalized 
log_2 intensities are indicated as Mean ± SD (b). 
 
  In the ACSA-2+/GLAST- sample set several genes of extracellular matrix epitopes such 
as Gjb2, Gjb6, Gja1 encoding connexin 26, 30 and 43 were found. All of these hemichannels 
are reported to be only expressed by astrocytes 247. Besides, tetraspanin (CD82) and vitronectin 
(VTN) that promote cell adhesion were identified in the ACSA-2+/GLAST- sample set (Fig. 
3.40). Furthermore, genes of the slit family, which interact with ligands expressed by neurons, 
were upregulated in the ACSA-2+/GLAST- samples. These genes were Slit1 and Slitrk1. 
Besides, the gene of the astrocyte specific markers glial fibrillary acidic protein (GFAP) 
(Supplementary Figure 16) and VCAM-1 (CD106) as well as the oligodendrocyte specific 
basic-loop-helix transcription factors Olig1 and Olig2 were upregulated in the ACSA-
2+/GLAST- samples (Fig. 3.40). In contrast, the neuronal gene Ptf1a was not expressed and 
Nestin was suppressed in the ACSA-2+/GLAST- sample set (compare Fig. 3.39). As shown in 
Table 6, genes coding for different receptors were enriched in the ACSA-2+/GLAST- data set. 
Out of these genes five genes of the solute carrier transporter family (Slc family) were 
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enriched in the ACSA-2+/GLAST- samples: Slc32a1 a vesicular inhibitory amino acid 
transporter, Slc6a11 encoding GAT-3, and the Slc6a12 a neurotransmitter transporter Slc6a12 
and Slc6a13, which correspond to solute carriers and indicate members of receptor signaling 
pathway family.   
 
 
 
Figure 3.40: Clustering of genes upregulated in the ACSA-2+/GLAST- sample set.  
          Data set was preprocessed using quantil normalization. Samples were compared using ANOVA. 
          Normalized gene samples with a p-value less than 0.05 (Tukey’s range test), less than one  
         outlier per sample group, a log_2 ratio of (2/-2) were considered for this analyses. Pathways  
         were identified using MetaCore. Samples of ACSA-2+/GLAST- (A+/G-), ACSA-2+/GLAST+  
         (A+/G+), ACSA-2-/GLAST+ (A-/G+) were visualized using MeV. Correlation coefficients are  
         indicated by color from blue (-6) to yellow (3) (a). Data further illustrated using bar diagrams.  
         Triplicates of normalized log_2 intensities are indicated as Mean ± SD (b). 
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  Genes such as Sox-2 and or PDGFR did not reveal significant differences between the 
tested samples (Supplementary Figure 17). Furthermore, ATOH1 (Math-1), Zic1, Tbr2 248,249, 
specific markers for granule cells of the cerebellum, showed low levels of gene expression in 
the tested samples. This indicates a low percentage of granule cell contaminations in  
ACSA-2+/GLAST-, ACSA-2+/GLAST+ and ACSA-2-/GLAST+ samples of the cerebellum. In 
summary, this transcriptome analysis supports the differences between ACSA-2+/GLAST- cells 
and ACSA-2+/GLAST- cells seen in the transplantation experiment. The gene expression 
profiling showed a close lineage relationship between ACSA-2+/GLAST- and ACSA-
2+/GLAST+ cells. ACSA-2-/GLAST+ were enriched for stem cell factors and genes of 
GABAergic phenotype indicating higher plasticity. In contrast, ACSA-2+/GLAST- showed an 
enrichment of cell adhesion and cell matrix proteins indicating a lower plasticity and more 
tissue integrated phenotype.  
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4.  Discussion  
4.1  Mapping astrocyte heterogeneity by cell surface marker expression 
  At the time of their discovery in the 1800s, astrocytes have been considered as passive 
cells that support neuronal activity. In the last 50 years, the functional variety of astrocytes was 
investigated in more detail. It was demonstrated that astrocytes are active elements of the 
neural network and different astrocyte subclasses with different molecular identities and 
specialized functions 250 were identified. Beside their housekeeping functions, astrocytes are an 
essential element of the blood-brain barrier and present neural stem cell characteristics as 
demonstrated by Doetsch et al. in 1999 68. However, addressing different astrocyte subgroups 
within the astrocyte cell compartment still is a major challenge. Moreover, there is an ongoing 
discussion whether astrocyte subsets exist or whether astrocytes adjust to the local 
microenvironment and thereby become a specified subset. First astrocyte subclassification 
studies were performed in 1987 by Miller and Raff. They identified protoplasmic and fibrous 
astrocytes based on morphological differences 32 and the expression levels of GFAP. In 2007, 
Cai et al. showed that protoplasmic and fibrous astrocytes differ in respect to their 
transcriptional regulation 251. However, there is currently no cell surface marker combination 
described that allows for the isolation of protoplasmic and fibrous astrocytes from wt mice. 
Besides, the cell bodies of protoplasmic and fibrous astrocytes can be located close to each 
other in the same brain region. This is based on the fact that astrocytes arise from different 
lineages or cell sources during development and that transcription factors and gene regulation 
promote the generation of different astrocyte subtypes at radial glia state 252. Therefore, it is 
rather difficult to discriminate protoplasmic and fibrous astrocytes in tissue sections by 
antibody staining. Protoplasmic and fibrous astrocytes are one example showing that 
morphological classification alone is not sufficient to class astrocyte subpopulations. The 
general aim is to subclassify astrocytes by functional properties based on the expression of one 
or two cell surface markers. The classical tool to study astrocytes is immunostaining. However, 
IHC and ICC results are sometimes difficult to interpret as markers only reveal a punctuated 
staining, like GLT-1 or ACSA-2, are less sensitive for the given application or are restricted to 
cellular compartments like Aquaporin-4 that is expressed on astrocyte endfeet 97. In the last 
two decades, novel methods such as the generation of different transgenic mice lines, patch 
clamp recordings, single cell electroporation approaches as well as flow cytometric analysis 
were introduced. Many of these efforts, including the transcriptome study performed by Cahoy 
et al. in 2008 88, the microarray analysis performed by Bachoo et al. in 2004 96 or the 
identification of different guidance molecules expressed by different astrocyte subtypes 253 lead 
to the identification of novel astrocyte markers. However, these studies also demonstrated that 
classical astrocyte markers, such as GS 254 or glutamate transporter (GLT-1) 255 are not 
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restricted to the astrocyte subset as these markers were demonstrated to be expressed by other 
neural cell types. In addition, these studies identified some novel astrocyte subpopulation 
specific markers like Kir4.1 93,256. Besides, they revealed some information about the marker 
expression pattern of astrocytes. Studies presented e.g. that calcium-binding protein S100β is 
predominantly expressed by mature astrocytes that surround blood vessels 92. All these studies 
emphasize that our knowledge about the marker expression on astrocyte subpopulations is still 
limited. As a consequence this illustrates that novel markers and novel tools are needed to 
address and analyse the functional divergence of astrocytes. Transgenic mice, which are often 
used for comprehensive analyses 88, are a powerful tool but also have several limitations. On 
the one hand, the transgene can be expressed by non-astrocytes, as shown for the GLAST-GFP 
mice 102. On the other hand, as reported for the GFAP-LacZ mice 257, it can occur that not all 
target cells express the transgene. These problems were overcome by the generation of the 
astrocyte specific antibody Anti-GLAST (ACSA-1) that allows for direct isolation of GLAST 
expressing primary astrocytes 104. An antibody based isolation strategy enables for the 
characterization of astrocytes on the single cell level. In addition, subsequent analyses such as 
gene expression profiling, molecular or cell-based assays can be performed. Therefore, this 
work aimed at the identification of novel astrocyte cell surface markers for the prospective 
characterization of astrocyte subpopulations. As shown by Jungblut et al. GLAST is expressed 
by common astrocytes in the CNS 104. Therefore, it was chosen as basis for the identification 
and characterization of astrocyte subpopulations. Within this study, the novel astrocyte marker 
ACSA-2 was characterized as an astrocyte specific cell surface marker. The Anti-ACSA-2 
antibody was generated by contralateral footpad immunization in rats using GFAP-eGFP 
sorted astrocytes. Differences between GLAST and ACSA-2 expression were seen in the 
neonatal and adult brain. Further analyses were performed to investigate astrocyte 
subpopulations based on the expression of this two cell surface markers in combination. These 
analyses revealed that GLAST and ACSA-2 are co-expressed by the majority of astrocytes 
including protoplasmic and fibrous astrocytes in the cortex (Fig. 3.16). Brain regions 
displaying discriminative ACSA-2 and GLAST expression were thereafter investigated in 
more detail. However, marker expression often correlates with the specification or the 
localization of a cell. This explains why different expression dynamics were seen between the 
tested areas of the CNS.   
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4.2  Generation of novel astrocyte subpopulation specific antibodies  
  and identification of novel astrocyte cell surface markers    
  Monoclonal antibodies are a valuable tool for research and clinics, as they bind to 
specific targets. Therefore, one approach of this study aimed at the generation of novel 
monoclonal astrocyte cell surface specific antibodies by immunization. Immunization 
strategies based on primary material were used previously for the generation of the ACSA-2 
antibody and the oligodendrocyte specific antibody MBP 258. In this approach, astrocytes 
served as immunogen and were isolated using the Anti-GLAST MicroBead Kit. An isolation 
strategy based on GLAST was chosen as this marker is expressed by common astrocytes of the 
CNS 104. Furthermore, the Anti-GLAST (ACSA-1) antibody allows for the enrichment and 
depletion of astrocytes to high purities. For the immunization approach high purities of the 
target cell group were mandatory to prevent antibody generation against impurities. Therefore, 
depleted astrocytes were applied as decoy to decrease unspecific immune response against 
non-target cells. The use of primary cells as immunogen further supported the generation of 
various antibody-producing clones within the immunization approach. However, the 
immunization strategy used in this study did not result in the generation of astrocyte 
subpopulation specific antibody clones. As shown in Figure 3.3, antibodies did either 
recognize all GLAST positive astrocytes or none. Further studies on the astrocyte proteome 
would help to understand which astrocyte cell surface molecules can classify astrocyte 
subclasses. The identified candidates could than be used for an immunization approach against 
‘defined-targets’.   
 
A further approach of this study was the identification of novel subpopulation specific markers 
by cell surface marker screening by flow cytometry. The screen was used to identify novel 
surface epitopes expressed by subpopulations of GLAST and/or ACSA-2 positive astrocytes. 
Flow cytometry allows for the screening of markers in a high throughput setup in a short time 
range. In addition, a flow cytometry based assay can be performed with rather low cell 
numbers (down to 1000 cells per sample). General limitation for the investigation of neural 
samples on the flow cytometer is the requirement of single cell suspensions, which are 
commonly obtained by tissue dissociation. The enzymes used for dissociation can potentially 
harm cell surface epitopes and thereby cause false negative results, as described for other cell 
sources before 259. One further disadvantage is that the information about the localization of a 
cell in a solid tissue is lost once single cell suspensions are generated. To address the 
localization of the identified markers in brain tissue, the markers were tested by IHC. However, 
13 of 15 markers were not suitable for IHC approaches. Therefore, it was decided to 
 
 Discussion  
 
-87- 
investigate the 15 markers also on whole brain tissue cultures after 3 days in vitro by ICC and 
by MICS (Multidimensional in situ Cytometry Survey technology) 196. In comparison to classic 
immunochemical approaches, which enable for the investigation of two or three markers on 
one tissue section at a time, the MICS experiment enables for the investigation of up to 100 
different markers using one tissue section 196. For this reason, this technique can also be used 
to study rare cells. Using this technology it was possible to investigate the expression profile, 
the distribution and the expression intensity of the identified marker panel on astrocytes and 
other neural cells. Different markers, such as VCAM-1 (CD106) revealed an inhomogenous 
distribution on the cell surface of the cultivated astrocytes. In the MICS analyses VCAM-1 
was not restricted to the astrocyte endfeet, as discussed for astrocytes in the SVZ 260. Besides 
VCAM-1, interferon-gamma receptor (CD119) was identified in this surface marker screening 
approach. The expression of CD119 was also investigated by MICS and IHC. In wt mice 
CD119 was expressed by all GLAST+ astrocytes. Therefore, CD119 was not considered as a 
suitable candidate to discriminate astrocyte subpopulations. However, Beurel et al. reported 
about a decreased expression of the CD119 membrane protein upon interferon-gamma 
treatment. Therefore, CD119 is considered to be a versatile astrocyte marker to study 
astrocytes in the context of neuroinflammatory diseases such as Alzheimer’s or multiple 
sclerosis 261. Moreover, CD119 might characterize a subpopulation of astrocytes in the 
diseased brain.  
 
 
4.3  Identification of the ACSA-2 antigen 
  The identification of the ACSA-2 antigen was addressed in several ways. One way 
was a ligand receptor capturing (LRC) approach198 that lead to the identification of two 
glycoproteins: GAT-3 and NrCAM. According to the expression profile described in the 
ALLEN BRAIN ATLAS and the IHC data of this study GAT-3 was the more promising 
candidate. In addition, a significant enrichment of the gene encoding GAT-3 (Slc6a11) was 
seen in the transcriptome analysis of the ACSA-2+/GLAST- samples. However, Western Blot 
analysis, immunoprecipitation and the overexpression of GAT-3-GFP in HEK cells did not 
confirm GAT-3 as target of the Anti-ACSA-2 antibody. In this work, Western Blot analysis 
and immunoprecipitation were used to prove or disprove the hits of the LRC approach. 
Immunoprecipitation is a complex process; it consists of different steps and for this reason it is 
error-prone. As all tested cell lines did not reveal any ACSA-2 antigen expression the only 
suitable cell source was primary material. In comparison to an adherent growing cell line, 
dissociated tissue is heterogeneous considering cell composition. In addition, the dissociation 
of primary material results in a high level of cell debris that is remained in the lysate after cell 
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lysis and often causes high background signals or false positive signals. In the experimental 
setup, the major problem was the unspecific binding of the catching antibody to intracellular 
components such as α-Actin, heat shock proteins or intermediate filaments. These proteins are 
ubiquitously expressed by all cells and are therefore present in the lysate at high concentrations. 
Thus, it is likely that the capture antibody binds preferably to unspecific binding partners than 
to its specific binding site.  
In addition, transmembrane proteins are integrated into the lipid bilayer and detergents are 
needed to solubilize these proteins 262. Membrane proteins can further be established as dimers, 
heteromers or oligomers. This bears the risk, that subunits are separated from each other during 
the solubilization or precipitation process. In addition, antibodies that recognize a 
conformational structure cannot bind their specific targets. If the target protein had been a 
known G protein-coupled receptor it would have been possible to co-immunoprecipitate the 
epitope using GPCRs 263. As the biochemical composition of the epitope was not known, the 
immoprecipitation was tested in different experimental setups to identify the optimal protocol. 
In one setup, sepharose, a classical matrix used for immunprecipitation, was tested. Sepharose 
is characterized by a high binding affinity and binding capacity. However, this leads to high 
background signals 264. To saturate unspecific binding sides several pre-clearing steps were 
performed. The other setup tested in this study was the immunoprecipitation based on Protein 
G MicroBeads 265. MircoBeads have lower binding capacity and lower avidity than Sepharose. 
Therefore, MicroBeads cause less background signals. The principle of the 
immunoprecipitation upon surface biotinylation was the use of a biotin linker for the 
discrimination of surface membrane and intracellular molecules. For detection, a Streptavidin 
HRP conjugate was used which binds to biotin at a very high affinity and therefore causes low 
background signals. The major problem of the biotinylation protocol was to obtain the 
recommended cell number of 1 x 108 sorted cells per approach. As 1 x 106 astrocytes can be 
obtained from one mouse brain using the Anti-ACSA-2 MicroBeads, 100 brains were needed 
for one biotinylation approach. In summary, the targets of the LRC could not be validated by 
Western Blot analysis neither by immunoprecipitation nor by the over-expression of the GAT-
3 protein. In a further approach a deglycosylation assay was established to address whether the 
ACSA-2 antibody recognizes a glycosylation pattern on astrocytes. The assay revealed a 
decreased signal of the ACSA-2 antibody staining upon deglycosylation. Glycosylation is the 
most complex posttranslational modification 266. Based on the glycoside hydrolases used in this 
work the ACSA-2 antibody can either recognize an O- or N-glycosylated glycoprotein, a 
glycolipid, a post-glycosylation modification of branches, unbranched side-chains or a sugar 
moiety involved in conformational stabilization N-glycans, O-glycans and glycolidips are 
products of the biosynthesis pathway. Besides, N-linked glycosylation patterns are more 
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frequent than O-linked glycosylation patterns. However, some glycoproteins reveal O- and N-
glycosylation, e.g. CD24 267. In addition, N-acetylglucosamine (GlcNAc) and N-
acetylneuraminic acid but also mannose, fructose and galactose can be added. These residues 
are often characteristic for tissues or developmental stages 268. In an ongoing approach it will 
be validated which glycosylation structure is recognized by the ACSA-2 antibody.  
 
 
4.4 Investigations of SVZ stem cells by surface marker expression  
  The investigation of self-renewing and multipotent stem cells in the adult brain is of 
emerging interest, as these cells are considered to serve as targets against neurodegenerative 
diseases. However, since the identification of transit-amplifying stem cells in 1999 by Doetsch 
et al. researchers try to identify a defined marker combination to address and isolate stem cells 
from the SVZ. Stem cells of the SVZ derive from radial glia. They have astrocyte 
characteristics such as marker expression. Moreover, these cells are able to give rise to 
neuronal progenitors during embryonic development 47,53,269. SVZ stem cells retain radial glia 
marker expression but also express markers shared by neuronal precursors such as β-III tubulin, 
PSA-NCAM and doublecortin. The first problem, when it comes to the identification of 
specific stem cell markers is the architecture of the murine SVZ. In comparison to human, 
where a gap separates the ependymal cell layer from the stem cell layer, the layers in the 
murine SVZ are tightly connected with each other. The stem cells of the SVZ, also named as 
B1 astrocytes, contact ependymal cells via gap junctions 81. Due to the tight architecture of the 
SVZ, it was difficult to evaluate if ependymal cells express ACSA-2 in this study. Besides the 
architecture, the major problem is to identify novel markers that allow for the classification of 
cellular identities in the SVZ, as summarized by Mamber et al in 2013. As discussed by 
Beckervordersandforth et al. marker expression is not static and markers can be shared by 
different identities within the SVZ 72. Several research groups try to address the generic profile 
of different astrocyte subpopulations in the SVZ. A panel of potential novel markers was 
identified by microarray analyses. Common markers discussed to classify stem cells are cell 
surface molecules including (Prominin-1), transporters (GLAST, GLT-1 and GAT-3), 
receptors (EGFR) 271,272 and cell adhesion molecules such as SSEA-1 and VCAM-1. 
Furthermore, different cytoskeletal components are described to be expressed by SVZ stem 
cells. This are intermediate filaments such as vimentin, GFAP and Nestin, which is not present 
in mature astrocytes 270. Additionally, transcription factors such as Sox-2 are potential SVZ 
stem cell markers. However, most of these markers were tested in previous studies and were 
reported to be shared by ependymal cells or surrounding astrocytes. Moreover, GFAP or 
Prominin-1 alone are not sufficient for the identification and isolation of SVZ stem cells. As 
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shown in independent studies, two or more markers in combination are needed to address SVZ 
stem cells 75. In addition, intracellular markers such as Sox-2 are not appropriate for the 
prospective isolation of NSCs as they require an intracellular labeling step. Thus, this study 
aimed at the isolation of SVZ stem cells by cell surface marker expression. In this study, the 
SVZ tissue was analyzed on the single cell level on a flow cytometer. The dissociation process 
of SVZ tissue from adult mice resulted in high frequencies of dead cells and high amount of 
cell debris. This was due to high cell connectivity in the adult brain tissue, as described before. 
In this study, GLAST and ACSA-2 were stained in combination with CD24 to discriminate 
ependymal cells from stem cells and surrounding astrocytes. This strategy was chosen, as 
CD24 is a published marker characterized to discriminate ependymal cells and SVZ stem cells 
in combination with Prominin-1 271. In this study, CD24 was shown to be versatile for the 
discrimination of ependymal cells from GLAST expressing astrocytes –including stem cells- in 
the SVZ on the flow cytometer. In parallel, the expression of ACSA-2 in the SVZ was 
investigated by flow cytometry. The expression study of GLAST and ACSA-2 revealed that 
these markers are co-expressed in the SVZ tissue, which was validated using different mouse 
strains. Thereafter, different markers found in literature were chosen to address the stem cell 
compartment in more detail. The stem cell marker Lgr5 was tested, as this marker is reported 
being expressed by distinct stem cell populations in various tissues 238. Markers used to 
discriminate ependymal cells such as Notch-1 and α-tubulin were also tested 272,273. However, 
all tested markers in this study were either co-expressed by ependymal cells or by surrounding 
astrocytes. In summary this work did not find a marker combination for the isolation of SVZ 
stem cells.     
 
 
4.5 GLAST and ACSA-2: A versatile tool to discriminate astrocyte  
   precursors of the neonatal cerebellum  
 The development of the cerebellum continues after birth. It has been shown that 
germinal niches of the prospective white matter give rise to interneurons, astrocytes and 
oligodendrocytes. Therefore the prospective white matter was named as the neurogenic niche 
of the cerebellum. The prospective white matter disappears when the cerebellum maturates 
241,274. Although the cerebellum is one of the best studied brain region origin and lineage 
relationships of cerebellar glia are less investigated 169. This study provides a novel approach to 
address stem cells and glial precursors of the neonatal cerebellar by the use of the astrocyte cell 
surface markers GLAST and ACSA-2. To address this, the cell differentiation capacities and 
the transcriptome of the ACSA-2+/GLAST+/-, ACSA-2-/GLAST+ and ACSA-2+/GLAST- cells 
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were investigated. GLAST is not a novel marker for the identification of multipotent 
precursors and stem cells of the murine brain. It was already shown that GLAST positive radial 
glia 47 of the cortex are neurogenic. GLAST is also described as a stem cell marker for SVZ 
stem cells. For the identification of cerebellar glia surface markers such as CD44 275,276, 
Prominin-1179,249 and CD15 249 were used in different studies. CD44 is a classical astrocyte 
marker. However, CD44 is not restricted to the astrocyte subset. In the cerebellum, CD44 is 
also expressed by neurons 275,276. In contrast, GLAST and ACSA-2 are restricted to the 
astrocyte lineage. Interestingly, the transplants revealed a high amount of granule cells in both 
groups. All samples used for the transplantion had purities between 75% and 95%. However, 
granule cell undergo clonal expansion. Therefore, low impurities of granule cells in the grafted 
fraction can lead to a high number of granule cells found in the graft after 30 days 277. Naruse 
et al. reported about a strong decrease of Nestin and Sox-2 expression on CD44+ isolated 
stem/progenitor cells at P10. The developmental analysis of this study revealed that 
frequencies of ACSA-2-/GLAST+ multipotent cells decrease with the onset of development 
and are not detectable later than P12. A2B5 defines developing glia and becomes down-
regulated when glia maturate. Therefore, the expression of A2B5 was addressed in this study. 
Analysis of A2B5 expression at P1 and P7 showed a significant decrease in A2B5 expression 
on ACSA-2-/GLAST+ cells at P7 compared to P1. As reported by Fleming et al. intermediate 
astrocyte precursors can be characterised by high expression levels of CD15 and low 
expression levels of Tenascin C (Tnclow CD15+ cells). To address a potential correlation 
between ACSA-2-/GLAST+ cells and Tnclow CD15+ cells, the expression of CD15 was 
monitored on ACSA-2+/GLAST-, ACSA-2-/GLAST+ and ACSA-2+/GLAST+/- cells. In fact, 
highest CD15 expression was detected on the ACSA-2-/GLAST+ subset (Fig. 3.31).  
Lee et al. studied cerebellar stem cells based on the expression of Prominin-1. They 
transplanted multipotent cells derived from cultivation as neurospheres. In this study, all 
sample groups were transplanted directly after cell sorting without any cultivation step to 
prevent any selection. The cells were further transplanted in the absence of any growth factors 
in order to prevent any specification due to extrinsic factors. To further prevent preselection in 
the dissociation step a gentle dissociation protocol was followed. However, the loss of certain 
subtypes within the dissociation process cannot be excluded. This work is the first study that 
describes an efficient enrichment of cerebellar precursor populations from wt mice based on 
the expression of two astrocyte cell surface markers. Lee et al. had a starting frequency of 
0.2% Prominin-1+ and lin- cells. Lee et al. characterized lin- cells as cells lacking neuronal and 
glial lineage markers 179. However, Prominin-1 has distinct splice variants and the isolation 
efficiency is dependent on the antibody clone 278. Fleming et al. reported about a frequency of 
less than 0.5% Tenascin C+/Prominin-1+ cells in their multipotent cell population.  
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Both approaches were based on transgenic mice. The system based on the expression of 
GLAST and ACSA-2 presented a population of 10% ACSA-2-/GLAST+ cells at P1. However, 
the frequency of stem cells within the ACSA-2-/GLAST+ needs to be addressed.  
This study showed that a novel multipotent precursor cell type of the early neonatal cerebellum 
can be characterized by the expression of GLAST and the absence of ACSA-2. Cells 
characterized by the expression of GLAST and ACSA-2 revealed a limited differentiation 
potential and were restricted to a glial cell fate, as seen by transplantation. The molecular and 
cellular interactions that regulate cell fate and control the differentiation of the glia lineage in 
the developing cerebellum are currently unknown. Based on the transplantation experiments of 
this study ACSA-2-/GLAST+ cells show higher plasticity. This further suggests that ACSA-2-
/GLAST+ cells are able to adapt to a given phenotype in respect to local conditions. In contrast,  
ACSA-2+/GLAST+/- were shown to have a lower plasticity. Therefore, this study suggests that 
this cell population is already ’primed’ and cannot acquire to a local environment.  
 
4.5.1 Gene expression profiling of ACSA-2+/GLAST-, ACSA-2+/GLAST+/- and  
  ACSA-2-/GLAST+ sorted cells from neonatal cerebellum    
  The gene expression profile of ACSA-2+/GLAST-, ACSA-2-/GLAST+ and  
ACSA-2+/GLAST+/- cells was investigated by microarray analysis. For better comparison 
between the transplantation experiment and the gene expression profiling samples were 
isolated using the same protocols. The isolated cells showed impurities between 7 to 25%. 
However, impurities within one sample group were comparable. The hybridisation of the 
ACSA-2+/GLAST+/- sample group revealed weak signals. However, this was normalized in the 
subsequent step by quantil normalization. ACSA-2+/GLAST+/- samples displayed an 
intermediate group between ACSA-2+/GLAST- and ACSA-2-/GLAST+ cells, which was 
already monitored in the flow cytometric analyses. In a correlation matrix the relationship 
between the ACSA-2-/GLAST+, ACSA-2+/GLAST- and ACSA-2+/GLAST+/- samples was 
illustrated. This illustration depicted a closer relationship between the ACSA-2+/GLAST- and 
the ACSA-2+/GLAST+/- sample sets. This data supports the idea that presence and abscence of 
ACSA-2 allow for the discrimination of astrocyte subpopulations in the cerebellum. The data 
set did not reveal a significant increase of genes described for the granule cell lineage (ATOH1 
(Math-1), Zic1, Tbr2 248,249). This supports that granule cells detected in the transplants are 
likely to be derived from clonal expansion. However, it has to be considered that the gene 
expression level does not correlate with the protein expression level. Stem cell factors 
described for embryonic stem cells (Nanog, Klf-4, Sox-2 240) were further not identified in the 
ACSA-2-/GLAST+ samples. This illustrated that ACSA-2-/GLAST+  cells are more restricted 
stem cells. Factors involved in dopaminergic or serotonergic differentiation were slightly 
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upregulated in the ACSA-2-/GLAST+ samples (Nkx2-.2, Lmx1a, Otx2 240,245). In contrast, a 
gene correlated with a GABAergic phenotype (Ptf1a) was upregulated in the ACSA-2-
/GLAST+ samples. This illustrated a specification of ACSA-2-/GLAST+  cells towards a 
GABAergic cell type. Besides, Nestin a common stem cell marker and Sox1, a gene described 
to be enriched in Bergmann glia precursors and neurosphere forming cells of the cerebellum 
were upregulated in the ACSA-2-/GLAST+ samples 279. One further gene expressed by 
Bergmann glia was Tenascin C, which was identified in the ACSA-2-/GLAST+ samples 280. 
The upregulation of Bergmann glia specific genes is supported by the transplantation 
experiment showing that ACSA-2-/GLAST+ differentiated into Bergmann glia whereas ACSA-
2+/GLAST+/- were not able to acquire this cell type. In addition, Achaete-scute homolog-1- 
Ascl1 (Mash1) was upregulated. It was shown, that mice lacking Ascl-1 prefentially 
differentiated into astrocytes 281. Leto et al. described Ascl-1 expressing cells as a precursor 
population of Ascl-1/Sox-2 expressing cells. The data of ex vivo sorted cells did not present 
Sox-2 expression 274 in any group. Therefore, ACSA-2-/GLAST+ cells are considered to be 
progenitors of an earlier developmental stage and though do not yet express Sox-2. The 
ACSA-2-/GLAST+ data set revealed the enrichment of the gene encoding Parvalbumin, a 
marker for interneurons. In addition, it showed the upregulation of a very important gene 
required for the differentiation of cerebellar cells into interneurons. This was pancreas 
transcription factor 1 subunit alpha (Ptf1a) 242. Moreover, Ptf1a is described as a marker for 
neurogenic cells of the prospective white matter. Thus, this study is considered to provide a 
novel transgen-free tool for the isolation of prospective white matter cells. Fleming et al. 
described that prospective white matter cells respond to SHH and differentiate into 
GABAergic interneurons and glia, as also shown for ACSA-2-/GLAST+ cells by 
transplantation. Fleming et al. studied the SHH pathway activity using a Gli1nlacZ mouse model 
249. In this study the activation of the Wnt and the SHH signaling pathways were addressed by 
gene expression profiling. In contrast to their observation that Gli1 is higher expressed in 
CD15+ glial precursors, the gene expression data of this study pointed to a higher expression of 
Gli1 in the neural stem cell compartment (ACSA-2-/GLAST+ cells). Besides, Gli1, Gli2 and 
Gli3 as well as the hedgehog interacting protein (hhip) and patched homologue 2 (Ptch2) were 
significantly enriched in the ACSA-2-/GLAST+ samples. Patched homologue 2 (Ptch2) is a 
direct target of Gli 282,283. The ACSA-2+/GLAST+/- sample set revealed an enrichment of genes 
encoding connexin 26 (Gjb2), connexin 30 (Gjb6) , connexin 43 (Gja1) and CD82 the 
extracellular matrix protein vitronectin. All hemichannels are exclusively expressed by 
astrocytes. Especially connexin 30 is broadly expressed on astrocytes and important for ion 
exchange 284. A further gene group related to cellular function and predominantly expressed by 
the ACSA-2+/GLAST+/- sample set were the members of the solute carrier transporter (Scl) 
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family. Solute carrier transporters are important for the transport of ions and organic molecules. 
Besides, the guidance molecules Slit1 and Slitrk1 were identified. In contrast to the 
SVZ/RMS/olfactory bulb system little is known about the role of guidance molecules in the 
cerebellum. Slitrk1 is reported to be important for neurite outgrowth. However, this was not 
specified for the cerebellum 285. In the ACSA-2+/GLAST+/- sample set neuronal genes were not 
identified. In contrast, an enrichment for genes such as VCAM, GFAP, Olig1 and Olig2 was 
seen in the ACSA-2+/GLAST+/- sample set. In summary, the transplantation assay and the gene 
expression profiling demonstrated ACSA-2+/GLAST+/- cells as glial precursors and ACSA-2-
/GLAST+ cells as multipotent cells of the cerebellum.  
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5. Outlook 
In this study combining the astrocyte specific cell surface markers ACSA-2 and GLAST 
successfully identified astrocyte subpopulations. Comprehensive analysis of GLAST and 
ACSA-2 expression in distinct brain areas revealed very significant differences in the 
cerebellum of neonatal mice. These subpopulations were described as ACSA-2-/GLAST+ 
and ACSA-2+/GLAST+ cells. The ACSA-2-/GLAST+ population will be further 
characterized for its cell integration capacity, stem cell potential and plasticity. In a further 
transplantation assay ACSA-2-/GLAST+ cells will be isolated from the cerebellum of  
β-actin GFP mice at neonatal age and transplanted into the cerebellum of adult mice.  
As a negative control, ACSA-2+/GLAST+ cells will be isolated and transplanted into a 
second group in parallel, as these cells did not reveal multipotent differentiation capacities 
in this study.   
 
Major focus of this work was to map the divergence of astrocyte subpopulations by cell 
surface markers. In one approach, the expression profile of the novel ACSA-2 antibody in 
the murine brain and its target were investigated. The glycopattern recognized by the 
ACSA-2 antibody will be further characterized for N- or O-glycosylation using specific 
glycoside hydrolases.  
 
ACSA-2 shows a broad expression in the mouse brain, spinal cord and retina. Analysis of 
retina and spinal cord were performed and revealed specific ACSA-2 staining in both areas. 
Therefore, the ACSA-2 antibody can be used in future studies to investigate and isolate 
astrocytes of spinal cord and retina.  
Moreover, similar expression patterns between GLAST and ACSA-2 expressing astrocytes 
of the neural retina and the cerebellum were seen. Further approaches, including gene 
expression profiling or patch clamp recordings, could address lineage relationships 
between ACSA-2-/GLAST+ cells of the cerebellum and the retina. In addition, the 
differentiation potential and the plasticity of ACSA-2-/GLAST+ cells of the retina or the 
cerebellum could be addressed by cell transplantation experiments. Therefore,  
ACSA-2-/GLAST+ cells of retina isolated and transplanted into the cerebellum or vice 
versa.   
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In this study one approach aimed at the identification of astrocyte cell surface markers by 
antibody screening. Apart from published markers such as the heat stable antigen (CD24) 
or the vascular cell adhesion protein 1 (VCAM (CD106)) the interferon-gamma receptor 
(CD119) was identified. However, as tested by MICS, CD119 was co-expressed on all 
GLAST+ astrocytes in wt mice and could not be validated as a subpopulation marker. 
Therefore, it would be interesting to study interferon-gamma receptor expression on 
astrocytes in the context of neuroinflammatory diseases e.g. in experimental autoimmune 
encephalomyelitis mice.   
 
In a side project, the expression profile of ACSA-2 on reactive astrocytes was investigated. 
GFAP is a marker for reactive astrocytes and is strongly induced upon reactive gliosis, e.g. 
in the Afg31l1 d/d Afg3l2 fl/fl GFAP cre mouse model. In the tested mouse model  
ACSA-2 and GFAP expression were not correlated. Therefore, ACSA-2 is considered 
being expressed by non-activated astrocytes and ACSA-2 could be used to study non-
activated vs. activated astrocytes in a reactive gliosis model. Stab-wound-lesions in the 
cortex	  could be introduced to study this subset in further detail. 
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I  Supplementary data:  
 
Supplementary Figure 1: Frequencies of marker expression in different brain regions.  
     The identification of novel astrocyte subpopulation markers was performed by  
        cell surface marker screening. 10 markers were identified and investigated in a  
     subsequent re-screening approach on forebrain, midbrain and cerebellar samples  
         in a co-staining with the GLAST and the ACSA-2 antibody. Except from CD24,  
      markers presented a comparable frequency on the ACSA-2 positive and the  
     GLAST positive astrocytes.  
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Supplementary Figure 2: Marker validation using MICS.   
     Expression of different markers identified by surface marker screening was  
     validated by MICS. The MICS experiment was performed on mixed mouse brain  
         cells derived from P1 mice. For MICS cells were cultivated for 7 days.  
     Exemplified for all positive tested markers are CD26 (b) and CD119 (e). Both 
     revealed co-expression (c,f) on all GLAST positive cells (a,d).  
 
   
 
Supplementary Figure 3:  Co-staining of ACSA-2 with CD45 and CD11b by MICS. 
      Dissociated neonatal mouse brain samples of P3 mice were used to discriminate  
      ACSA-2 staining on CD45 positive hematopoietic cells (a) and CD11b positive  
      microglia (b) by flow cytometry. CD45 positive and CD11b positive cells  
      presented co-expression with ACSA-2 to less than 2%, which is considered as  
      background staining. Dissociated neonatal mouse brain samples of P1 mice were  
      used for MICS. ACSA-2 did not present co-expression with CD11b (c-e). 
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Supplementary Figure 4:   Candidates obtained by LRC approach.  
       The LRC was performed to identify the target of the ACSA-2 antibody.  
       This approach was conducted at the ETH Zurich using nitrogen frozen  
       brain sections derived from P1 mice. The capturing is based on a TRICEPS  
       linker followed by a mass spec. analysis step 198. The LRC pointed to two  
       candidates: GABA transporter 3 (GAT-3) and Neuronal cell adhesion molecule  
       (NrCAM).   
 
  
  
  
  
  
  
 
 
 
 
 
 
 
  
 
Supplementary Figure 5: Identification of the ACSA-2 antigen by Western Blot analysis.  
       Western Blot analysis against ACSA-2 was performed on lysates derived from  
     adult mouse brains. A band of 40 kDa was identified. Analysis of this band by  
      mass spectroscopy did not identify the antigen of ACSA-2 and pointed to α-Actin,  
      which was  considered as an unspecific hit.  
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Supplementary Figure 6:   Immunohistochemical analysis of ACSA-2 and GAT-3 expression.   
                   The expression profile of ACSA-2 and GAT-3 was investigated on adult mouse  
                    brain sagittal sections stained as floating sections (40 µm). GAT-3 and ACSA-2  
                         show a high level of co-expression in parts of the olfactory bulb, midbrain,  
                      cerebellum and brain stem.  
 
 
 
 
Supplementary Figure 7:   Immunocytochemical analysis of ACSA-2 and GAT-3 expression on  
                   astrocytes.  
                   ACSA-2 positive astrocytes were isolated using Anti-ACSA-2 MicroBeads.  
                    Cells were plated on Poly-L lysin coated cover slips and cultivated for 3 days in  
                    complete medium. Cells were fixed with 2% PFA and stained against ACSA-2  
                    (b,e) in the absence of Triton-X-100. Thereafter cells were permeabilized and  
                    stained against GAT-3 (a,d). Merged picture (c,f) show co-expression of  
                    ACSA-2 and GAT-3. Scale bar represents 10 µm. 
 
  Supplementary Data  
 
-V- 
 
 
 
 
 
 
 
 
Supplementary Figure 8:   Vector map of pCMV6-AC-GFP (Order no: MG222134).  
                    The vector is a cDNA clone containing the sequence of the mouse solute carrier  
        family 6 member 11 (Slc6a11). Encoding GAT-3. The insert is tagged  
                     by a GFP. The plasmid was amplified using common protocols (2.8.1-2.8.3). 
 
 
 
 
 
Supplementary Figure 9:  Transfection efficiency.   
                   Cells were transfected with the Slc6a11 plasmid (Supplementary Figure 8).  
                    Cells were harvested 24 h after transfection, fixed and analyzed on the flow  
                    cytometer. The Slc6a11 construct incorporats a GFP sequence. The  
                    fluorescence signal of GFP was measured in the FITC channel. Untransfected  
                    cells did not show a signal in the FITC channel (a). In this experiment 34% of  
                    the cells were tranfected cells (b).  
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Supplementary Figure 10: Expression of GLAST and ACSA-2 in neonatal mouse brain areas.   
      Brain tissue samples were dissociated from whole brain tissue, brain areas of the  
       olfactory bulb, cortical hemispheres, hippocampus, midbrain/diencephalon and  
       cerebellum at P1/P3/P5 and P7 (n=3). Cells were stained with the GLAST and  
       the ACSA-2 antibodies and measured on the flow cytometer. Frequencies of  
       ACSA-2+/GLAST-, ACSA-2+/GLAST+ cells ACSA-2+/GLAST- cells were  
       analyzed and illustrated as bar diagram (± SD). 
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Supplementary Figure 11: Isolation of ACSA-2+/-/GLAST+/- cells from neonatal cerebellum.  
        The neonatal cerebellum (P0 to P2) (A) was dissociated and ACSA-2+/GLAST-  
         (B), ACSA-2+/GLAST+/- (C) and ACSA-2-/GLAST+ cells (D) were isolated.  
         Cells were depleted (B, D) prior to isolation or enriched directly (C) using  
       MicroBead conjugates. Purities were determined on the MACSQuant by co- 
        labeling of Anti-ACSA-2 and Anti-GLAST (ACSA-1).  
 
 
 
Supplementary Figure 12: Isolation of ACSA-2-/GLAST+ cells from P9 cerebellum.  
       Dissociated cerebelli of P9 mice were used for the enrichment of ACSA-2- 
        /GLAST+ cells. Fractions were plated, stained against BLBP and GLAST and the 
       total number of cells per cover slip was counted and depicted as bar diagrams.  
       The isolation protocol was suitable. ACSA-2-/GLAST+ were enriched to 3-fold  
       in the positive cell fraction (Pos) compared to the original cell fraction (Ori). The  
       recovery was moderate low frequencies of BLBP/GLAST+ cells were identified  
       in the negative cell fraction (Neg). 
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Supplementary Figure 13: Neurosphere assay.   
      The differentiation potential of ACSA-2+/GLAST+/- and ACSA-2-/GLAST+ cells  
       was investigated in vitro by neurosphere assay. 50,000 cells were seeded in a  
       24 well plate in the presence of 20 ng/mL EGF and FGF (Fig. 2.1). Although  
          ACSA-2-/GLAST+ were able to form larger spheres (a) than ACSA-2+/GLAST+/-  
         cells (b) as monitored at magnification on the light microscopy. Both  
        fractions were able to differentiate into βIII tubulin positive neurons and GFAP  
       positive astrocytes in the absence of EGF and FGF on poly-L-lysine coated  
       cover slips (c). In addition, very few oligodendrocytes were detected after  
             differentiation (not shown).  
 
 
Supplementary Figure 14: Integration capacity of transplants into hosts at P1 and P3.  
      Sorted ACSA-2-/GLAST+ and ACSA-2+/GLAST+/- cells from P0-P3 cerebelli  
       were transplanted into P1 and P3 hosts. Cell types were classified by  
       morphology and immunostaining. For each group of ACSA-2-/GLAST+ and  
       ACSA-2+/GLAST+/- hosts the mean of integrated cells in P3 and P1 was  
      determined and is shown as bar diagram (± SD). 
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Supplementary Figure 15: Discrimination of astrocytes and oligodendrocytes in the transplants.  
       Isolated ACSA-2-/GLAST+ and ACSA-2+/GLAST+/- cells were transplanted  
       into same-aged donors. The differentiation into astrocytes and oligodendrocytes  
       was investigated by GFAP and Olig2 staining. For each group 3 animals with a  
       high cell integration (> 50 cells/section) were chosen. Percentages of astrocytes  
       and oligodendrocytes were calculated and illustrated as stacked bar plots. 
 
 
Supplementary Figure 16: Clustering of genes identified by gen expression profiling.  
            The data set was preprocessed using quantil normalization. Samples were  
                compared by ANOVA. Normalized gene samples presented a p-value higher  
         than 0.05 (Tukey’s range test). Pathways were identified using MetaCore.  
         Samples of ACSA-2+/GLAST- (A+/G-), ACSA-2+/GLAST+ (A+/G+),  
        ACSA-2-/GLAST+ (A-/G+) were visualized using MeV. Correlation  
        coefficients are indicated by color key: Blue (-6) to yellow (3.0). 
 
 
II Appendix I: Cell surface marker screen – Antibody list 
 
Marker Dye Clone Lot Concentration 
1 CD1d PE 1B1     
2 CD2 PE RM2-5 E00979-1630 10 µg/mL 
  CD2 APC RM2-5 BD Lyoplate 0.5 µg/mL 
3 CD3 PE 17A2 B126693 10 µg/mL 
4 CD3e PE 145-2C11     
5 CD4 APC GK1.5 BD Lyoplate 0.5 µg/mL 
  CD4 PE GK1.5     
6 CD5 APC 53-7.3 BD Lyoplate 0.5 µg/mL 
  CD5 APC 53-7.3 E07049-1630 10 µg/mL 
  CD5 Biotin 53-7.3 B128879 10 µg/mL 
7 CD8a PE 53-67     
  CD8a APC 53-67 BD Lyoplate 0.5 µg/mL 
8 CD9 PE MZ3 B137401 10 µg/mL 
  CD9 APC KMC8 BD Lyoplate 0.5 µg/mL 
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9 CD11a APC M17/4 BD Lyoplate 0.5 µg/mL 
10 CD11b APC M1/70 BD Lyoplate 0.5 µg/mL 
  CD11b PE M1/70.15.11.5     
11 CD11c PE N418     
12 CD13 PE RE-242 8533 10 µg/mL 
  CD13 APC RE-242 BD Lyoplate 0.5 µg/mL 
13 CD14 APC rmC5-3 BD Lyoplate 0.5 µg/mL 
  CD14 PE rmC5-3 53274 10 µg/mL 
14 CD15 PE VIMV6     
15 CD16/32 PE 93     
  CD16/32 APC 2.G2 BD Lyoplate 0.5 µg/mL 
16 CD18 APC C71/16 BD Lyoplate 0.5 µg/mL 
  CD18 Biotin C71/16 27781 10 µg/mL 
17 CD19 APC 1 D3 BD Lyoplate 0.5 µg/mL 
  CD19 PE 6 D 5     
18 CD21/35 APC 7G6 BD Lyoplate 0.5 µg/mL 
  CD21/35 PE 7  E  9      
19 CD22 FITC Ox97 3116485 10 µg/mL 
  CD22 PE C2 CO52 10 µg/mL 
20 CD22.2 FITC Cy34.1 82707 10 µg/mL 
  CD23 APC B3B4 BD Lyoplate 0.5 µg/mL 
21 CD23 Biotin B3B4 B101603 10 µg/mL 
  CD23 FITC B3B4 96786 10 µg/mL 
  CD23  PE B3B4 57969 2.5 µg/mL 
22 CD24 APC M1/69 BD Lyoplate 0.5 µg/mL 
  CD24 Biotin M1/69 42453 10 µg/mL 
  CD24 FITC M1/69 E015148 10 µg/mL 
  CD24 PE 30-F1 E019757 10 µg/mL 
  CD24 PE 30-F1 E019757 10 µg/mL 
  CD24 PE 30-F1 E019757 10 µg/mL 
23 CD25 APC PC61 BD Lyoplate 0.5 µg/mL 
  CD25 PE 7 D 4     
24 CD26 APC H194-112 BD Lyoplate 0.5 µg/mL 
  CD26 FITC H194-112 40143 10 µg/mL 
25 CD27 PE LG3A10   10 µg/mL 
26 CD28 APC 37.51 BD Lyoplate 0.5 µg/mL 
  CD28 PE 37.51     
27 CD29 APC 9EG7 BD Lyoplate 0.5 µg/mL 
  CD29 PE HMß1-1     
28 CD30 Biotin MEC13.3 45230 10 µg/mL 
29 CD31 APC MEC13.3 BD Lyoplate 0.5 µg/mL 
  CD31 PE MEC13.3 14611 10 µg/mL 
  CD31 PE MEC13.3 14611 10 µg/mL 
  CD31 Biotin MEC13.3   10 µg/mL 
30 CD34 PE RAM34 73417 10 µg/mL 
  CD34 APC RAM34 BD Lyoplate 0.5 µg/mL 
31 CD35 APC 8C12 BD Lyoplate 0.5 µg/mL 
32 CD36 PE No72.1   10 µg/mL 
33 CD38 APC 90 BD Lyoplate 0.5 µg/mL 
  CD38 Pur HIT2 B101603 10 µg/mL 
  CD38 PE 90/CD38 70421 10 µg/mL 
  CD38 Biotin 90 B106207 10 µg/mL 
34 CD40 PE FGK45.5     
35 CD41 APC MWREG30 BD Lyoplate 0.5 µg/mL 
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  CD41 FITC MWReg30 56305 10 µg/mL 
  CD41 APC MWReg30 E10380-1631 4 µg/mL 
  CD41 FITC MWReg30 56305 20 µg/mL 
36 CD43 APC S7 BD Lyoplate 0.5 µg/mL 
  CD43 PE L11     
37 CD44 APC IM7 BD Lyoplate 0.5 µg/mL 
  CD44 PE IM7.8.1     
  CD44 PE IM7 E01239-366 2 µg/mL 
38 CD45 APC 30-F11 BD Lyoplate 0.5 µg/mL 
  CD45 PE 30F11     
39 CD45.1 PE A20     
40 CD45.2 PE 104-2     
41 CD45R APC RA3-6B2 BD Lyoplate 0.5 µg/mL 
42 CD45R PE RA3-6B2     
43 CD45RA APC 14 8 BD Lyoplate 0.5 µg/mL 
44 CD45RB PE   D809-Q524Y n.calculated 
45 CD45RC  APC DNL-1.9 BD Lyoplate 0.5 µg/mL 
46 CD47 APC MIAP301 BD Lyoplate 0.5 µg/mL 
47 CD48 PE HM48-1   10 µg/mL 
48 CD49b APC DXS BD Lyoplate 0.5 µg/mL 
  CD49b PE DX5     
49 CD49D APC 9C10(MRF4.B) BD Lyoplate 0.5 µg/mL 
50 CD49e APC 5H10-27 BD Lyoplate 0.5 µg/mL 
  CD49e PE 
5H10-27 
(MFR5) 82702 10 µg/mL 
  CD49e PE 
5H10-27 
(MFR5) 82702 2 µg/mL 
51 CD49f PE R1-2     
52 CD51 APC RMV-7 BD Lyoplate 0.5 µg/mL 
  CD51 Biotin RMV-7 42371 10 µg/mL 
53 CD53 APC OX-79 BD Lyoplate 0.5 µg/mL 
54 CD54 Biotin 3 E 2  40251 10 µg/mL 
55 CD55 PE Rico-5 45695 10 µg/mL 
56 CD61 Biotin 2C9.G2 66973 10 µg/mL 
57 CD61 FITC 2C9.G2 15763 10 µg/mL 
58 CD62E APC 10E9.6 BD Lyoplate 0.5 µg/mL 
59 CD62P Biotin RB40.43 50110 10 µg/mL 
60 CD62L APC mEL-14 BD Lyoplate 0.5 µg/mL 
  CD62 L PE mEL-14     
61 CD69 PE L78 8905 1 zu 10 
62 CD70 APC FR70 BD Lyoplate 0.5 µg/mL 
  CD70 PE FR70     
63 CD71 APC C2 BD Lyoplate 0.5 µg/mL 
  CD71 Biotin C2     
64 CD72 FITC K10.6 9892 10 µg/mL 
65 CD72 b/c APC JY/93 BD Lyoplate 0.5 µg/mL 
66 CD73 PE TY/23 69498 10 µg/mL 
  CD73 APC TY/23 BD Lyoplate 0.5 µg/mL 
  CD73 PE TY/23 14174   
67 CD74 Pur LN2 36068 10 µg/mL 
68 CD79b Pur HM79B 63464   
69 CD80 APC 1G10/b7 BD Lyoplate 0.5 µg/mL 
  CD80 FITC 16-10A1 9530 10 µg/mL 
  CD80 PE 16-10A1 34045 10 µg/mL 
70 CD81 PE Eaat2 21109 10 µg/mL 
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  CD81  Biotin Eaat2 30599 10 µg/mL 
71 CD83 PE Michel-19 B122661 10 µg/mL 
  CD83 APC Michel-19 BD Lyoplate 0.5 µg/mL 
72 CD86 APC PO3 BD Lyoplate 0.5 µg/mL 
  CD86  PE 24 F   10 µg/mL 
  CD86 PE PO3.3     
  CD86 FITC GL1 7110 10 µg/mL 
73 CD90.1 PE His51     
74 CD90.2 APC 30-H12 BD Lyoplate 0.5 µg/mL 
75 CD90.2 PE 30-H12     
76 CD93 FITC AA4.1 E00719-196 10 µg/mL 
  CD93 APC AA4.1 E029489   
  CD93 Biotin AA4.1 E008623   
77 CD94 APC 18D3 BD Lyoplate 0.5 µg/mL 
  CD94 Biotin 18d3 12702   
78 CD95 PE 15A7 E01394-204   
79 CD98 APC H202-141 BD Lyoplate 0.5 µg/mL 
80 CD100 Biotin BMA12 E02654-1-1630   
81 CD102 APC 3C4(MIC2/4) BD Lyoplate 0.5 µg/mL 
  CD102 Biotin 3C4 61794 10 µg/mL 
82 CD103 APC M290 BD Lyoplate 0.5 µg/mL 
  CD103 FITC 2   E   7   10 µg/mL 
83 CD104 APC 346-11A BD Lyoplate 0.5 µg/mL 
84 CD105 PE MJ7/18     
85 CD106 FITC 429 E000558 10 µg/mL 
  CD106 APC 429 BD Lyoplate 0.5 µg/mL 
  CD106 Alexa 647 429 6825   
  CD106 PE 429 142218   
86 CD107b APC ABL-93 24095   
87 CD115 PE AFS98   10 µg/mL 
88 CD117 APC 2B8 BD Lyoplate 0.5 µg/mL 
  CD117 PE 3C1     
89 CD118 PE   980779   
90 CD119 Biotin 2 E 2 66391 10 µg/mL 
91 CD121a APC 35F5 BD Lyoplate 0.5 µg/mL 
92 CD121b APC 4.00E+02 BD Lyoplate 0.5 µg/mL 
93 CD122 PE 5H4   10 µg/mL 
  CD122 APC TM-BETA1 BD Lyoplate 0.5 µg/mL 
94 CD123 APC 5B11 BD Lyoplate 0.5 µg/mL 
  CD123 Biotin 5B11 E000228 10 µg/mL 
95 CD124 APC mIL4R-M1 BD Lyoplate 0.5 µg/mL 
  CD124 Biotin mIL4R-M1 30599 10 µg/mL 
96 CD125 APC T21 BD Lyoplate 0.5 µg/mL 
97 CD126 PE D7715A7 70421 10 µg/mL 
98 CD127 APC B12-1 BD Lyoplate 0.5 µg/mL 
  CD127 PE 3C1     
99 CD131 APC JORO50 BD Lyoplate 0.5 µg/mL 
  CD131 PE JORO50 63983 10 µg/mL 
100 CD132 APC TUGm2 BD Lyoplate 0.5 µg/mL 
  CD132 Biotin TUGm2 53852 10 µg/mL 
101 CD134 APC Ox-86 BD Lyoplate 0.5 µg/mL 
  CD134 PE Ox-86 B129281 10 µg/mL 
102 CD135 APC A2F10.1 BD Lyoplate 0.5 µg/mL 
  CD135 PE A2F10.1 60614 10 µg/mL 
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103 CD137 APC 1AH2 BD Lyoplate 0.5 µg/mL 
  CD137 PE 17B5 12-1371-83 10 µg/mL 
104 CD138 APC 281-2 BD Lyoplate 0.5 µg/mL 
  CD138 FITC 281-2 10611 10 µg/mL 
105 CD140a APC APA5 BD Lyoplate 0.5 µg/mL 
  CD140a PE APA5     
  CD140a PE APA5     
106 CD140b PE APB5     
107 CD144 APC 11D4.1 BD Lyoplate 0.5 µg/mL 
  CD144 PUR   59054   
108 CD146 PE ME-9F1     
109 CD147 APC RL73 BD Lyoplate 0.5 µg/mL 
110 CD152 PE UC10-4F10-11 68895 10 µg/mL 
  CD152 PE UC10-4F10-11 68895   
111 CD153 APC RM153 BD Lyoplate 0.5 µg/mL 
  CD153 PE RM153 E01274-1631   
112 CD154 PE MR1     
113 CD162 APC 2PH1 BD Lyoplate 0.5 µg/mL 
  CD162 PE 2PH1 63676 10 µg/mL 
114 CD166 PE eBioALC48 E015555-1373   
115 CD172A APC P84 BD Lyoplate 0.5 µg/mL 
116 CD172A APC P84 E14163-102   
117 CD178 Biotin MFL3 45020 10 µg/mL 
118 CD178.1 Biotin KAY-10 63818 10 µg/mL 
119 CD179a APC R3/VPREB BD Lyoplate 0.5 µg/mL 
120 CD179b APC LM34 BD Lyoplate 0.5 µg/mL 
  CD179b Biotin LM34 46674 10 µg/mL 
121 CD180 APC RP/14 BD Lyoplate 0.5 µg/mL 
  CD180 Biotin RP/14 44142 10 µg/mL 
122 CD184 PE 2B11/CXCR4 26361 10 µg/mL 
  CD184 Biotin 2B11/CXCR4 37846 10 µg/mL 
  CD184 APC 2B11/CXCR4 BD Lyoplate 0.5 µg/mL 
123 CD185 APC 2G8 BD Lyoplate 0.5 µg/mL 
124 CD195 APC C43-3448 BD Lyoplate 0.5 µg/mL 
125 CD197 APC 4B12 BD Lyoplate 0.5 µg/mL 
126 CD200 APC OX-90 BD Lyoplate 0.5 µg/mL 
  CD200 Biotin OX-90 B116104   
127 CD205 PE NLDC145     
128 CD209a APC Ox-90 BD Lyoplate 0.5 µg/mL 
129 CD210 APC 5H10 BD Lyoplate 0.5 µg/mL 
  CD210 PE 1B1.3a 43380 10 µg/mL 
130 CD223 PE C9B7W 30101 10 µg/mL 
  CD223 APC C9B7W BD Lyoplate 0.5 µg/mL 
  CD223 PE C9B7W     
131 CD224.2 Biotin 2B4 44892 10 µg/mL 
132 CD229.1 Biotin 30C7 7002 10 µg/mL 
134 CD244.1 APC C9.1 BD Lyoplate 0.5 µg/mL 
135 CD252 APC RM134L BD Lyoplate 0.5 µg/mL 
136 CD253 APC N2B2 BD Lyoplate 0.5 µg/mL 
  CD253 PE N2B5     
137 CD254 APC IK22-5 BD Lyoplate 0.5 µg/mL 
138 CD262 PE MD5-1 B127799   
139 CD267 APC 8F10 BD Lyoplate 0.5 µg/mL 
140 CD268 PE 7H22-E16     
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141 CD271 PE       
142 CD273 APC TY25 BD Lyoplate 0.5 µg/mL 
  CD273 PE TY25 69347 10 µg/mL 
143 CD274 APC MIH5 BD Lyoplate 0.5 µg/mL 
144 CD278 APC 7E.17G9 BD Lyoplate 0.5 µg/mL 
  CD278 PE E7.17G9     
145 CD279 PE J43 64077 10 µg/mL 
  CD279 PE HA2-7B1     
146 CD284 APC MTS5510 BD Lyoplate 0.5 µg/mL 
  CD284 PE MTS510     
  CD284 PE MTS510 66992   
  CD284 PE MTS510 66992   
147 CD309 APC AVas12 BD Lyoplate 0.5 µg/mL 
  CD309 PE AVas12     
148 CD314 APC CX5 BD Lyoplate 0.5 µg/mL 
  CD314 PE CX5 1748   
149 CD326 PE caa7-9G8     
  CD326 APC G8.8 BD Lyoplate 0.5 µg/mL 
150 CD335 APC 29A1.4 BD Lyoplate 0.5 µg/mL 
            
151 A2B5 PE 105H29     
            
152 BP-1 FITC 6C3 E023756 10 µg/mL 
  BP-1 PE FG35.4 E02013-260   
153 BCL-2         
154 CCR2 PE 454301     
155 Clec12A PE inhouse     
156 Crry/p65 APC 1F2 BD Lyoplate 0.5 µg/mL 
157 DCs APC 33D1 BD Lyoplate 0.5 µg/mL 
158 DCAR1 PE SKa5-3D5     
159 DCIR2 PE 33D1     
160 DDR-2 PUR N-20 A0810   
161 Dectin-2 FITC KVa7-6E7     
162 Delta like 1 PE     1 zu 50 
163 Do11.10 PE KJ1-26     
164 Early B cell APC 493 BD Lyoplate 0.5 µg/mL 
165 EOMES Pur 21Mags8 E034391   
166 E-Cadherin Pur       
167 EGF-receptor Pur        
168 Erythroid cells APC Terr-119 BD Lyoplate 0.5 µg/mL 
169 FceRI alpha PE MAR-1 E01907-1460 10 µg/mL 
  FceRI alpha PE MAR-1     
170 Feeder PE mEF-SK4     
171 FET 4 Biotin       
172 FR4 PE TH6     
173 F4/80 APC 6F12 BD Lyoplate 0.5 µg/mL 
  F4/80 PE BM8   10 µg/mL 
174 Fgfr3 CD333         
175 FLK-1 PE       
176 gamma d. TcR PE UC7 13D5 97702   
177 Galectin-9 PE 10A82 B131154 10 µg/mL 
178 GITR APC DTA-1 BD Lyoplate 0.5 µg/mL 
  GITR PE RB6-8C5     
179 GR-1         
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180 GL-7 Biotin GL7 E027851 10 µg/mL 
181 H2kk PE H100-27.R55     
182 I-A/I-E APC 2G9 BD Lyoplate 0.5 µg/mL 
183 Integrin beta 7 PE FIB27 B126977   
184 Int 7ß chain APC FIB27 BD Lyoplate 0.5 µg/mL 
185 IL12R Biotin       
186 IL21R APC 4A9 BD Lyoplate 0.5 µg/mL 
187 ICOS         
188 Jagged 1 CD339 PE HMJ1-29 E11619-1630 10 µg/mL 
189 Jagged 2 PE HMJ2-1 B136766 10 µg/mL 
190 Jagged 2  PE HMJ2-1 B134201   
191 KLRG1 PE 2F1     
  KLRG1 APC 2F1 BD Lyoplate 0.5 µg/mL 
192 LPAM-1 APC DATK32 BD Lyoplate 0.5 µg/mL 
193 Ly-6A/E APC E13-161.7 BD Lyoplate 0.5 µg/mL 
194 Ly-6C PE 1G7.G10     
195 Ly-6D APC 49-H4 BD Lyoplate 0.5 µg/mL 
196 Ly-6G APC 1A8 BD Lyoplate 0.5 µg/mL 
  Ly-6G PE 1AB     
197 Ly-6G/ly-6C APC RB6-BC5 BD Lyoplate 0.5 µg/mL 
198 Ly 49D PE 4 E 5 B136428 10 µg/mL 
199 MHC class II PE M5/114.15.2     
200 Mac-3 APC M3/84 BD Lyoplate 0.5 µg/mL 
201 MAdCAM-1 APC MECA-89 BD Lyoplate 0.5 µg/mL 
202 MD-1 APC 20D5 BD Lyoplate 0.5 µg/mL 
203 mPDCA-1 PE JF05-1C2.4.1     
204 NK1.1 PE PK136     
205 NKG2A/C/E APC 20D5 BD Lyoplate 0.5 µg/mL 
206 NTK/NK Cell Antigen APC U5A2-13 BD Lyoplate 0.5 µg/mL 
207 NKp46 PE 29A1.4     
208 Notch1 PE 22  E 5     
209 Notch1 PE     0.5 
210 Notch2 PE     0.5 
  Notch2 PE HMN2-35 B124873 10 µg/mL 
211 Notch3 PE HMN3-133     
212 Notch4  PE HMN-14 B118926   
213 OX-90 PE     10 µg/mL 
214 O4 PE       
215 Panendothelial cell AG APC MECA_32 BD Lyoplate 0.5 µg/mL 
216 PDCA-1 PE JF05-1C2.4.1     
217 PIRA/B APC 6C1 BD Lyoplate 0.5 µg/mL 
218 PSA-NCAM PE 2-2B     
219 Pre-BCR APC       
220 Prominin PE MB9-3G8     
221 Sca-1 PE D/7     
222 SiglecH PE 551.3D3     
223 SiglecF APC E50-2440 BD Lyoplate 0.5 µg/mL 
  SiglecF PE E50-2440   2,5 µg/mL 
224 Syndecan APC KY/8.2 BD Lyoplate 0.5 µg/mL 
225 SSEA 3 Pur        
225 T/B cell activation APC U5A2-13 BD Lyoplate 0.5 µg/mL 
227 TcR PE     10 µg/mL 
  TcR FITC     10 µg/mL 
228 Trail Biotin N2B2     
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229 Tim-3 PE RMT3-23   10 µg/mL 
  Tim-3         
230 Vegfr3 Biotin BAF743 DDN0207101   
231 Vgamma3TCR APC 536 BD Lyoplate 0.5 µg/mL 
232 4-1BB APC TKS_1 BD Lyoplate 0.5 µg/mL 
 
III Appendix II: Gene list gen expression profiling 
    
A-G+ vs 
A+G-     
GeneName ProbeName 
Tukey.p-
value Fold_Change  log_2 ratio 
Nphs1 A_55_P1996479 2.23E-04 32.078 5.004 
Mybpc1 A_55_P2165299 2.17E-04 21.736 4.442 
Kirrel2 A_51_P512306 9.23E-04 16.965 4.085 
Ptf1a A_51_P226711 8.48E-04 16.421 4.038 
A_30_P01019652 A_30_P01019652 3.32E-04 15.263 3.932 
ENSMUST00000112841 A_66_P110542 6.14E-04 15.216 3.928 
Gdf10 A_51_P185247 2.39E-04 13.987 3.806 
Myh8 A_51_P143296 1.35E-03 13.905 3.798 
Slco4a1 A_55_P1989653 1.96E-04 13.704 3.777 
Ccbe1 A_52_P39083 6.05E-05 13.408 3.745 
Greb1l A_52_P60353 1.05E-05 13.118 3.714 
LOC552873 A_55_P2237142 9.08E-04 12.924 3.692 
Npy A_51_P454873 2.69E-04 12.454 3.639 
Ass1 A_55_P2143070 1.92E-04 11.967 3.581 
Msx2 A_55_P2043486 3.02E-04 11.774 3.558 
0610040J01Rik A_51_P483617 1.54E-04 9.935 3.313 
Scube2 A_55_P2060429 8.71E-05 9.533 3.253 
Prdm13 A_55_P2044897 1.38E-03 9.370 3.228 
A_30_P01030328 A_30_P01030328 3.70E-04 9.151 3.194 
Hmga2 A_52_P300730 2.44E-04 9.013 3.172 
Wipf3 A_51_P316951 1.99E-04 8.972 3.166 
Col25a1 A_55_P2160750 9.46E-05 8.969 3.165 
Tbc1d4 A_52_P381430 5.23E-04 8.960 3.164 
Gm5089 A_55_P2030496 1.81E-04 8.907 3.155 
Ass1 A_55_P2004781 5.80E-04 8.861 3.148 
Wif1 A_51_P484526 7.20E-04 8.700 3.121 
Col2a1 A_55_P2004179 2.05E-06 8.616 3.107 
Hhip A_55_P1969276 5.77E-05 8.465 3.082 
Cdh4 A_55_P2150831 6.59E-04 8.095 3.017 
Gas2l3 A_55_P2120189 2.22E-06 7.959 2.993 
Tbc1d4 A_55_P2024953 7.06E-05 7.890 2.980 
LOC100048332 A_55_P1970715 1.35E-03 7.687 2.943 
Cdh4 A_52_P402897 4.19E-04 7.613 2.929 
LOC674761 A_55_P2093231 1.36E-04 7.423 2.892 
LOC552901 A_55_P2243828 3.20E-04 7.220 2.852 
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Cxcr4 A_52_P585124 1.86E-04 7.140 2.836 
Atp1b1 A_51_P151484 4.84E-04 7.133 2.835 
Myh7 A_55_P2093232 4.96E-05 7.089 2.826 
Scube2 A_55_P2232988 5.32E-04 7.067 2.821 
Lrba A_55_P2100305 2.57E-05 7.030 2.814 
Irx4 A_51_P412508 7.22E-04 6.866 2.780 
Mbp A_55_P1992160 3.12E-05 6.523 2.706 
Mybpc1 A_55_P2008443 2.25E-04 6.366 2.671 
Gas2l3 A_55_P2100475 7.16E-06 6.086 2.606 
Fam118a A_55_P2147886 6.72E-04 5.996 2.584 
Lmcd1 A_51_P405912 3.78E-04 5.881 2.556 
Dach1 A_65_P07627 2.62E-04 5.879 2.556 
Dach1 A_55_P1959763 4.56E-04 5.848 2.548 
Lmcd1 A_55_P1985273 7.24E-07 5.846 2.548 
Auts2 A_55_P2015807 1.86E-04 5.786 2.533 
Gas2l3 A_55_P2064676 2.36E-06 5.770 2.529 
A_30_P01025154 A_30_P01025154 2.21E-04 5.712 2.514 
Stk10 A_51_P192130 1.39E-04 5.690 2.509 
A_30_P01018665 A_30_P01018665 3.87E-04 5.686 2.508 
Gucy1a3 A_55_P1992049 2.22E-04 5.665 2.502 
Pla2g5 A_55_P1962693 9.12E-04 5.496 2.459 
LOC100048353 A_55_P2098603 4.91E-05 5.470 2.452 
Gria4 A_52_P349182 2.92E-04 5.251 2.393 
A_30_P01029151 A_30_P01029151 1.05E-03 5.238 2.389 
Gli1 A_55_P2183587 1.14E-04 5.227 2.386 
Vcan A_55_P1960208 1.10E-03 5.184 2.374 
Gpr126 A_66_P114451 6.47E-04 5.160 2.368 
Emid1 A_55_P1954276 4.83E-05 5.095 2.349 
Rad51 A_55_P2008126 7.32E-05 5.068 2.342 
A_30_P01031644 A_30_P01031644 2.49E-04 5.061 2.340 
A_30_P01027548 A_30_P01027548 1.37E-04 4.928 2.301 
Magi2 A_66_P106750 5.31E-04 4.790 2.260 
Vwa5b1 A_55_P2081990 2.67E-04 4.719 2.239 
Kit A_66_P128434 1.08E-03 4.691 2.230 
Fam60a A_55_P2180551 1.23E-03 4.690 2.230 
ENSMUST00000054333 A_55_P2057051 5.15E-04 4.683 2.228 
D6Ertd131e A_55_P2360501 3.47E-04 4.606 2.204 
1700084M14Rik A_51_P428297 1.48E-03 4.571 2.193 
A_30_P01024922 A_30_P01024922 3.60E-04 4.546 2.185 
Nav2 A_55_P2071961 1.08E-04 4.491 2.167 
Pion A_66_P129710 6.06E-05 4.482 2.164 
A_30_P01024586 A_30_P01024586 7.04E-04 4.465 2.159 
XM_888730 A_55_P2022870 4.87E-04 4.415 2.143 
Fzd1 A_52_P597634 3.30E-05 4.409 2.141 
Gm9631 A_55_P2013029 1.86E-03 4.385 2.133 
AU024581 A_55_P2417212 3.36E-04 4.383 2.132 
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A_30_P01017899 A_30_P01017899 9.25E-04 4.281 2.098 
A_30_P01029325 A_30_P01029325 1.33E-03 4.269 2.094 
Cep55 A_55_P2187918 7.08E-05 4.237 2.083 
Kif15 A_52_P227391 1.83E-03 4.235 2.083 
A_30_P01028127 A_30_P01028127 2.55E-03 4.215 2.076 
Hells A_51_P351970 6.45E-04 4.200 2.071 
Ptch2 A_55_P1999408 4.56E-04 4.179 2.063 
Baz1a A_66_P139196 7.39E-04 4.176 2.062 
A_30_P01031709 A_30_P01031709 1.16E-03 4.158 2.056 
Arid3b A_51_P161554 6.03E-06 4.132 2.047 
A_30_P01029269 A_30_P01029269 9.03E-05 4.130 2.046 
Ttll2 A_55_P1962756 1.10E-03 4.078 2.028 
2900072G11Rik A_55_P2422243 1.56E-04 4.057 2.021 
Nes A_55_P1953728 9.83E-06 4.054 2.020 
Cdc6 A_52_P219473 1.43E-03 4.032 2.012 
A_30_P01033354 A_30_P01033354 9.99E-06 4.025 2.009 
Pvalb A_55_P2114437 5.52E-04 4.011 2.004 
A_30_P01023742 A_30_P01023742 8.52E-05 4.011 2.004 
Med12l A_55_P2134616 1.72E-03 4.001 2.001 
 
    
A-G+ vs 
A+G-     
GeneName ProbeName 
Tukey.p-
value Fold_Change  log_2 ratio 
Mag A_55_P2062757 2.89E-02 -4.004 -2.002 
Slc25a18 A_55_P2103225 1.39E-02 -4.004 -2.002 
Ccdc19 A_55_P2015485 8.02E-03 -4.007 -2.003 
Higd1b A_55_P2111523 1.58E-01 -4.017 -2.006 
Bcl6 A_52_P161495 3.02E-04 -4.018 -2.007 
Slc14a1 A_51_P312336 6.34E-03 -4.018 -2.007 
3110082D06Rik A_51_P161257 5.53E-03 -4.024 -2.009 
Aqp11 A_55_P1995507 1.45E-03 -4.024 -2.009 
Tmem117 A_51_P207940 5.45E-04 -4.028 -2.010 
Scd1 A_52_P682382 1.70E-02 -4.029 -2.011 
Nrsn2 A_55_P2009427 4.55E-02 -4.038 -2.014 
Rora A_55_P2078123 2.73E-03 -4.047 -2.017 
A_30_P01022407 A_30_P01022407 1.93E-03 -4.049 -2.018 
Frat1 A_52_P584188 7.63E-03 -4.061 -2.022 
Pld2 A_55_P2049567 1.43E-02 -4.069 -2.025 
Slc22a8 A_55_P1995407 4.52E-03 -4.069 -2.025 
Padi2 A_55_P2074656 4.38E-02 -4.073 -2.026 
Hebp1 A_51_P376347 1.70E-05 -4.074 -2.027 
Il34 A_51_P268234 1.50E-02 -4.076 -2.027 
S100a6 A_51_P281089 1.39E-03 -4.076 -2.027 
Tle2 A_55_P2185543 6.56E-04 -4.084 -2.030 
Foxc1 A_55_P1967761 9.00E-03 -4.097 -2.035 
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4933407E14Rik A_55_P2253284 6.13E-04 -4.098 -2.035 
Slc25a34 A_55_P2073248 2.59E-03 -4.104 -2.037 
Trnp1 A_55_P2123673 1.33E-02 -4.104 -2.037 
Cfh A_55_P2017418 2.04E-02 -4.120 -2.043 
Ddit4 A_51_P245796 5.15E-03 -4.128 -2.046 
Qprt A_51_P394014 1.76E-02 -4.128 -2.046 
Acot5 A_55_P2038362 3.14E-04 -4.148 -2.053 
Slc6a9 A_55_P1973838 4.91E-03 -4.148 -2.053 
Igfbp2 A_66_P135391 2.22E-03 -4.161 -2.057 
Srpx A_55_P2207255 5.08E-02 -4.170 -2.060 
Fhl2 A_51_P140237 7.14E-03 -4.174 -2.062 
1110017D15Rik A_55_P2133365 1.91E-02 -4.176 -2.062 
A_30_P01026000 A_30_P01026000 4.99E-05 -4.181 -2.064 
Metrnl A_52_P355084 1.22E-04 -4.186 -2.066 
Neat1 A_51_P234692 2.26E-02 -4.187 -2.066 
Chst10 A_51_P445562 1.43E-04 -4.196 -2.069 
Retsat A_51_P319070 3.51E-03 -4.197 -2.070 
Dnahc2 A_55_P2106180 7.45E-04 -4.197 -2.070 
A_30_P01021613 A_30_P01021613 4.45E-05 -4.202 -2.071 
Nr2f2 A_55_P2128283 1.18E-04 -4.209 -2.074 
Lepr A_55_P2177911 4.01E-02 -4.219 -2.077 
Arhgdig A_55_P2096762 2.14E-02 -4.221 -2.078 
A_30_P01029720 A_30_P01029720 2.36E-02 -4.230 -2.081 
Clu A_55_P2017929 5.78E-03 -4.262 -2.092 
Lrrc46 A_52_P375546 4.43E-03 -4.262 -2.092 
Tmco4 A_55_P2180944 2.20E-03 -4.269 -2.094 
S100a16 A_66_P114627 2.15E-03 -4.274 -2.096 
Ppp1r3d A_51_P169516 9.84E-03 -4.277 -2.097 
Plcg2 A_51_P279163 2.04E-03 -4.293 -2.102 
Pear1 A_52_P278295 2.15E-02 -4.298 -2.104 
Emid2 A_55_P1954271 6.77E-03 -4.317 -2.110 
Csdc2 A_51_P183561 8.68E-03 -4.318 -2.111 
Slc38a3 A_51_P139030 7.94E-05 -4.324 -2.113 
Gjb2 A_52_P382886 4.24E-02 -4.329 -2.114 
Ednra A_52_P156190 1.04E-04 -4.330 -2.115 
Cdhr4 A_55_P2141782 3.41E-03 -4.341 -2.118 
Col16a1 A_55_P2124751 2.44E-04 -4.342 -2.119 
A2m A_55_P2459897 4.92E-03 -4.351 -2.122 
Prkcz A_55_P1987761 7.37E-03 -4.370 -2.128 
Cyp4v3 A_52_P302345 1.76E-03 -4.370 -2.128 
Epas1 A_51_P250058 1.38E-02 -4.374 -2.129 
Sod3 A_55_P2077558 1.37E-03 -4.376 -2.130 
ENSMUST00000051089 A_51_P361620 5.89E-03 -4.377 -2.130 
Aldh1a2 A_52_P58145 1.15E-02 -4.377 -2.130 
Adcy2 A_51_P337523 1.28E-03 -4.400 -2.138 
Zdhhc2 A_51_P117226 8.20E-03 -4.411 -2.141 
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Slc24a3 A_55_P2099650 2.42E-04 -4.418 -2.144 
A_30_P01026656 A_30_P01026656 3.87E-03 -4.452 -2.155 
Gatm A_51_P461319 4.09E-04 -4.460 -2.157 
Amy1 A_55_P1983418 1.02E-03 -4.477 -2.163 
C1s A_55_P2042612 9.40E-03 -4.480 -2.164 
Cml5 A_52_P2710 3.93E-02 -4.489 -2.167 
Rgs9 A_55_P2032232 1.22E-02 -4.502 -2.171 
A_30_P01023417 A_30_P01023417 2.81E-03 -4.517 -2.176 
Cebpb A_55_P2165869 3.04E-05 -4.519 -2.176 
Zfp503 A_55_P2001998 2.79E-04 -4.522 -2.177 
ENSMUST00000000102 A_55_P2185362 2.16E-02 -4.552 -2.187 
A_30_P01023251 A_30_P01023251 1.63E-02 -4.558 -2.189 
1110006E14Rik A_55_P2419296 3.19E-02 -4.565 -2.191 
Acp5 A_55_P2037608 3.11E-02 -4.579 -2.195 
Lrrc51 A_55_P2099627 3.87E-02 -4.580 -2.196 
Parm1 A_51_P114693 8.07E-04 -4.582 -2.196 
Ank2 A_55_P2131288 8.92E-06 -4.585 -2.197 
Spon2 A_52_P381484 2.39E-02 -4.592 -2.199 
Rapgef5 A_55_P1968568 4.04E-02 -4.598 -2.201 
A_30_P01027987 A_30_P01027987 1.34E-03 -4.611 -2.205 
Rnf128 A_55_P2007088 4.84E-03 -4.636 -2.213 
Pdk4 A_51_P350453 1.49E-03 -4.648 -2.217 
Nr1d1 A_51_P223776 7.04E-04 -4.672 -2.224 
Sdsl A_55_P2055557 1.07E-04 -4.695 -2.231 
Wdr16 A_51_P288558 5.92E-03 -4.704 -2.234 
Sfrp5 A_55_P2020203 1.10E-02 -4.714 -2.237 
Gm5151 A_55_P2087061 2.74E-02 -4.719 -2.239 
Osr1 A_55_P1962901 1.10E-02 -4.731 -2.242 
Klhdc9 A_51_P479352 4.86E-04 -4.737 -2.244 
Gm2a A_52_P353417 1.18E-03 -4.767 -2.253 
Hbegf A_51_P181565 1.38E-04 -4.798 -2.263 
Isg15 A_55_P2103698 4.04E-03 -4.803 -2.264 
Kcnd3 A_66_P122219 1.35E-03 -4.810 -2.266 
Lnx1 A_55_P2076462 2.82E-03 -4.832 -2.273 
Osmr A_51_P319460 5.08E-03 -4.867 -2.283 
Ccdc67 A_55_P2002642 5.35E-02 -4.869 -2.284 
Olfm1 A_55_P2160296 1.63E-02 -4.877 -2.286 
Foxj1 A_51_P456870 2.71E-03 -4.885 -2.289 
Sema4a A_55_P2014229 1.40E-02 -4.889 -2.290 
H2-Bl A_55_P1981494 2.28E-05 -4.894 -2.291 
Susd4 A_55_P1954393 2.79E-06 -4.897 -2.292 
Rgs9 A_55_P1969032 4.92E-03 -4.908 -2.295 
Vpreb3 A_55_P2136906 1.71E-02 -4.916 -2.298 
A2ld1 A_51_P262230 6.71E-04 -4.923 -2.300 
Rarres1 A_51_P401184 4.46E-03 -4.923 -2.300 
LOC100046471 A_55_P2028382 6.20E-06 -4.938 -2.304 
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Lgals3 A_55_P2171116 1.05E-03 -4.940 -2.305 
4933430H15Rik A_51_P485472 5.41E-04 -4.952 -2.308 
Gm10134 A_55_P2277171 1.17E-02 -4.988 -2.319 
Lor A_51_P495269 2.21E-03 -4.988 -2.319 
Sphk1 A_55_P2186005 1.67E-03 -5.000 -2.322 
Cxcl1 A_51_P363187 7.24E-03 -5.009 -2.325 
VCAM-1 A_51_P210956 6.09E-04 -5.012 -2.326 
Adm A_51_P265571 8.47E-04 -5.016 -2.327 
Meg3 A_51_P455997 9.52E-04 -5.019 -2.328 
Dync1i1 A_55_P2090429 1.40E-02 -5.039 -2.333 
Tmem229a A_66_P139666 3.97E-03 -5.040 -2.334 
Vstm2a A_55_P1973377 1.68E-02 -5.040 -2.334 
Aif1 A_51_P400543 2.97E-02 -5.051 -2.337 
Itgb3 A_52_P553890 7.69E-04 -5.060 -2.339 
Cd82 A_55_P2137927 3.80E-02 -5.081 -2.345 
Apod A_55_P2093286 4.39E-03 -5.118 -2.356 
Cgref1 A_51_P372550 2.02E-03 -5.125 -2.358 
Crlf1 A_55_P2052240 7.15E-03 -5.127 -2.358 
Klf2 A_51_P144264 1.10E-04 -5.159 -2.367 
Lst1 A_55_P2052834 1.51E-02 -5.160 -2.368 
Erbb4 A_55_P2119892 7.81E-03 -5.173 -2.371 
Lhfp A_51_P505868 1.03E-05 -5.182 -2.374 
C1qtnf2 A_52_P601021 1.74E-02 -5.187 -2.375 
Rsph1 A_51_P373901 7.28E-03 -5.191 -2.376 
Gnal A_55_P2119633 2.63E-02 -5.198 -2.378 
Socs3 A_51_P474459 1.46E-04 -5.214 -2.383 
Mirg A_66_P121059 6.34E-04 -5.220 -2.384 
H19 A_55_P1961127 3.95E-03 -5.258 -2.395 
Entpd2 A_55_P1974645 1.53E-03 -5.263 -2.396 
Alcam A_51_P359272 2.59E-03 -5.265 -2.397 
A_30_P01028827 A_30_P01028827 9.32E-03 -5.274 -2.399 
Tm4sf1 A_51_P240614 5.33E-04 -5.274 -2.399 
Hist1h1c A_51_P516133 2.44E-06 -5.274 -2.399 
Lrtm2 A_55_P1954231 5.82E-03 -5.285 -2.402 
Tmem100 A_52_P368306 1.26E-03 -5.291 -2.404 
Slc22a6 A_51_P360655 8.96E-03 -5.291 -2.404 
Rnase4 A_51_P237383 3.84E-03 -5.300 -2.406 
Sepp1 A_51_P470328 1.24E-05 -5.317 -2.411 
A_30_P01028007 A_30_P01028007 6.14E-03 -5.341 -2.417 
BC026782 A_52_P796840 1.27E-02 -5.346 -2.419 
A_30_P01021588 A_30_P01021588 5.07E-03 -5.385 -2.429 
Mfsd2a A_51_P279437 4.13E-04 -5.391 -2.431 
Mtus2 A_55_P2083252 2.56E-02 -5.396 -2.432 
Crlf1 A_52_P304720 2.41E-02 -5.413 -2.437 
Rsph1 A_55_P2044684 1.49E-03 -5.462 -2.450 
Cadm2 A_55_P2142928 5.31E-04 -5.466 -2.451 
 
  Supplementary Data  
 
-XXII- 
Parp10 A_55_P2130970 2.34E-03 -5.466 -2.451 
Ranbp3l A_55_P1969306 2.03E-02 -5.472 -2.452 
Rapgef3 A_51_P116906 3.16E-04 -5.481 -2.455 
1520402A15Rik A_52_P547491 1.59E-02 -5.493 -2.458 
Rtp4 A_51_P304170 3.28E-04 -5.514 -2.463 
Vtn A_51_P109840 2.39E-02 -5.533 -2.468 
Cadm2 A_51_P442642 5.12E-04 -5.548 -2.472 
A_30_P01026972 A_30_P01026972 3.88E-03 -5.548 -2.472 
Eml2 A_55_P1989921 3.23E-03 -5.550 -2.473 
Chst11 A_51_P275101 4.13E-03 -5.562 -2.476 
Olfml3 A_55_P2102540 2.78E-02 -5.606 -2.487 
Acsl6 A_51_P380699 9.02E-03 -5.649 -2.498 
Gpr146 A_55_P2027392 7.71E-04 -5.661 -2.501 
Negr1 A_55_P2012572 1.09E-03 -5.667 -2.503 
Hist2h3c2-ps A_55_P2142251 1.86E-04 -5.675 -2.505 
Sall1 A_55_P1977850 1.92E-03 -5.676 -2.505 
Gm3088 A_55_P2163897 7.13E-04 -5.692 -2.509 
Epha5 A_55_P2100425 9.08E-03 -5.694 -2.510 
Tap2 A_55_P2017645 8.32E-04 -5.698 -2.511 
Ccdc113 A_55_P1981704 9.05E-03 -5.706 -2.513 
Samd9l A_55_P2151601 1.24E-02 -5.714 -2.515 
A_30_P01033149 A_30_P01033149 2.88E-03 -5.756 -2.525 
A_30_P01032682 A_30_P01032682 1.52E-04 -5.764 -2.527 
LOC100045638 A_55_P1974984 7.50E-03 -5.790 -2.534 
B3gat2 A_55_P2079679 3.73E-02 -5.810 -2.539 
1190002A17Rik A_51_P101006 2.61E-02 -5.812 -2.539 
A_30_P01032789 A_30_P01032789 2.76E-03 -5.830 -2.544 
Aspa A_51_P259975 7.24E-04 -5.834 -2.545 
Ccdc85a A_55_P1980521 7.97E-06 -5.838 -2.546 
Gpr17 A_51_P170463 2.90E-02 -5.842 -2.547 
Hspa1a A_55_P2068459 1.80E-02 -5.862 -2.552 
Ephx2 A_55_P2002572 3.66E-03 -5.877 -2.555 
Rgs16 A_51_P249286 1.06E-04 -5.889 -2.558 
A_30_P01032469 A_30_P01032469 7.68E-03 -5.893 -2.559 
Synm A_55_P2052696 1.36E-02 -5.897 -2.560 
Tctex1d1 A_55_P2051270 1.07E-02 -5.899 -2.561 
Ifi27l2a A_52_P90363 4.23E-02 -5.901 -2.561 
Cdh13 A_51_P114826 2.18E-03 -5.915 -2.565 
Slc7a10 A_51_P268193 1.62E-03 -5.934 -2.569 
A_30_P01025068 A_30_P01025068 4.18E-03 -5.938 -2.570 
Mbp A_52_P329451 5.77E-03 -5.940 -2.571 
Tcp11 A_55_P1986421 5.60E-03 -5.942 -2.571 
Lgi3 A_51_P356967 5.47E-03 -5.971 -2.578 
Plxdc2 A_55_P2022211 2.64E-05 -5.975 -2.579 
Crip3 A_51_P325501 1.19E-03 -5.977 -2.580 
Papss2 A_55_P2080021 1.49E-03 -6.002 -2.586 
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Serp2 A_52_P539310 2.95E-02 -6.013 -2.588 
1700016K19Rik A_55_P2068356 5.32E-03 -6.017 -2.589 
Fzd9 A_51_P511015 6.42E-04 -6.048 -2.597 
Tmem132b A_52_P38908 1.15E-02 -6.069 -2.602 
Rbp4 A_55_P2006118 1.18E-03 -6.080 -2.604 
Meg3 A_55_P2033407 5.11E-04 -6.124 -2.615 
Car2 A_51_P455647 3.38E-04 -6.145 -2.620 
Plp1 A_55_P2069850 4.21E-03 -6.165 -2.624 
Crispld2 A_55_P2052016 1.82E-02 -6.167 -2.625 
Meg3 A_52_P196568 4.24E-02 -6.169 -2.625 
Ccno A_51_P291501 6.68E-03 -6.199 -2.632 
ENSMUST00000097840 A_66_P139703 7.34E-03 -6.223 -2.638 
A_30_P01026518 A_30_P01026518 4.69E-03 -6.235 -2.641 
Hspb8 A_51_P464387 3.50E-03 -6.240 -2.642 
Mrgprf A_55_P2116180 1.13E-02 -6.259 -2.646 
A_30_P01020627 A_30_P01020627 3.86E-03 -6.264 -2.647 
Slc6a13 A_51_P438083 5.43E-03 -6.272 -2.649 
Nrxn3 A_55_P2054643 9.99E-04 -6.272 -2.649 
Morn5 A_51_P201785 2.42E-03 -6.303 -2.656 
Dapl1 A_51_P391955 6.71E-03 -6.312 -2.658 
A_30_P01026799 A_30_P01026799 2.73E-03 -6.327 -2.662 
A_30_P01033229 A_30_P01033229 3.81E-03 -6.366 -2.671 
Slc7a11 A_52_P368057 3.95E-03 -6.429 -2.685 
C1qtnf4 A_52_P633489 1.09E-02 -6.444 -2.688 
Stk33 A_51_P511511 1.32E-04 -6.446 -2.689 
Zfp503 A_51_P126626 4.24E-04 -6.449 -2.689 
Kcna6 A_52_P130787 4.10E-04 -6.476 -2.695 
Srgn A_55_P2094925 2.18E-02 -6.480 -2.696 
Crabp2 A_55_P2059432 3.40E-03 -6.489 -2.698 
Pid1 A_52_P269158 3.95E-05 -6.491 -2.699 
Cpe A_55_P2024704 6.94E-05 -6.530 -2.707 
Pdzk1ip1 A_55_P2011678 8.82E-03 -6.555 -2.713 
Gabbr1 A_55_P2082135 7.29E-04 -6.561 -2.714 
Rcan2 A_55_P1961736 7.35E-05 -6.564 -2.715 
Nek5 A_51_P347529 1.38E-02 -6.582 -2.719 
Apoc1 A_55_P1975370 1.94E-04 -6.589 -2.720 
Sult1a1 A_51_P321341 1.44E-03 -6.596 -2.722 
Wnt4 A_51_P130475 3.78E-03 -6.632 -2.730 
A_30_P01018420 A_30_P01018420 3.65E-03 -6.635 -2.730 
Sult1a1 A_55_P2005475 8.84E-04 -6.641 -2.732 
S100a1 A_55_P1979645 4.88E-04 -6.653 -2.734 
A_30_P01018307 A_30_P01018307 1.21E-02 -6.665 -2.737 
Sidt1 A_51_P393305 5.93E-03 -6.699 -2.744 
Tekt4 A_51_P387868 4.44E-04 -6.765 -2.758 
Gabbr1 A_52_P16232 7.77E-04 -6.790 -2.764 
Hif3a A_55_P2015541 9.40E-05 -6.847 -2.776 
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Wnt5b A_55_P1984976 4.30E-04 -6.878 -2.782 
Ncan A_55_P2453279 8.42E-04 -6.950 -2.797 
Aebp1 A_55_P2035662 3.00E-04 -6.952 -2.798 
1700045I19Rik A_51_P408703 7.96E-03 -6.952 -2.798 
Cdc42ep2 A_52_P155554 1.01E-04 -6.964 -2.800 
Hist2h2aa1 A_55_P1962084 1.74E-04 -6.996 -2.807 
Fam189a2 A_52_P369123 8.30E-03 -7.010 -2.810 
Zdhhc2 A_52_P651248 3.89E-02 -7.059 -2.820 
Wnt7a A_52_P79782 1.01E-03 -7.096 -2.827 
Arhgdig A_51_P172085 2.80E-02 -7.116 -2.831 
Creg2 A_55_P2140651 1.36E-03 -7.193 -2.847 
Aldh1a1 A_51_P334942 4.44E-03 -7.263 -2.861 
4930506M07Rik A_51_P200561 3.68E-02 -7.268 -2.862 
Gfap A_52_P52303 1.40E-02 -7.295 -2.867 
Dynlrb2 A_51_P227962 2.93E-03 -7.413 -2.890 
Asrgl1 A_55_P2056310 3.43E-03 -7.426 -2.893 
S100a1 A_55_P1979650 3.50E-04 -7.469 -2.901 
Nrxn3 A_66_P127136 1.46E-02 -7.532 -2.913 
Gm7676 A_55_P2087265 1.91E-03 -7.589 -2.924 
Gjb6 A_52_P482251 5.40E-03 -7.626 -2.931 
Atp13a5 A_52_P607195 6.69E-04 -7.648 -2.935 
Foxc2 A_51_P196444 9.64E-03 -7.666 -2.939 
Ctgf A_51_P157042 3.65E-04 -7.706 -2.946 
6430519N07Rik A_55_P2205226 3.01E-02 -7.754 -2.955 
Maob A_51_P302566 1.08E-05 -7.768 -2.958 
Oprl1 A_55_P2066593 6.40E-02 -7.789 -2.962 
Fam166b A_66_P137660 2.28E-03 -7.789 -2.962 
Gbp2 A_51_P203955 1.13E-02 -7.830 -2.969 
Epha8 A_55_P2100485 4.73E-02 -7.868 -2.976 
Rap1gap A_55_P2039225 7.35E-04 -7.893 -2.981 
Irgm1 A_51_P262171 1.08E-04 -7.915 -2.985 
ENSMUST00000110985 A_55_P2096602 2.83E-03 -7.953 -2.992 
Wnt6 A_52_P415155 2.85E-03 -8.019 -3.004 
Car10 A_55_P2397904 9.19E-04 -8.053 -3.010 
Cbr2 A_55_P2122605 8.62E-03 -8.279 -3.050 
Tmem51 A_51_P125842 1.49E-04 -8.294 -3.052 
Sulf2 A_52_P193925 2.37E-05 -8.305 -3.054 
Lims2 A_55_P2174203 1.49E-02 -8.389 -3.069 
Nrxn1 A_52_P121342 7.06E-05 -8.409 -3.072 
Ifitm1 A_55_P2146254 1.50E-03 -8.415 -3.073 
Mt1 A_52_P423810 4.20E-03 -8.427 -3.075 
Sphk1 A_51_P501248 3.26E-05 -8.453 -3.080 
Cybrd1 A_55_P1956472 1.79E-04 -8.483 -3.085 
Plin5 A_55_P2104259 6.33E-04 -8.503 -3.088 
Fam134b A_51_P428578 5.91E-03 -8.547 -3.096 
Thy1 A_55_P2072035 1.83E-03 -8.586 -3.102 
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Wdr63 A_55_P1975989 7.60E-03 -8.655 -3.114 
Cpe A_55_P2025038 2.01E-04 -8.688 -3.119 
Fam92b A_52_P26626 6.59E-03 -8.721 -3.125 
Hdc A_51_P254656 1.68E-02 -8.733 -3.127 
4930579J09Rik A_51_P358462 2.96E-03 -8.745 -3.129 
Mal A_55_P2113160 6.31E-03 -8.815 -3.140 
Lyl1 A_51_P143190 3.55E-02 -8.877 -3.150 
Rgs4 A_55_P2026738 1.01E-03 -9.088 -3.184 
Crispld2 A_55_P2004016 6.97E-03 -9.363 -3.227 
Nrxn1 A_55_P2054628 2.41E-04 -9.533 -3.253 
Mpzl2 A_52_P322421 6.10E-03 -9.603 -3.264 
Slc6a20a A_55_P2032916 2.49E-03 -9.707 -3.279 
Dner A_52_P671132 8.76E-05 -9.727 -3.282 
Gfap A_55_P2157250 3.51E-03 -9.788 -3.291 
Cpne7 A_55_P2150962 6.73E-05 -9.887 -3.306 
Trim47 A_55_P2066697 1.04E-05 -10.004 -3.323 
Rspo1 A_51_P142421 6.17E-03 -10.060 -3.331 
Dok7 A_51_P155458 1.41E-02 -10.070 -3.332 
1190002H23Rik A_51_P226269 9.19E-06 -10.161 -3.345 
Gabbr1 A_51_P464900 1.12E-03 -10.175 -3.347 
Cmbl A_51_P272283 4.27E-03 -10.235 -3.356 
Fam176a A_51_P140641 4.88E-03 -10.285 -3.363 
Dcdc2a A_52_P640922 2.48E-06 -10.285 -3.363 
Csgalnact1 A_55_P2077618 9.03E-05 -10.335 -3.370 
Gpr182 A_51_P436068 1.27E-03 -10.339 -3.370 
Gja1 A_52_P174915 3.86E-05 -10.339 -3.370 
Rap1gap A_55_P2068096 5.57E-04 -10.350 -3.372 
Itih2 A_51_P196726 9.58E-04 -10.418 -3.381 
Ntsr2 A_52_P266686 4.15E-04 -10.461 -3.387 
Pygl A_51_P452779 5.95E-07 -10.615 -3.408 
Itpka A_51_P273609 1.26E-03 -10.633 -3.411 
Adora2b A_55_P1993503 2.25E-04 -10.677 -3.417 
Cxcl14 A_51_P209183 4.35E-04 -10.808 -3.434 
Dbc1 A_55_P2124941 3.70E-02 -10.970 -3.456 
Htra1 A_51_P225224 2.10E-04 -10.985 -3.458 
Dbx2 A_51_P352452 2.69E-05 -11.096 -3.472 
Cldn10a A_51_P456465 3.21E-04 -11.318 -3.501 
Igsf1 A_55_P2059864 9.50E-04 -11.373 -3.508 
1700001C02Rik A_55_P2111825 1.41E-03 -11.444 -3.517 
Trim47 A_55_P2105256 1.40E-05 -11.917 -3.575 
C2cd4b A_55_P2054261 6.18E-04 -11.963 -3.581 
Gbx2 A_51_P179578 1.65E-04 -12.143 -3.602 
Paqr7 A_51_P430973 3.49E-05 -12.406 -3.633 
Fam183b A_55_P2137527 1.19E-03 -12.424 -3.635 
AU021034 A_55_P1973526 1.58E-05 -12.523 -3.647 
Plcd4 A_52_P327588 1.46E-04 -12.707 -3.668 
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3110035E14Rik A_52_P400355 4.17E-02 -12.871 -3.686 
Cebpd A_51_P444447 2.14E-06 -12.879 -3.687 
Pla2g3 A_55_P2043033 4.63E-04 -12.938 -3.694 
Cpe A_55_P2152248 2.05E-04 -13.246 -3.728 
Ntsr2 A_55_P1974527 3.42E-04 -13.473 -3.752 
Gstt3 A_51_P377856 1.32E-03 -13.534 -3.759 
Odf3b A_51_P422369 4.54E-03 -13.553 -3.761 
Meig1 A_55_P2093705 5.03E-04 -13.595 -3.765 
C2 A_51_P497985 1.01E-04 -13.713 -3.778 
Cidea A_51_P199168 1.90E-03 -14.065 -3.814 
Ccdc153 A_52_P352735 1.52E-02 -14.182 -3.826 
Pla2g3 A_55_P2043039 3.64E-03 -14.221 -3.830 
Adora2b A_66_P118906 2.16E-04 -14.231 -3.831 
Trim9 A_55_P2073059 3.77E-04 -14.296 -3.838 
Cybrd1 A_52_P124734 1.20E-04 -14.360 -3.844 
Plcd4 A_55_P2090359 2.36E-04 -14.445 -3.853 
Adra2a A_55_P2021505 1.10E-04 -14.861 -3.894 
Slc39a12 A_55_P2036392 1.82E-04 -14.944 -3.902 
Olig1 A_52_P603038 2.87E-05 -15.600 -3.964 
Slit1 A_55_P1958379 2.00E-03 -15.720 -3.975 
Chst1 A_55_P2061620 2.47E-03 -15.923 -3.993 
Lrfn2 A_51_P229498 6.06E-04 -16.033 -4.003 
Odz2 A_55_P2011290 1.09E-02 -16.302 -4.027 
Ppp1r3c A_52_P30451 5.71E-05 -17.630 -4.140 
Foxb1 A_55_P2026405 1.54E-04 -17.772 -4.152 
Mgll A_55_P2063316 6.76E-05 -18.405 -4.202 
C4b A_55_P2078633 3.14E-04 -18.469 -4.207 
Slc39a12 A_55_P2036394 5.41E-05 -19.047 -4.252 
Kcnd2 A_52_P124472 3.56E-04 -19.113 -4.257 
Kcnj16 A_55_P2156304 8.21E-06 -19.522 -4.287 
Fndc5 A_52_P213696 7.11E-05 -20.407 -4.351 
Fmod A_51_P207622 6.30E-04 -20.821 -4.380 
Slc16a11 A_55_P2061338 6.27E-05 -21.422 -4.421 
Olig2 A_52_P223626 3.01E-05 -21.578 -4.432 
Dclk3 A_51_P419637 7.51E-05 -22.131 -4.468 
Ptpn5 A_55_P1955726 2.38E-03 -23.047 -4.527 
Slc14a2 A_55_P1964028 1.24E-05 -26.529 -4.730 
Agt A_66_P112356 1.36E-04 -26.538 -4.730 
Mgll A_55_P2114863 6.30E-05 -26.584 -4.733 
Mgll A_55_P2063312 1.60E-05 -27.096 -4.760 
Slc6a11 A_51_P271311 1.90E-05 -28.960 -4.856 
Fgfr3 A_65_P06147 1.01E-04 -29.375 -4.877 
Slc13a3 A_55_P2067518 4.79E-05 -32.684 -5.031 
Ptgds A_55_P2100928 4.30E-06 -32.729 -5.033 
Slc6a12 A_51_P323812 2.56E-04 -34.416 -5.105 
Fgfr3 A_55_P1996578 2.11E-04 -34.763 -5.120 
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Trim9 A_52_P625640 4.70E-05 -39.165 -5.292 
Grm5 A_55_P2033425 1.02E-05 -42.754 -5.418 
Hsd11b1 A_51_P127297 1.30E-05 -43.789 -5.453 
Baalc A_55_P2075469 5.18E-04 -43.880 -5.456 
 
 
 
  Literature  
 
-I- 
IV  Literature: 1	   De	  Robertis,	  E.	  M.	  Spemann's	  organizer	  and	  self-­‐regulation	  in	  amphibian	  embryos.	  Nature	  reviews.	  Molecular	  cell	  biology	  7,	  296-­‐302,	  doi:10.1038/nrm1855	  (2006).	  2	   Liu,	  A.	  &	  Niswander,	  L.	  A.	  Bone	  morphogenetic	  protein	  signalling	  and	  vertebrate	  nervous	  system	  development.	  Nature	  reviews.	  Neuroscience	  6,	  945-­‐954,	  doi:10.1038/nrn1805	  (2005).	  3	   Kimelberg,	  H.	  K.	  &	  Norenberg,	  M.	  D.	  Astrocytes.	  Scientific	  American	  260,	  66-­‐72,	  74,	  76	  (1989).	  4	   O'Kusky,	  J.	  &	  Colonnier,	  M.	  A	  laminar	  analysis	  of	  the	  number	  of	  neurons,	  glia,	  and	  synapses	  in	  the	  adult	  cortex	  (area	  17)	  of	  adult	  macaque	  monkeys.	  The	  
Journal	  of	  comparative	  neurology	  210,	  278-­‐290,	  doi:10.1002/cne.902100307	  (1982).	  5	   Rose,	  C.	  R.	  &	  Ransom,	  B.	  R.	  Gap	  junctions	  equalize	  intracellular	  Na+	  concentration	  in	  astrocytes.	  Glia	  20,	  299-­‐307	  (1997).	  6	   Wang,	  X.	  et	  al.	  Astrocytic	  Ca2+	  signaling	  evoked	  by	  sensory	  stimulation	  in	  vivo.	  
Nature	  neuroscience	  9,	  816-­‐823,	  doi:10.1038/nn1703	  (2006).	  7	   Wang,	  X.,	  Takano,	  T.	  &	  Nedergaard,	  M.	  Astrocytic	  calcium	  signaling:	  mechanism	  and	  implications	  for	  functional	  brain	  imaging.	  Methods	  in	  
molecular	  biology	  489,	  93-­‐109,	  doi:10.1007/978-­‐1-­‐59745-­‐543-­‐5_5	  (2009).	  8	   Ransom,	  B.	  R.	  Gap	  junctions.	  Vol.	  299-­‐318	  (Oxford	  University	  press,	  1995).	  9	   Charles,	  A.	  Intercellular	  calcium	  waves	  in	  glia.	  Glia	  24,	  39-­‐49	  (1998).	  10	   Scemes,	  E.,	  Dermietzel,	  R.	  &	  Spray,	  D.	  C.	  Calcium	  waves	  between	  astrocytes	  from	  Cx43	  knockout	  mice.	  Glia	  24,	  65-­‐73	  (1998).	  11	   Bushong,	  E.	  A.,	  Martone,	  M.	  E.,	  Jones,	  Y.	  Z.	  &	  Ellisman,	  M.	  H.	  Protoplasmic	  astrocytes	  in	  CA1	  stratum	  radiatum	  occupy	  separate	  anatomical	  domains.	  J	  
Neurosci	  22,	  183-­‐192	  (2002).	  12	   Ventura,	  R.	  &	  Harris,	  K.	  M.	  Three-­‐dimensional	  relationships	  between	  hippocampal	  synapses	  and	  astrocytes.	  J	  Neurosci	  19,	  6897-­‐6906	  (1999).	  13	   Halassa,	  M.	  M.,	  Fellin,	  T.,	  Takano,	  H.,	  Dong,	  J.	  H.	  &	  Haydon,	  P.	  G.	  Synaptic	  islands	  defined	  by	  the	  territory	  of	  a	  single	  astrocyte.	  J	  Neurosci	  27,	  6473-­‐6477,	  doi:10.1523/JNEUROSCI.1419-­‐07.2007	  (2007).	  14	   Barres,	  B.	  A.	  The	  mystery	  and	  magic	  of	  glia:	  a	  perspective	  on	  their	  roles	  in	  health	  and	  disease.	  Neuron	  60,	  430-­‐440,	  doi:10.1016/j.neuron.2008.10.013	  (2008).	  15	   Christopherson,	  K.	  S.	  et	  al.	  Thrombospondins	  are	  astrocyte-­‐secreted	  proteins	  that	  promote	  CNS	  synaptogenesis.	  Cell	  120,	  421-­‐433,	  doi:10.1016/j.cell.2004.12.020	  (2005).	  16	   Schousboe,	  A.	  Transport	  and	  metabolism	  of	  glutamate	  and	  GABA	  in	  neurons	  are	  glial	  cells.	  International	  review	  of	  neurobiology	  22,	  1-­‐45	  (1981).	  17	   Volterra,	  A.	  &	  Meldolesi,	  J.	  Astrocytes,	  from	  brain	  glue	  to	  communication	  elements:	  the	  revolution	  continues.	  Nat	  Rev	  Neurosci	  6,	  626-­‐640,	  doi:10.1038/nrn1722	  (2005).	  18	   Haydon,	  P.	  G.	  &	  Carmignoto,	  G.	  Astrocyte	  control	  of	  synaptic	  transmission	  and	  neurovascular	  coupling.	  Physiol	  Rev	  86,	  1009-­‐1031,	  doi:10.1152/physrev.00049.2005	  (2006).	  19	   Halassa,	  M.	  M.,	  Fellin,	  T.	  &	  Haydon,	  P.	  G.	  The	  tripartite	  synapse:	  roles	  for	  gliotransmission	  in	  health	  and	  disease.	  Trends	  in	  molecular	  medicine	  13,	  54-­‐63,	  doi:10.1016/j.molmed.2006.12.005	  (2007).	  
 
  Literature  
 
-II- 
20	   Pfrieger,	  F.	  W.	  &	  Ungerer,	  N.	  Cholesterol	  metabolism	  in	  neurons	  and	  astrocytes.	  
Progress	  in	  lipid	  research	  50,	  357-­‐371,	  doi:10.1016/j.plipres.2011.06.002	  (2011).	  21	   Rudge,	  J.	  S.	  et	  al.	  Expression	  of	  Ciliary	  Neurotrophic	  Factor	  and	  the	  Neurotrophins-­‐Nerve	  Growth	  Factor,	  Brain-­‐Derived	  Neurotrophic	  Factor	  and	  Neurotrophin	  3-­‐in	  Cultured	  Rat	  Hippocampal	  Astrocytes.	  The	  European	  
journal	  of	  neuroscience	  4,	  459-­‐471	  (1992).	  22	   Anderson,	  C.	  M.	  &	  Swanson,	  R.	  A.	  Astrocyte	  glutamate	  transport:	  review	  of	  properties,	  regulation,	  and	  physiological	  functions.	  Glia	  32,	  1-­‐14	  (2000).	  23	   Danbolt,	  N.	  C.	  Glutamate	  uptake.	  Prog	  Neurobiol	  65,	  1-­‐105	  (2001).	  24	   Wen,	  H.	  et	  al.	  Ontogeny	  of	  water	  transport	  in	  rat	  brain:	  postnatal	  expression	  of	  the	  aquaporin-­‐4	  water	  channel.	  The	  European	  journal	  of	  neuroscience	  11,	  935-­‐945	  (1999).	  25	   Kofuji,	  P.	  &	  Newman,	  E.	  A.	  Potassium	  buffering	  in	  the	  central	  nervous	  system.	  
Neuroscience	  129,	  1045-­‐1056,	  doi:10.1016/j.neuroscience.2004.06.008	  (2004).	  26	   Deitmer,	  J.	  W.	  &	  Schlue,	  W.	  R.	  The	  regulation	  of	  intracellular	  pH	  by	  identified	  glial	  cells	  and	  neurones	  in	  the	  central	  nervous	  system	  of	  the	  leech.	  The	  Journal	  
of	  physiology	  388,	  261-­‐283	  (1987).	  27	   Sontheimer,	  H.	  Astrocytes,	  as	  well	  as	  neurons,	  express	  a	  diversity	  of	  ion	  channels.	  Canadian	  journal	  of	  physiology	  and	  pharmacology	  70	  Suppl,	  S223-­‐238	  (1992).	  28	   Sontheimer,	  H.,	  Black,	  J.	  A.	  &	  Waxman,	  S.	  G.	  Voltage-­‐gated	  Na+	  channels	  in	  glia:	  properties	  and	  possible	  functions.	  Trends	  in	  neurosciences	  19,	  325-­‐331	  (1996).	  29	   Wiese,	  S.,	  Karus,	  M.	  &	  Faissner,	  A.	  Astrocytes	  as	  a	  source	  for	  extracellular	  matrix	  molecules	  and	  cytokines.	  Frontiers	  in	  pharmacology	  3,	  120,	  doi:10.3389/fphar.2012.00120	  (2012).	  30	   Wells,	  G.	  M.	  et	  al.	  Quantitation	  of	  matrix	  metalloproteinases	  in	  cultured	  rat	  astrocytes	  using	  the	  polymerase	  chain	  reaction	  with	  a	  multi-­‐competitor	  cDNA	  standard.	  Glia	  18,	  332-­‐340	  (1996).	  31	   Oberheim,	  N.	  A.,	  Goldman,	  S.	  A.	  &	  Nedergaard,	  M.	  Heterogeneity	  of	  astrocytic	  form	  and	  function.	  Methods	  Mol	  Biol	  814,	  23-­‐45,	  doi:10.1007/978-­‐1-­‐61779-­‐452-­‐0_3	  (2012).	  32	   Miller,	  R.	  H.	  &	  Raff,	  M.	  C.	  Fibrous	  and	  protoplasmic	  astrocytes	  are	  biochemically	  and	  developmentally	  distinct.	  J	  Neurosci	  4,	  585-­‐592	  (1984).	  33	   Rakic,	  P.	  Mode	  of	  cell	  migration	  to	  the	  superficial	  layers	  of	  fetal	  monkey	  neocortex.	  The	  Journal	  of	  comparative	  neurology	  145,	  61-­‐83,	  doi:10.1002/cne.901450105	  (1972).	  34	   Hatten,	  M.	  E.	  New	  directions	  in	  neuronal	  migration.	  Science	  297,	  1660-­‐1663,	  doi:10.1126/science.1074572	  (2002).	  35	   Nedergaard,	  M.,	  Ransom,	  B.	  &	  Goldman,	  S.	  A.	  New	  roles	  for	  astrocytes:	  redefining	  the	  functional	  architecture	  of	  the	  brain.	  Trends	  Neurosci	  26,	  523-­‐530,	  doi:10.1016/j.tins.2003.08.008	  (2003).	  36	   Shu,	  T.	  &	  Richards,	  L.	  J.	  Cortical	  axon	  guidance	  by	  the	  glial	  wedge	  during	  the	  development	  of	  the	  corpus	  callosum.	  J	  Neurosci	  21,	  2749-­‐2758	  (2001).	  37	   Kaneko,	  N.	  et	  al.	  New	  neurons	  clear	  the	  path	  of	  astrocytic	  processes	  for	  their	  rapid	  migration	  in	  the	  adult	  brain.	  Neuron	  67,	  213-­‐223,	  doi:10.1016/j.neuron.2010.06.018	  (2010).	  
 
  Literature  
 
-III- 
38	   Abbott,	  N.	  J.,	  Patabendige,	  A.	  A.,	  Dolman,	  D.	  E.,	  Yusof,	  S.	  R.	  &	  Begley,	  D.	  J.	  Structure	  and	  function	  of	  the	  blood-­‐brain	  barrier.	  Neurobiology	  of	  disease	  37,	  13-­‐25,	  doi:10.1016/j.nbd.2009.07.030	  (2010).	  39	   Fu,	  L.,	  Zhu,	  X.,	  Yi,	  F.,	  Liu,	  G.	  H.	  &	  Izpisua	  Belmonte,	  J.	  C.	  Regenerative	  medicine:	  transdifferentiation	  in	  vivo.	  Cell	  Res	  24,	  141-­‐142,	  doi:10.1038/cr.2013.165	  (2014).	  40	   Kornblum,	  H.	  I.	  Introduction	  to	  neural	  stem	  cells.	  Stroke	  38,	  810-­‐816,	  doi:10.1161/01.STR.0000255757.12198.0f	  (2007).	  41	   Ulloa,	  F.	  &	  Marti,	  E.	  Wnt	  won	  the	  war:	  antagonistic	  role	  of	  Wnt	  over	  Shh	  controls	  dorso-­‐ventral	  patterning	  of	  the	  vertebrate	  neural	  tube.	  Dev	  Dyn	  239,	  69-­‐76,	  doi:10.1002/dvdy.22058	  (2010).	  42	   Mori,	  T.,	  Buffo,	  A.	  &	  Gotz,	  M.	  The	  novel	  roles	  of	  glial	  cells	  revisited:	  the	  contribution	  of	  radial	  glia	  and	  astrocytes	  to	  neurogenesis.	  Current	  topics	  in	  
developmental	  biology	  69,	  67-­‐99,	  doi:10.1016/S0070-­‐2153(05)69004-­‐7	  (2005).	  43	   Gotz,	  M.	  &	  Huttner,	  W.	  B.	  The	  cell	  biology	  of	  neurogenesis.	  Nature	  reviews.	  
Molecular	  cell	  biology	  6,	  777-­‐788,	  doi:10.1038/nrm1739	  (2005).	  44	   Kriegstein,	  A.	  &	  Alvarez-­‐Buylla,	  A.	  The	  glial	  nature	  of	  embryonic	  and	  adult	  neural	  stem	  cells.	  Annual	  review	  of	  neuroscience	  32,	  149-­‐184,	  doi:10.1146/annurev.neuro.051508.135600	  (2009).	  45	   Alvarez-­‐Buylla,	  A.,	  Garcia-­‐Verdugo,	  J.	  M.	  &	  Tramontin,	  A.	  D.	  A	  unified	  hypothesis	  on	  the	  lineage	  of	  neural	  stem	  cells.	  Nature	  reviews.	  Neuroscience	  2,	  287-­‐293,	  doi:10.1038/35067582	  (2001).	  46	   Bentivoglio,	  M.	  &	  Mazzarello,	  P.	  The	  history	  of	  radial	  glia.	  Brain	  research	  
bulletin	  49,	  305-­‐315	  (1999).	  47	   Malatesta,	  P.,	  Hartfuss,	  E.	  &	  Gotz,	  M.	  Isolation	  of	  radial	  glial	  cells	  by	  fluorescent-­‐activated	  cell	  sorting	  reveals	  a	  neuronal	  lineage.	  Development	  127,	  5253-­‐5263	  (2000).	  48	   Shibata,	  T.	  et	  al.	  Glutamate	  transporter	  GLAST	  is	  expressed	  in	  the	  radial	  glia-­‐astrocyte	  lineage	  of	  developing	  mouse	  spinal	  cord.	  The	  Journal	  of	  
neuroscience	  :	  the	  official	  journal	  of	  the	  Society	  for	  Neuroscience	  17,	  9212-­‐9219	  (1997).	  49	   Choi,	  B.	  H.	  Radial	  glia	  of	  developing	  human	  fetal	  spinal	  cord:	  Golgi,	  immunohistochemical	  and	  electron	  microscopic	  study.	  Brain	  Res	  227,	  249-­‐267	  (1981).	  50	   Kurtz,	  A.	  et	  al.	  The	  expression	  pattern	  of	  a	  novel	  gene	  encoding	  brain-­‐fatty	  acid	  binding	  protein	  correlates	  with	  neuronal	  and	  glial	  cell	  development.	  
Development	  120,	  2637-­‐2649	  (1994).	  51	   Hartfuss,	  E.,	  Galli,	  R.,	  Heins,	  N.	  &	  Gotz,	  M.	  Characterization	  of	  CNS	  precursor	  subtypes	  and	  radial	  glia.	  Developmental	  biology	  229,	  15-­‐30,	  doi:10.1006/dbio.2000.9962	  (2001).	  52	   Misson,	  J.	  P.,	  Edwards,	  M.	  A.,	  Yamamoto,	  M.	  &	  Caviness,	  V.	  S.,	  Jr.	  Identification	  of	  radial	  glial	  cells	  within	  the	  developing	  murine	  central	  nervous	  system:	  studies	  based	  upon	  a	  new	  immunohistochemical	  marker.	  Brain	  research.	  
Developmental	  brain	  research	  44,	  95-­‐108	  (1988).	  53	   Campbell,	  K.	  &	  Gotz,	  M.	  Radial	  glia:	  multi-­‐purpose	  cells	  for	  vertebrate	  brain	  development.	  Trends	  in	  neurosciences	  25,	  235-­‐238	  (2002).	  54	   Rakic,	  P.	  Neuron-­‐glia	  relationship	  during	  granule	  cell	  migration	  in	  developing	  cerebellar	  cortex.	  A	  Golgi	  and	  electronmicroscopic	  study	  in	  Macacus	  Rhesus.	  
 
  Literature  
 
-IV- 
The	  Journal	  of	  comparative	  neurology	  141,	  283-­‐312,	  doi:10.1002/cne.901410303	  (1971).	  55	   Noctor,	  S.	  C.,	  Martinez-­‐Cerdeno,	  V.,	  Ivic,	  L.	  &	  Kriegstein,	  A.	  R.	  Cortical	  neurons	  arise	  in	  symmetric	  and	  asymmetric	  division	  zones	  and	  migrate	  through	  specific	  phases.	  Nat	  Neurosci	  7,	  136-­‐144,	  doi:10.1038/nn1172	  (2004).	  56	   Voigt,	  T.	  Development	  of	  glial	  cells	  in	  the	  cerebral	  wall	  of	  ferrets:	  direct	  tracing	  of	  their	  transformation	  from	  radial	  glia	  into	  astrocytes.	  The	  Journal	  of	  
comparative	  neurology	  289,	  74-­‐88,	  doi:10.1002/cne.902890106	  (1989).	  57	   Levitt,	  P.,	  Cooper,	  M.	  L.	  &	  Rakic,	  P.	  Coexistence	  of	  neuronal	  and	  glial	  precursor	  cells	  in	  the	  cerebral	  ventricular	  zone	  of	  the	  fetal	  monkey:	  an	  ultrastructural	  immunoperoxidase	  analysis.	  J	  Neurosci	  1,	  27-­‐39	  (1981).	  58	   Guo,	  Z.	  et	  al.	  Early	  postnatal	  GFAP-­‐expressing	  cells	  produce	  multilineage	  progeny	  in	  cerebrum	  and	  astrocytes	  in	  cerebellum	  of	  adult	  mice.	  Brain	  Res	  
1532,	  14-­‐20,	  doi:10.1016/j.brainres.2013.08.003	  (2013).	  59	   Surzenko,	  N.,	  Crowl,	  T.,	  Bachleda,	  A.,	  Langer,	  L.	  &	  Pevny,	  L.	  SOX2	  maintains	  the	  quiescent	  progenitor	  cell	  state	  of	  postnatal	  retinal	  Muller	  glia.	  Development	  
140,	  1445-­‐1456,	  doi:10.1242/dev.071878	  (2013).	  60	   Kriegstein,	  A.	  &	  Parnavelas,	  J.	  G.	  Changing	  concepts	  of	  cortical	  development.	  
Cereb	  Cortex	  13,	  541	  (2003).	  61	   Kriegstein,	  A.	  R.	  &	  Gotz,	  M.	  Radial	  glia	  diversity:	  a	  matter	  of	  cell	  fate.	  Glia	  43,	  37-­‐43,	  doi:10.1002/glia.10250	  (2003).	  62	   Fishell,	  G.	  &	  Kriegstein,	  A.	  R.	  Neurons	  from	  radial	  glia:	  the	  consequences	  of	  asymmetric	  inheritance.	  Curr	  Opin	  Neurobiol	  13,	  34-­‐41	  (2003).	  63	   Reynolds,	  B.	  A.	  &	  Weiss,	  S.	  Generation	  of	  neurons	  and	  astrocytes	  from	  isolated	  cells	  of	  the	  adult	  mammalian	  central	  nervous	  system.	  Science	  255,	  1707-­‐1710	  (1992).	  64	   Kaplan,	  M.	  S.	  &	  Hinds,	  J.	  W.	  Neurogenesis	  in	  the	  adult	  rat:	  electron	  microscopic	  analysis	  of	  light	  radioautographs.	  Science	  197,	  1092-­‐1094	  (1977).	  65	   Ernst,	  A.	  et	  al.	  Neurogenesis	  in	  the	  striatum	  of	  the	  adult	  human	  brain.	  Cell	  156,	  1072-­‐1083,	  doi:10.1016/j.cell.2014.01.044	  (2014).	  66	   Davis,	  A.	  A.	  &	  Temple,	  S.	  A	  self-­‐renewing	  multipotential	  stem	  cell	  in	  embryonic	  rat	  cerebral	  cortex.	  Nature	  372,	  263-­‐266,	  doi:10.1038/372263a0	  (1994).	  67	   Richards,	  L.	  J.,	  Kilpatrick,	  T.	  J.	  &	  Bartlett,	  P.	  F.	  De	  novo	  generation	  of	  neuronal	  cells	  from	  the	  adult	  mouse	  brain.	  Proc	  Natl	  Acad	  Sci	  U	  S	  A	  89,	  8591-­‐8595	  (1992).	  68	   Doetsch,	  F.,	  Caille,	  I.,	  Lim,	  D.	  A.,	  Garcia-­‐Verdugo,	  J.	  M.	  &	  Alvarez-­‐Buylla,	  A.	  Subventricular	  zone	  astrocytes	  are	  neural	  stem	  cells	  in	  the	  adult	  mammalian	  brain.	  Cell	  97,	  703-­‐716	  (1999).	  69	   Spassky,	  N.	  et	  al.	  Adult	  ependymal	  cells	  are	  postmitotic	  and	  are	  derived	  from	  radial	  glial	  cells	  during	  embryogenesis.	  J	  Neurosci	  25,	  10-­‐18,	  doi:10.1523/JNEUROSCI.1108-­‐04.2005	  (2005).	  70	   Park,	  D.	  et	  al.	  Nestin	  is	  required	  for	  the	  proper	  self-­‐renewal	  of	  neural	  stem	  cells.	  Stem	  cells	  28,	  2162-­‐2171,	  doi:10.1002/stem.541	  (2010).	  71	   Doetsch,	  F.,	  Garcia-­‐Verdugo,	  J.	  M.	  &	  Alvarez-­‐Buylla,	  A.	  Cellular	  composition	  and	  three-­‐dimensional	  organization	  of	  the	  subventricular	  germinal	  zone	  in	  the	  adult	  mammalian	  brain.	  J	  Neurosci	  17,	  5046-­‐5061	  (1997).	  72	   Beckervordersandforth,	  R.	  et	  al.	  In	  vivo	  fate	  mapping	  and	  expression	  analysis	  reveals	  molecular	  hallmarks	  of	  prospectively	  isolated	  adult	  neural	  stem	  cells.	  
Cell	  stem	  cell	  7,	  744-­‐758,	  doi:10.1016/j.stem.2010.11.017	  (2010).	  
 
  Literature  
 
-V- 
73	   Coskun,	  V.	  et	  al.	  CD133+	  neural	  stem	  cells	  in	  the	  ependyma	  of	  mammalian	  postnatal	  forebrain.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  the	  
United	  States	  of	  America	  105,	  1026-­‐1031,	  doi:10.1073/pnas.0710000105	  (2008).	  74	   Walker,	  T.	  L.	  et	  al.	  Prominin-­‐1	  allows	  prospective	  isolation	  of	  neural	  stem	  cells	  from	  the	  adult	  murine	  hippocampus.	  J	  Neurosci	  33,	  3010-­‐3024,	  doi:10.1523/JNEUROSCI.3363-­‐12.2013	  (2013).	  75	   Mich,	  J.	  K.	  et	  al.	  Prospective	  identification	  of	  functionally	  distinct	  stem	  cells	  and	  neurosphere-­‐initiating	  cells	  in	  adult	  mouse	  forebrain.	  Elife	  3,	  e02669,	  doi:10.7554/eLife.02669	  (2014).	  76	   Kiss,	  J.	  Z.	  &	  Rougon,	  G.	  Cell	  biology	  of	  polysialic	  acid.	  Curr	  Opin	  Neurobiol	  7,	  640-­‐646	  (1997).	  77	   Chazal,	  G.,	  Durbec,	  P.,	  Jankovski,	  A.,	  Rougon,	  G.	  &	  Cremer,	  H.	  Consequences	  of	  neural	  cell	  adhesion	  molecule	  deficiency	  on	  cell	  migration	  in	  the	  rostral	  migratory	  stream	  of	  the	  mouse.	  J	  Neurosci	  20,	  1446-­‐1457	  (2000).	  78	   Jankovski,	  A.	  &	  Sotelo,	  C.	  Subventricular	  zone-­‐olfactory	  bulb	  migratory	  pathway	  in	  the	  adult	  mouse:	  cellular	  composition	  and	  specificity	  as	  determined	  by	  heterochronic	  and	  heterotopic	  transplantation.	  The	  Journal	  of	  
comparative	  neurology	  371,	  376-­‐396,	  doi:10.1002/(SICI)1096-­‐9861(19960729)371:3&lt;376::AID-­‐CNE3&gt;3.0.CO;2-­‐#	  (1996).	  79	   Menezes,	  J.	  R.,	  Marins,	  M.,	  Alves,	  J.	  A.,	  Froes,	  M.	  M.	  &	  Hedin-­‐Pereira,	  C.	  Cell	  migration	  in	  the	  postnatal	  subventricular	  zone.	  Brazilian	  journal	  of	  medical	  
and	  biological	  research	  =	  Revista	  brasileira	  de	  pesquisas	  medicas	  e	  biologicas	  /	  
Sociedade	  Brasileira	  de	  Biofisica	  ...	  [et	  al.]	  35,	  1411-­‐1421	  (2002).	  80	   Alvarez-­‐Buylla,	  A.,	  Seri,	  B.	  &	  Doetsch,	  F.	  Identification	  of	  neural	  stem	  cells	  in	  the	  adult	  vertebrate	  brain.	  Brain	  research	  bulletin	  57,	  751-­‐758	  (2002).	  81	   Mirzadeh,	  Z.,	  Merkle,	  F.	  T.,	  Soriano-­‐Navarro,	  M.,	  Garcia-­‐Verdugo,	  J.	  M.	  &	  Alvarez-­‐Buylla,	  A.	  Neural	  stem	  cells	  confer	  unique	  pinwheel	  architecture	  to	  the	  ventricular	  surface	  in	  neurogenic	  regions	  of	  the	  adult	  brain.	  Cell	  stem	  cell	  3,	  265-­‐278,	  doi:10.1016/j.stem.2008.07.004	  (2008).	  82	   Raff,	  M.	  C.,	  Abney,	  E.	  R.,	  Cohen,	  J.,	  Lindsay,	  R.	  &	  Noble,	  M.	  Two	  types	  of	  astrocytes	  in	  cultures	  of	  developing	  rat	  white	  matter:	  differences	  in	  morphology,	  surface	  gangliosides,	  and	  growth	  characteristics.	  J	  Neurosci	  3,	  1289-­‐1300	  (1983).	  83	   Eng,	  L.	  F.	  Glial	  fibrillary	  acidic	  protein	  (GFAP):	  the	  major	  protein	  of	  glial	  intermediate	  filaments	  in	  differentiated	  astrocytes.	  Journal	  of	  
neuroimmunology	  8,	  203-­‐214	  (1985).	  84	   Bignami,	  A.,	  Eng,	  L.	  F.,	  Dahl,	  D.	  &	  Uyeda,	  C.	  T.	  Localization	  of	  the	  glial	  fibrillary	  acidic	  protein	  in	  astrocytes	  by	  immunofluorescence.	  Brain	  research	  43,	  429-­‐435	  (1972).	  85	   Rothstein,	  J.	  D.	  et	  al.	  Knockout	  of	  glutamate	  transporters	  reveals	  a	  major	  role	  for	  astroglial	  transport	  in	  excitotoxicity	  and	  clearance	  of	  glutamate.	  Neuron	  16,	  675-­‐686	  (1996).	  86	   Martinez-­‐Hernandez,	  A.,	  Bell,	  K.	  P.	  &	  Norenberg,	  M.	  D.	  Glutamine	  synthetase:	  glial	  localization	  in	  brain.	  Science	  195,	  1356-­‐1358	  (1977).	  87	   Wender,	  R.	  et	  al.	  Astrocytic	  glycogen	  influences	  axon	  function	  and	  survival	  during	  glucose	  deprivation	  in	  central	  white	  matter.	  The	  Journal	  of	  
neuroscience	  :	  the	  official	  journal	  of	  the	  Society	  for	  Neuroscience	  20,	  6804-­‐6810	  (2000).	  
 
  Literature  
 
-VI- 
88	   Cahoy,	  J.	  D.	  et	  al.	  A	  transcriptome	  database	  for	  astrocytes,	  neurons,	  and	  oligodendrocytes:	  a	  new	  resource	  for	  understanding	  brain	  development	  and	  function.	  The	  Journal	  of	  neuroscience	  :	  the	  official	  journal	  of	  the	  Society	  for	  
Neuroscience	  28,	  264-­‐278,	  doi:10.1523/JNEUROSCI.4178-­‐07.2008	  (2008).	  89	   Sofroniew,	  M.	  V.	  &	  Vinters,	  H.	  V.	  Astrocytes:	  biology	  and	  pathology.	  Acta	  
Neuropathol	  119,	  7-­‐35,	  doi:10.1007/s00401-­‐009-­‐0619-­‐8	  (2010).	  90	   Allaman,	  I.,	  Belanger,	  M.	  &	  Magistretti,	  P.	  J.	  Astrocyte-­‐neuron	  metabolic	  relationships:	  for	  better	  and	  for	  worse.	  Trends	  in	  neurosciences	  34,	  76-­‐87,	  doi:10.1016/j.tins.2010.12.001	  (2011).	  91	   Benesova,	  J.	  et	  al.	  Distinct	  expression/function	  of	  potassium	  and	  chloride	  channels	  contributes	  to	  the	  diverse	  volume	  regulation	  in	  cortical	  astrocytes	  of	  GFAP/EGFP	  mice.	  PloS	  one	  7,	  e29725,	  doi:10.1371/journal.pone.0029725	  (2012).	  92	   Deloulme,	  J.	  C.	  et	  al.	  Nuclear	  expression	  of	  S100B	  in	  oligodendrocyte	  progenitor	  cells	  correlates	  with	  differentiation	  toward	  the	  oligodendroglial	  lineage	  and	  modulates	  oligodendrocytes	  maturation.	  Molecular	  and	  cellular	  
neurosciences	  27,	  453-­‐465,	  doi:10.1016/j.mcn.2004.07.008	  (2004).	  93	   Higashi,	  K.	  et	  al.	  An	  inwardly	  rectifying	  K(+)	  channel,	  Kir4.1,	  expressed	  in	  astrocytes	  surrounds	  synapses	  and	  blood	  vessels	  in	  brain.	  American	  journal	  of	  
physiology.	  Cell	  physiology	  281,	  C922-­‐931	  (2001).	  94	   Stahlberg,	  A.	  et	  al.	  Defining	  cell	  populations	  with	  single-­‐cell	  gene	  expression	  profiling:	  correlations	  and	  identification	  of	  astrocyte	  subpopulations.	  Nucleic	  
acids	  research	  39,	  e24,	  doi:10.1093/nar/gkq1182	  (2011).	  95	   Benesova,	  J.	  et	  al.	  Quantification	  of	  astrocyte	  volume	  changes	  during	  ischemia	  in	  situ	  reveals	  two	  populations	  of	  astrocytes	  in	  the	  cortex	  of	  GFAP/EGFP	  mice.	  
Journal	  of	  neuroscience	  research	  87,	  96-­‐111,	  doi:10.1002/jnr.21828	  (2009).	  96	   Bachoo,	  R.	  M.	  et	  al.	  Molecular	  diversity	  of	  astrocytes	  with	  implications	  for	  neurological	  disorders.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  the	  
United	  States	  of	  America	  101,	  8384-­‐8389,	  doi:10.1073/pnas.0402140101	  (2004).	  97	   Nielsen,	  S.	  et	  al.	  Specialized	  membrane	  domains	  for	  water	  transport	  in	  glial	  cells:	  high-­‐resolution	  immunogold	  cytochemistry	  of	  aquaporin-­‐4	  in	  rat	  brain.	  J	  
Neurosci	  17,	  171-­‐180	  (1997).	  98	   Vives,	  V.,	  Alonso,	  G.,	  Solal,	  A.	  C.,	  Joubert,	  D.	  &	  Legraverend,	  C.	  Visualization	  of	  S100B-­‐positive	  neurons	  and	  glia	  in	  the	  central	  nervous	  system	  of	  EGFP	  transgenic	  mice.	  The	  Journal	  of	  comparative	  neurology	  457,	  404-­‐419,	  doi:10.1002/cne.10552	  (2003).	  99	   Yang,	  Y.	  et	  al.	  Molecular	  comparison	  of	  GLT1+	  and	  ALDH1L1+	  astrocytes	  in	  vivo	  in	  astroglial	  reporter	  mice.	  Glia	  59,	  200-­‐207,	  doi:10.1002/glia.21089	  (2011).	  100	   Nolte,	  C.	  et	  al.	  GFAP	  promoter-­‐controlled	  EGFP-­‐expressing	  transgenic	  mice:	  a	  tool	  to	  visualize	  astrocytes	  and	  astrogliosis	  in	  living	  brain	  tissue.	  Glia	  33,	  72-­‐86	  (2001).	  101	   Zhuo,	  L.	  et	  al.	  Live	  astrocytes	  visualized	  by	  green	  fluorescent	  protein	  in	  transgenic	  mice.	  Developmental	  biology	  187,	  36-­‐42,	  doi:10.1006/dbio.1997.8601	  (1997).	  102	   Regan,	  M.	  R.	  et	  al.	  Variations	  in	  promoter	  activity	  reveal	  a	  differential	  expression	  and	  physiology	  of	  glutamate	  transporters	  by	  glia	  in	  the	  developing	  and	  mature	  CNS.	  The	  Journal	  of	  neuroscience	  :	  the	  official	  journal	  of	  the	  Society	  
 
  Literature  
 
-VII- 
for	  Neuroscience	  27,	  6607-­‐6619,	  doi:10.1523/JNEUROSCI.0790-­‐07.2007	  (2007).	  103	   Schmid,	  R.	  S.,	  Yokota,	  Y.	  &	  Anton,	  E.	  S.	  Generation	  and	  characterization	  of	  brain	  lipid-­‐binding	  protein	  promoter-­‐based	  transgenic	  mouse	  models	  for	  the	  study	  of	  radial	  glia.	  Glia	  53,	  345-­‐351,	  doi:10.1002/glia.20274	  (2006).	  104	   Jungblut,	  M.	  et	  al.	  Isolation	  and	  characterization	  of	  living	  primary	  astroglial	  cells	  using	  the	  new	  GLAST-­‐specific	  monoclonal	  antibody	  ACSA-­‐1.	  Glia	  60,	  894-­‐907,	  doi:10.1002/glia.22322	  (2012).	  105	   Pekny,	  M.,	  Wilhelmsson,	  U.	  &	  Pekna,	  M.	  The	  dual	  role	  of	  astrocyte	  activation	  and	  reactive	  gliosis.	  Neuroscience	  letters	  565,	  30-­‐38,	  doi:10.1016/j.neulet.2013.12.071	  (2014).	  106	   Pekny,	  M.	  &	  Nilsson,	  M.	  Astrocyte	  activation	  and	  reactive	  gliosis.	  Glia	  50,	  427-­‐434,	  doi:10.1002/glia.20207	  (2005).	  107	   Miller,	  D.	  W.,	  Cookson,	  M.	  R.	  &	  Dickson,	  D.	  W.	  Glial	  cell	  inclusions	  and	  the	  pathogenesis	  of	  neurodegenerative	  diseases.	  Neuron	  glia	  biology	  1,	  13-­‐21,	  doi:10.1017/s1740925x04000043	  (2004).	  108	   Salmina,	  A.	  B.	  Neuron-­‐glia	  interactions	  as	  therapeutic	  targets	  in	  neurodegeneration.	  Journal	  of	  Alzheimer's	  disease	  :	  JAD	  16,	  485-­‐502,	  doi:10.3233/JAD-­‐2009-­‐0988	  (2009).	  109	   Hanisch,	  U.	  K.	  &	  Kettenmann,	  H.	  Microglia:	  active	  sensor	  and	  versatile	  effector	  cells	  in	  the	  normal	  and	  pathologic	  brain.	  Nature	  neuroscience	  10,	  1387-­‐1394,	  doi:10.1038/nn1997	  (2007).	  110	   Landreth,	  G.	  E.	  Microglia	  in	  central	  nervous	  system	  diseases.	  Journal	  of	  
neuroimmune	  pharmacology	  :	  the	  official	  journal	  of	  the	  Society	  on	  
NeuroImmune	  Pharmacology	  4,	  369-­‐370,	  doi:10.1007/s11481-­‐009-­‐9173-­‐3	  (2009).	  111	   Mariani,	  M.	  M.	  &	  Kielian,	  T.	  Microglia	  in	  infectious	  diseases	  of	  the	  central	  nervous	  system.	  Journal	  of	  neuroimmune	  pharmacology	  :	  the	  official	  journal	  of	  
the	  Society	  on	  NeuroImmune	  Pharmacology	  4,	  448-­‐461,	  doi:10.1007/s11481-­‐009-­‐9170-­‐6	  (2009).	  112	   Nelson,	  P.	  T.,	  Soma,	  L.	  A.	  &	  Lavi,	  E.	  Microglia	  in	  diseases	  of	  the	  central	  nervous	  system.	  Annals	  of	  medicine	  34,	  491-­‐500	  (2002).	  113	   Sheng,	  W.	  S.,	  Hu,	  S.,	  Feng,	  A.	  &	  Rock,	  R.	  B.	  Reactive	  oxygen	  species	  from	  human	  astrocytes	  induced	  functional	  impairment	  and	  oxidative	  damage.	  
Neurochemical	  research	  38,	  2148-­‐2159,	  doi:10.1007/s11064-­‐013-­‐1123-­‐z	  (2013).	  114	   Lenaz,	  G.	  Role	  of	  mitochondria	  in	  oxidative	  stress	  and	  ageing.	  Biochimica	  et	  
biophysica	  acta	  1366,	  53-­‐67	  (1998).	  115	   Snyder,	  C.	  M.,	  Shroff,	  E.	  H.,	  Liu,	  J.	  &	  Chandel,	  N.	  S.	  Nitric	  oxide	  induces	  cell	  death	  by	  regulating	  anti-­‐apoptotic	  BCL-­‐2	  family	  members.	  PloS	  one	  4,	  e7059,	  doi:10.1371/journal.pone.0007059	  (2009).	  116	   Park,	  S.	  J.	  et	  al.	  Astrocytes,	  but	  not	  microglia,	  rapidly	  sense	  H(2)O(2)via	  STAT6	  phosphorylation,	  resulting	  in	  cyclooxygenase-­‐2	  expression	  and	  prostaglandin	  release.	  Journal	  of	  immunology	  188,	  5132-­‐5141,	  doi:10.4049/jimmunol.1101600	  (2012).	  117	   Chen,	  Y.	  et	  al.	  Astrocytes	  protect	  neurons	  from	  nitric	  oxide	  toxicity	  by	  a	  glutathione-­‐dependent	  mechanism.	  Journal	  of	  neurochemistry	  77,	  1601-­‐1610	  (2001).	  
 
  Literature  
 
-VIII- 
118	   Blom,	  M.	  A.	  et	  al.	  NSAIDS	  inhibit	  the	  IL-­‐1	  beta-­‐induced	  IL-­‐6	  release	  from	  human	  post-­‐mortem	  astrocytes:	  the	  involvement	  of	  prostaglandin	  E2.	  Brain	  
Res	  777,	  210-­‐218	  (1997).	  119	   Eng,	  L.	  F.	  &	  Ghirnikar,	  R.	  S.	  GFAP	  and	  astrogliosis.	  Brain	  pathology	  4,	  229-­‐237	  (1994).	  120	   Landis,	  D.	  M.	  The	  early	  reactions	  of	  non-­‐neuronal	  cells	  to	  brain	  injury.	  Annual	  
review	  of	  neuroscience	  17,	  133-­‐151,	  doi:10.1146/annurev.ne.17.030194.001025	  (1994).	  121	   Pekny,	  M.	  &	  Pekna,	  M.	  Astrocyte	  intermediate	  filaments	  in	  CNS	  pathologies	  and	  regeneration.	  The	  Journal	  of	  pathology	  204,	  428-­‐437,	  doi:10.1002/path.1645	  (2004).	  122	   Robel,	  S.,	  Berninger,	  B.	  &	  Gotz,	  M.	  The	  stem	  cell	  potential	  of	  glia:	  lessons	  from	  reactive	  gliosis.	  Nature	  reviews.	  Neuroscience	  12,	  88-­‐104,	  doi:10.1038/nrn2978	  (2011).	  123	   Faulkner,	  J.	  R.	  et	  al.	  Reactive	  astrocytes	  protect	  tissue	  and	  preserve	  function	  after	  spinal	  cord	  injury.	  J	  Neurosci	  24,	  2143-­‐2155,	  doi:10.1523/JNEUROSCI.3547-­‐03.2004	  (2004).	  124	   Yang,	  H.	  Y.,	  Lieska,	  N.,	  Shao,	  D.,	  Kriho,	  V.	  &	  Pappas,	  G.	  D.	  Proteins	  of	  the	  intermediate	  filament	  cytoskeleton	  as	  markers	  for	  astrocytes	  and	  human	  astrocytomas.	  Molecular	  and	  chemical	  neuropathology	  /	  sponsored	  by	  the	  
International	  Society	  for	  Neurochemistry	  and	  the	  World	  Federation	  of	  
Neurology	  and	  research	  groups	  on	  neurochemistry	  and	  cerebrospinal	  fluid	  21,	  155-­‐176,	  doi:10.1007/BF02815349	  (1994).	  125	   Fine,	  E.	  J.,	  Ionita,	  C.	  C.	  &	  Lohr,	  L.	  The	  history	  of	  the	  development	  of	  the	  cerebellar	  examination.	  Seminars	  in	  neurology	  22,	  375-­‐384,	  doi:10.1055/s-­‐2002-­‐36759	  (2002).	  126	   Rapoport,	  M.,	  van	  Reekum,	  R.	  &	  Mayberg,	  H.	  The	  role	  of	  the	  cerebellum	  in	  cognition	  and	  behavior:	  a	  selective	  review.	  The	  Journal	  of	  neuropsychiatry	  and	  
clinical	  neurosciences	  12,	  193-­‐198	  (2000).	  127	   Gowen,	  E.	  &	  Miall,	  R.	  C.	  The	  cerebellum	  and	  motor	  dysfunction	  in	  neuropsychiatric	  disorders.	  Cerebellum	  6,	  268-­‐279,	  doi:10.1080/14734220601184821	  (2007).	  128	   Kim,	  J.	  Y.	  et	  al.	  Medulloblastoma	  tumorigenesis	  diverges	  from	  cerebellar	  granule	  cell	  differentiation	  in	  patched	  heterozygous	  mice.	  Developmental	  
biology	  263,	  50-­‐66	  (2003).	  129	   Wang,	  V.	  Y.	  &	  Zoghbi,	  H.	  Y.	  Genetic	  regulation	  of	  cerebellar	  development.	  
Nature	  reviews.	  Neuroscience	  2,	  484-­‐491,	  doi:10.1038/35081558	  (2001).	  130	   Llinas,	  R.,	  Hillman,	  D.	  E.	  &	  Precht,	  W.	  Neuronal	  circuit	  reorganization	  in	  mammalian	  agranular	  cerebellar	  cortex.	  Journal	  of	  neurobiology	  4,	  69-­‐94,	  doi:10.1002/neu.480040106	  (1973).	  131	   Brodal,	  A.	  Anatomical	  studies	  of	  cerebellar	  fibre	  connections	  with	  special	  reference	  to	  problems	  of	  functional	  localization.	  Progress	  in	  brain	  research	  25,	  135-­‐173,	  doi:10.1016/S0079-­‐6123(08)60964-­‐4	  (1967).	  132	   Hallonet,	  M.	  E.,	  Teillet,	  M.	  A.	  &	  Le	  Douarin,	  N.	  M.	  A	  new	  approach	  to	  the	  development	  of	  the	  cerebellum	  provided	  by	  the	  quail-­‐chick	  marker	  system.	  
Development	  108,	  19-­‐31	  (1990).	  133	   Wingate,	  R.	  J.	  &	  Hatten,	  M.	  E.	  The	  role	  of	  the	  rhombic	  lip	  in	  avian	  cerebellum	  development.	  Development	  126,	  4395-­‐4404	  (1999).	  
 
  Literature  
 
-IX- 
134	   Sgaier,	  S.	  K.	  et	  al.	  Morphogenetic	  and	  cellular	  movements	  that	  shape	  the	  mouse	  cerebellum;	  insights	  from	  genetic	  fate	  mapping.	  Neuron	  45,	  27-­‐40,	  doi:10.1016/j.neuron.2004.12.021	  (2005).	  135	   Larsell,	  O.	  [The	  corpus	  cerebelli	  in	  birds	  &	  mammals].	  Archivio	  di	  scienze	  
biologiche	  42,	  90-­‐104	  (1958).	  136	   Larsell,	  O.	  The	  morphogenesis	  and	  adult	  pattern	  of	  the	  lobules	  and	  fissures	  of	  the	  cerebellum	  of	  the	  white	  rat.	  The	  Journal	  of	  comparative	  neurology	  97,	  281-­‐356	  (1952).	  137	   Sudarov,	  A.	  &	  Joyner,	  A.	  L.	  Cerebellum	  morphogenesis:	  the	  foliation	  pattern	  is	  orchestrated	  by	  multi-­‐cellular	  anchoring	  centers.	  Neural	  development	  2,	  26,	  doi:10.1186/1749-­‐8104-­‐2-­‐26	  (2007).	  138	   Sillitoe,	  R.	  V.	  &	  Joyner,	  A.	  L.	  Morphology,	  molecular	  codes,	  and	  circuitry	  produce	  the	  three-­‐dimensional	  complexity	  of	  the	  cerebellum.	  Annual	  review	  of	  
cell	  and	  developmental	  biology	  23,	  549-­‐577,	  doi:10.1146/annurev.cellbio.23.090506.123237	  (2007).	  139	   Martinez,	  S.	  &	  Alvarado-­‐Mallart,	  R.	  M.	  Rostral	  Cerebellum	  Originates	  from	  the	  Caudal	  Portion	  of	  the	  So-­‐Called	  'Mesencephalic'	  Vesicle:	  A	  Study	  Using	  Chick/Quail	  Chimeras.	  The	  European	  journal	  of	  neuroscience	  1,	  549-­‐560	  (1989).	  140	   Zhang,	  L.	  &	  Goldman,	  J.	  E.	  Developmental	  fates	  and	  migratory	  pathways	  of	  dividing	  progenitors	  in	  the	  postnatal	  rat	  cerebellum.	  The	  Journal	  of	  
comparative	  neurology	  370,	  536-­‐550,	  doi:10.1002/(SICI)1096-­‐9861(19960708)370:4&lt;536::AID-­‐CNE9&gt;3.0.CO;2-­‐5	  (1996).	  141	   Hoshino,	  M.	  et	  al.	  Ptf1a,	  a	  bHLH	  transcriptional	  gene,	  defines	  GABAergic	  neuronal	  fates	  in	  cerebellum.	  Neuron	  47,	  201-­‐213,	  doi:10.1016/j.neuron.2005.06.007	  (2005).	  142	   Cheng,	  L.	  et	  al.	  Tlx3	  and	  Tlx1	  are	  post-­‐mitotic	  selector	  genes	  determining	  glutamatergic	  over	  GABAergic	  cell	  fates.	  Nature	  neuroscience	  7,	  510-­‐517,	  doi:10.1038/nn1221	  (2004).	  143	   Morales,	  D.	  &	  Hatten,	  M.	  E.	  Molecular	  markers	  of	  neuronal	  progenitors	  in	  the	  embryonic	  cerebellar	  anlage.	  J	  Neurosci	  26,	  12226-­‐12236,	  doi:10.1523/JNEUROSCI.3493-­‐06.2006	  (2006).	  144	   Altman,	  J.	  &	  Bayer,	  S.	  A.	  Embryonic	  development	  of	  the	  rat	  cerebellum.	  I.	  Delineation	  of	  the	  cerebellar	  primordium	  and	  early	  cell	  movements.	  The	  
Journal	  of	  comparative	  neurology	  231,	  1-­‐26,	  doi:10.1002/cne.902310103	  (1985).	  145	   Pierce,	  E.	  T.	  Histogenesis	  of	  the	  deep	  cerebellar	  nuclei	  in	  the	  mouse:	  an	  autoradiographic	  study.	  Brain	  research	  95,	  503-­‐518	  (1975).	  146	   Hatten,	  M.	  E.	  &	  Heintz,	  N.	  Mechanisms	  of	  neural	  patterning	  and	  specification	  in	  the	  developing	  cerebellum.	  Annual	  review	  of	  neuroscience	  18,	  385-­‐408,	  doi:10.1146/annurev.ne.18.030195.002125	  (1995).	  147	   Sidman,	  R.	  L.	  &	  Rakic,	  P.	  Neuronal	  migration,	  with	  special	  reference	  to	  developing	  human	  brain:	  a	  review.	  Brain	  research	  62,	  1-­‐35	  (1973).	  148	   Altman,	  J.	  Postnatal	  development	  of	  the	  cerebellar	  cortex	  in	  the	  rat.	  I.	  The	  external	  germinal	  layer	  and	  the	  transitional	  molecular	  layer.	  The	  Journal	  of	  
comparative	  neurology	  145,	  353-­‐397,	  doi:10.1002/cne.901450305	  (1972).	  149	   Silbereis,	  J.,	  Cheng,	  E.,	  Ganat,	  Y.	  M.,	  Ment,	  L.	  R.	  &	  Vaccarino,	  F.	  M.	  Precursors	  with	  glial	  fibrillary	  acidic	  protein	  promoter	  activity	  transiently	  generate	  GABA	  interneurons	  in	  the	  postnatal	  cerebellum.	  Stem	  cells	  27,	  1152-­‐1163,	  doi:10.1002/stem.18	  (2009).	  
 
  Literature  
 
-X- 
150	   Alder,	  J.,	  Cho,	  N.	  K.	  &	  Hatten,	  M.	  E.	  Embryonic	  precursor	  cells	  from	  the	  rhombic	  lip	  are	  specified	  to	  a	  cerebellar	  granule	  neuron	  identity.	  Neuron	  17,	  389-­‐399	  (1996).	  151	   Gao,	  W.	  Q.	  &	  Hatten,	  M.	  E.	  Immortalizing	  oncogenes	  subvert	  the	  establishment	  of	  granule	  cell	  identity	  in	  developing	  cerebellum.	  Development	  120,	  1059-­‐1070	  (1994).	  152	   Wechsler-­‐Reya,	  R.	  J.	  &	  Scott,	  M.	  P.	  Control	  of	  neuronal	  precursor	  proliferation	  in	  the	  cerebellum	  by	  Sonic	  Hedgehog.	  Neuron	  22,	  103-­‐114	  (1999).	  153	   Miller,	  T.	  E.	  et	  al.	  Lgr5	  Marks	  Post-­‐Mitotic,	  Lineage	  Restricted	  Cerebellar	  Granule	  Neurons	  during	  Postnatal	  Development.	  PLoS	  One	  9,	  e114433,	  doi:10.1371/journal.pone.0114433	  (2014).	  154	   Akazawa,	  C.,	  Ishibashi,	  M.,	  Shimizu,	  C.,	  Nakanishi,	  S.	  &	  Kageyama,	  R.	  A	  mammalian	  helix-­‐loop-­‐helix	  factor	  structurally	  related	  to	  the	  product	  of	  Drosophila	  proneural	  gene	  atonal	  is	  a	  positive	  transcriptional	  regulator	  expressed	  in	  the	  developing	  nervous	  system.	  The	  Journal	  of	  biological	  
chemistry	  270,	  8730-­‐8738	  (1995).	  155	   Wingate,	  R.	  J.	  The	  rhombic	  lip	  and	  early	  cerebellar	  development.	  Current	  
opinion	  in	  neurobiology	  11,	  82-­‐88	  (2001).	  156	   Edmondson,	  J.	  C.	  &	  Hatten,	  M.	  E.	  Glial-­‐guided	  granule	  neuron	  migration	  in	  vitro:	  a	  high-­‐resolution	  time-­‐lapse	  video	  microscopic	  study.	  J	  Neurosci	  7,	  1928-­‐1934	  (1987).	  157	   Hatten,	  M.	  E.	  Neuronal	  regulation	  of	  astroglial	  morphology	  and	  proliferation	  in	  vitro.	  The	  Journal	  of	  cell	  biology	  100,	  384-­‐396	  (1985).	  158	   Gasser,	  U.	  E.	  &	  Hatten,	  M.	  E.	  Central	  nervous	  system	  neurons	  migrate	  on	  astroglial	  fibers	  from	  heterotypic	  brain	  regions	  in	  vitro.	  Proceedings	  of	  the	  
National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America	  87,	  4543-­‐4547	  (1990).	  159	   Hatten,	  M.	  E.	  Central	  nervous	  system	  neuronal	  migration.	  Annual	  review	  of	  
neuroscience	  22,	  511-­‐539,	  doi:10.1146/annurev.neuro.22.1.511	  (1999).	  160	   Edmondson,	  J.	  C.,	  Liem,	  R.	  K.,	  Kuster,	  J.	  E.	  &	  Hatten,	  M.	  E.	  Astrotactin:	  a	  novel	  neuronal	  cell	  surface	  antigen	  that	  mediates	  neuron-­‐astroglial	  interactions	  in	  cerebellar	  microcultures.	  The	  Journal	  of	  cell	  biology	  106,	  505-­‐517	  (1988).	  161	   Borghesani,	  P.	  R.	  et	  al.	  BDNF	  stimulates	  migration	  of	  cerebellar	  granule	  cells.	  
Development	  129,	  1435-­‐1442	  (2002).	  162	   Mori,	  T.	  et	  al.	  Inducible	  gene	  deletion	  in	  astroglia	  and	  radial	  glia-­‐-­‐a	  valuable	  tool	  for	  functional	  and	  lineage	  analysis.	  Glia	  54,	  21-­‐34,	  doi:10.1002/glia.20350	  (2006).	  163	   Carletti,	  B.	  &	  Rossi,	  F.	  Neurogenesis	  in	  the	  cerebellum.	  The	  Neuroscientist	  :	  a	  
review	  journal	  bringing	  neurobiology,	  neurology	  and	  psychiatry	  14,	  91-­‐100,	  doi:10.1177/1073858407304629	  (2008).	  164	   van	  der	  Lugt,	  N.	  M.	  et	  al.	  Posterior	  transformation,	  neurological	  abnormalities,	  and	  severe	  hematopoietic	  defects	  in	  mice	  with	  a	  targeted	  deletion	  of	  the	  bmi-­‐1	  proto-­‐oncogene.	  Genes	  &	  development	  8,	  757-­‐769	  (1994).	  165	   Englund,	  C.	  et	  al.	  Unipolar	  brush	  cells	  of	  the	  cerebellum	  are	  produced	  in	  the	  rhombic	  lip	  and	  migrate	  through	  developing	  white	  matter.	  J	  Neurosci	  26,	  9184-­‐9195,	  doi:10.1523/JNEUROSCI.1610-­‐06.2006	  (2006).	  166	   Jensen,	  P.,	  Smeyne,	  R.	  &	  Goldowitz,	  D.	  Analysis	  of	  cerebellar	  development	  in	  math1	  null	  embryos	  and	  chimeras.	  J	  Neurosci	  24,	  2202-­‐2211,	  doi:10.1523/JNEUROSCI.3427-­‐03.2004	  (2004).	  
 
  Literature  
 
-XI- 
167	   Silbereis,	  J.	  et	  al.	  Astroglial	  cells	  in	  the	  external	  granular	  layer	  are	  precursors	  of	  cerebellar	  granule	  neurons	  in	  neonates.	  Molecular	  and	  cellular	  neurosciences	  
44,	  362-­‐373,	  doi:10.1016/j.mcn.2010.05.001	  (2010).	  168	   Okano-­‐Uchida,	  T.,	  Himi,	  T.,	  Komiya,	  Y.	  &	  Ishizaki,	  Y.	  Cerebellar	  granule	  cell	  precursors	  can	  differentiate	  into	  astroglial	  cells.	  Proceedings	  of	  the	  National	  
Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America	  101,	  1211-­‐1216,	  doi:10.1073/pnas.0307972100	  (2004).	  169	   Buffo,	  A.	  &	  Rossi,	  F.	  Origin,	  lineage	  and	  function	  of	  cerebellar	  glia.	  Prog	  
Neurobiol	  109,	  42-­‐63,	  doi:10.1016/j.pneurobio.2013.08.001	  (2013).	  170	   Bower,	  J.	  M.	  The	  organization	  of	  cerebellar	  cortical	  circuitry	  revisited:	  implications	  for	  function.	  Annals	  of	  the	  New	  York	  Academy	  of	  Sciences	  978,	  135-­‐155	  (2002).	  171	   Voogd,	  J.	  &	  Glickstein,	  M.	  The	  anatomy	  of	  the	  cerebellum.	  Trends	  in	  cognitive	  
sciences	  2,	  307-­‐313	  (1998).	  172	   Alcantara,	  S.,	  Ruiz,	  M.,	  De	  Castro,	  F.,	  Soriano,	  E.	  &	  Sotelo,	  C.	  Netrin	  1	  acts	  as	  an	  attractive	  or	  as	  a	  repulsive	  cue	  for	  distinct	  migrating	  neurons	  during	  the	  development	  of	  the	  cerebellar	  system.	  Development	  127,	  1359-­‐1372	  (2000).	  173	   Ashwell,	  K.	  W.	  &	  Zhang,	  L.	  L.	  Ontogeny	  of	  afferents	  to	  the	  fetal	  rat	  cerebellum.	  
Acta	  anatomica	  145,	  17-­‐23	  (1992).	  174	   Komine,	  O.	  et	  al.	  The	  monolayer	  formation	  of	  Bergmann	  glial	  cells	  is	  regulated	  by	  Notch/RBP-­‐J	  signaling.	  Developmental	  biology	  311,	  238-­‐250,	  doi:10.1016/j.ydbio.2007.08.042	  (2007).	  175	   Xu,	  H.	  et	  al.	  Bergmann	  glia	  function	  in	  granule	  cell	  migration	  during	  cerebellum	  development.	  Molecular	  neurobiology	  47,	  833-­‐844,	  doi:10.1007/s12035-­‐013-­‐8405-­‐y	  (2013).	  176	   Seil,	  F.	  J.	  Interactions	  between	  cerebellar	  Purkinje	  cells	  and	  their	  associated	  astrocytes.	  Histology	  and	  histopathology	  16,	  955-­‐968	  (2001).	  177	   Hatten,	  M.	  E.,	  Liem,	  R.	  K.	  &	  Mason,	  C.	  A.	  Two	  forms	  of	  cerebellar	  glial	  cells	  interact	  differently	  with	  neurons	  in	  vitro.	  The	  Journal	  of	  cell	  biology	  98,	  193-­‐204	  (1984).	  178	   Kenney,	  A.	  M.	  &	  Segal,	  R.	  A.	  Subtracting	  the	  Math:	  prominin-­‐positive	  cerebellar	  stem	  cells	  in	  white	  matter.	  Nature	  neuroscience	  8,	  699-­‐701,	  doi:10.1038/nn0605-­‐699	  (2005).	  179	   Lee,	  A.	  et	  al.	  Isolation	  of	  neural	  stem	  cells	  from	  the	  postnatal	  cerebellum.	  
Nature	  neuroscience	  8,	  723-­‐729,	  doi:10.1038/nn1473	  (2005).	  180	   Kobielak,	  A.	  &	  Fuchs,	  E.	  Alpha-­‐catenin:	  at	  the	  junction	  of	  intercellular	  adhesion	  and	  actin	  dynamics.	  Nature	  reviews.	  Molecular	  cell	  biology	  5,	  614-­‐625,	  doi:10.1038/nrm1433	  (2004).	  181	   Tanaka,	  M.	  et	  al.	  Connexin43	  and	  bergmann	  glial	  gap	  junctions	  in	  cerebellar	  function.	  Frontiers	  in	  neuroscience	  2,	  225-­‐233,	  doi:10.3389/neuro.01.038.2008	  (2008).	  182	   Polgar,	  L.	  The	  catalytic	  triad	  of	  serine	  peptidases.	  Cellular	  and	  molecular	  life	  
sciences	  :	  CMLS	  62,	  2161-­‐2172,	  doi:10.1007/s00018-­‐005-­‐5160-­‐x	  (2005).	  183	   Hedin,	  S.	  G.	  Observations	  on	  the	  action	  of	  trypsin.	  The	  Journal	  of	  physiology	  32,	  468-­‐485	  (1905).	  184	   Milstein,	  C.	  The	  hybridoma	  revolution:	  an	  offshoot	  of	  basic	  research.	  
BioEssays	  :	  news	  and	  reviews	  in	  molecular,	  cellular	  and	  developmental	  biology	  
21,	  966-­‐973,	  doi:10.1002/(SICI)1521-­‐1878(199911)21:11<966::AID-­‐BIES9>3.0.CO;2-­‐Z	  (1999).	  
 
  Literature  
 
-XII- 
185	   Kohler,	  G.	  &	  Milstein,	  C.	  Continuous	  cultures	  of	  fused	  cells	  secreting	  antibody	  of	  predefined	  specificity.	  Nature	  256,	  495-­‐497	  (1975).	  186	   Tjio,	  J.	  H.	  &	  Puck,	  T.	  T.	  Genetics	  of	  somatic	  mammalian	  cells.	  II.	  Chromosomal	  constitution	  of	  cells	  in	  tissue	  culture.	  The	  Journal	  of	  experimental	  medicine	  108,	  259-­‐268	  (1958).	  187	   Wurm,	  F.	  M.	  Production	  of	  recombinant	  protein	  therapeutics	  in	  cultivated	  mammalian	  cells.	  Nature	  biotechnology	  22,	  1393-­‐1398,	  doi:10.1038/nbt1026	  (2004).	  188	   Graham,	  F.	  L.,	  Smiley,	  J.,	  Russell,	  W.	  C.	  &	  Nairn,	  R.	  Characteristics	  of	  a	  human	  cell	  line	  transformed	  by	  DNA	  from	  human	  adenovirus	  type	  5.	  The	  Journal	  of	  
general	  virology	  36,	  59-­‐74	  (1977).	  189	   Siden,	  E.	  J.,	  Baltimore,	  D.,	  Clark,	  D.	  &	  Rosenberg,	  N.	  E.	  Immunoglobulin	  synthesis	  by	  lymphoid	  cells	  transformed	  in	  vitro	  by	  Abelson	  murine	  leukemia	  virus.	  Cell	  16,	  389-­‐396	  (1979).	  190	   Jacques,	  T.	  S.	  et	  al.	  Neural	  precursor	  cell	  chain	  migration	  and	  division	  are	  regulated	  through	  different	  beta1	  integrins.	  Development	  125,	  3167-­‐3177	  (1998).	  191	   Neumann,	  E.,	  Schaefer-­‐Ridder,	  M.,	  Wang,	  Y.	  &	  Hofschneider,	  P.	  H.	  Gene	  transfer	  into	  mouse	  lyoma	  cells	  by	  electroporation	  in	  high	  electric	  fields.	  The	  EMBO	  
journal	  1,	  841-­‐845	  (1982).	  192	   Aihara,	  H.	  &	  Miyazaki,	  J.	  Gene	  transfer	  into	  muscle	  by	  electroporation	  in	  vivo.	  
Nature	  biotechnology	  16,	  867-­‐870,	  doi:10.1038/nbt0998-­‐867	  (1998).	  193	   de	  Melo,	  J.	  &	  Blackshaw,	  S.	  In	  vivo	  electroporation	  of	  developing	  mouse	  retina.	  
Journal	  of	  visualized	  experiments	  :	  JoVE,	  doi:10.3791/2847	  (2011).	  194	   Saito,	  T.	  &	  Nakatsuji,	  N.	  Efficient	  gene	  transfer	  into	  the	  embryonic	  mouse	  brain	  using	  in	  vivo	  electroporation.	  Developmental	  biology	  240,	  237-­‐246,	  doi:10.1006/dbio.2001.0439	  (2001).	  195	   Boutin,	  C.,	  Diestel,	  S.,	  Desoeuvre,	  A.,	  Tiveron,	  M.	  C.	  &	  Cremer,	  H.	  Efficient	  in	  vivo	  electroporation	  of	  the	  postnatal	  rodent	  forebrain.	  PloS	  one	  3,	  e1883,	  doi:10.1371/journal.pone.0001883	  (2008).	  196	   Schubert,	  W.	  et	  al.	  Analyzing	  proteome	  topology	  and	  function	  by	  automated	  multidimensional	  fluorescence	  microscopy.	  Nature	  biotechnology	  24,	  1270-­‐1278,	  doi:10.1038/nbt1250	  (2006).	  197	   Frei,	  A.	  P.	  et	  al.	  Direct	  identification	  of	  ligand-­‐receptor	  interactions	  on	  living	  cells	  and	  tissues.	  Nature	  biotechnology	  30,	  997-­‐1001,	  doi:10.1038/nbt.2354	  (2012).	  198	   Frei,	  A.	  P.,	  Moest,	  H.,	  Novy,	  K.	  &	  Wollscheid,	  B.	  Ligand-­‐based	  receptor	  identification	  on	  living	  cells	  and	  tissues	  using	  TRICEPS.	  Nature	  protocols	  8,	  1321-­‐1336,	  doi:10.1038/nprot.2013.072	  (2013).	  199	   Fleige,	  S.	  &	  Pfaffl,	  M.	  W.	  RNA	  integrity	  and	  the	  effect	  on	  the	  real-­‐time	  qRT-­‐PCR	  performance.	  Molecular	  aspects	  of	  medicine	  27,	  126-­‐139,	  doi:10.1016/j.mam.2005.12.003	  (2006).	  200	   Hennersdorf,	  F.	  et	  al.	  Identification	  of	  CD13,	  CD107a,	  and	  CD164	  as	  novel	  basophil-­‐activation	  markers	  and	  dissection	  of	  two	  response	  patterns	  in	  time	  kinetics	  of	  IgE-­‐dependent	  upregulation.	  Cell	  research	  15,	  325-­‐335,	  doi:10.1038/sj.cr.7290301	  (2005).	  201	   Nomenclature	  for	  clusters	  of	  differentiation	  (CD)	  of	  antigens	  defined	  on	  human	  leukocyte	  populations.	  IUIS-­‐WHO	  Nomenclature	  Subcommittee.	  
Bulletin	  of	  the	  World	  Health	  Organization	  62,	  809-­‐815	  (1984).	  
 
  Literature  
 
-XIII- 
202	   Pennartz,	  S.,	  Reiss,	  S.,	  Biloune,	  R.,	  Hasselmann,	  D.	  &	  Bosio,	  A.	  Generation	  of	  single-­‐cell	  suspensions	  from	  mouse	  neural	  tissue.	  Journal	  of	  visualized	  
experiments	  :	  JoVE,	  doi:10.3791/1267	  (2009).	  203	   Kokovay,	  E.	  et	  al.	  VCAM1	  is	  essential	  to	  maintain	  the	  structure	  of	  the	  SVZ	  niche	  and	  acts	  as	  an	  environmental	  sensor	  to	  regulate	  SVZ	  lineage	  progression.	  Cell	  
stem	  cell	  11,	  220-­‐230,	  doi:10.1016/j.stem.2012.06.016	  (2012).	  204	   Bayraktar,	  O.	  A.,	  Fuentealba,	  L.	  C.,	  Alvarez-­‐Buylla,	  A.	  &	  Rowitch,	  D.	  H.	  Astrocyte	  Development	  and	  Heterogeneity.	  Cold	  Spring	  Harbor	  perspectives	  in	  biology,	  doi:10.1101/cshperspect.a020362	  (2014).	  205	   Chaboub,	  L.	  S.	  &	  Deneen,	  B.	  Developmental	  origins	  of	  astrocyte	  heterogeneity:	  the	  final	  frontier	  of	  CNS	  development.	  Developmental	  neuroscience	  34,	  379-­‐388,	  doi:10.1159/000343723	  000343723	  (2012).	  206	   Brooks,	  P.	  C.,	  Lin,	  J.	  M.,	  French,	  D.	  L.	  &	  Quigley,	  J.	  P.	  Subtractive	  immunization	  yields	  monoclonal	  antibodies	  that	  specifically	  inhibit	  metastasis.	  The	  Journal	  of	  
cell	  biology	  122,	  1351-­‐1359	  (1993).	  207	   Reyes-­‐Haro,	  D.,	  Mora-­‐Loyola,	  E.,	  Soria-­‐Ortiz,	  B.	  &	  Garcia-­‐Colunga,	  J.	  Regional	  density	  of	  glial	  cells	  in	  the	  rat	  corpus	  callosum.	  Biological	  research	  46,	  27-­‐32,	  doi:10.4067/S0716-­‐97602013000100004	  (2013).	  208	   Moransard,	  M.	  et	  al.	  NG2	  expressed	  by	  macrophages	  and	  oligodendrocyte	  precursor	  cells	  is	  dispensable	  in	  experimental	  autoimmune	  encephalomyelitis.	  
Brain	  :	  a	  journal	  of	  neurology	  134,	  1315-­‐1330,	  doi:10.1093/brain/awr070	  (2011).	  209	   Baumann,	  N.	  &	  Pham-­‐Dinh,	  D.	  Biology	  of	  oligodendrocyte	  and	  myelin	  in	  the	  mammalian	  central	  nervous	  system.	  Physiological	  reviews	  81,	  871-­‐927	  (2001).	  210	   Kohwi,	  M.	  et	  al.	  A	  subpopulation	  of	  olfactory	  bulb	  GABAergic	  interneurons	  is	  derived	  from	  Emx1-­‐	  and	  Dlx5/6-­‐expressing	  progenitors.	  J	  Neurosci	  27,	  6878-­‐6891	  (2007).	  211	   Soltani,	  M.	  H.	  et	  al.	  Microtubule-­‐associated	  protein	  2,	  a	  marker	  of	  neuronal	  differentiation,	  induces	  mitotic	  defects,	  inhibits	  growth	  of	  melanoma	  cells,	  and	  predicts	  metastatic	  potential	  of	  cutaneous	  melanoma.	  The	  American	  journal	  of	  
pathology	  166,	  1841-­‐1850	  (2005).	  212	   Sehgal,	  A.	  et	  al.	  Cell	  adhesion	  molecule	  Nr-­‐CAM	  is	  over-­‐expressed	  in	  human	  brain	  tumors.	  International	  journal	  of	  cancer.	  Journal	  international	  du	  cancer	  
76,	  451-­‐458	  (1998).	  213	   Lein,	  E.	  S.	  et	  al.	  Genome-­‐wide	  atlas	  of	  gene	  expression	  in	  the	  adult	  mouse	  brain.	  
Nature	  445,	  168-­‐176,	  doi:10.1038/nature05453	  (2007).	  214	   Minelli,	  A.,	  Barbaresi,	  P.	  &	  Conti,	  F.	  Postnatal	  development	  of	  high-­‐affinity	  plasma	  membrane	  GABA	  transporters	  GAT-­‐2	  and	  GAT-­‐3	  in	  the	  rat	  cerebral	  cortex.	  Brain	  research.	  Developmental	  brain	  research	  142,	  7-­‐18	  (2003).	  215	   Minelli,	  A.,	  DeBiasi,	  S.,	  Brecha,	  N.	  C.,	  Zuccarello,	  L.	  V.	  &	  Conti,	  F.	  GAT-­‐3,	  a	  high-­‐affinity	  GABA	  plasma	  membrane	  transporter,	  is	  localized	  to	  astrocytic	  processes,	  and	  it	  is	  not	  confined	  to	  the	  vicinity	  of	  GABAergic	  synapses	  in	  the	  cerebral	  cortex.	  J	  Neurosci	  16,	  6255-­‐6264	  (1996).	  216	   Aub,	  J.	  C.,	  Tieslau,	  C.	  &	  Lankester,	  A.	  Reactions	  of	  Normal	  and	  Tumor	  Cell	  Surfaces	  to	  Enzymes.	  I.	  Wheat-­‐Germ	  Lipase	  and	  Associated	  Mucopolysaccharides.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  the	  
United	  States	  of	  America	  50,	  613-­‐619	  (1963).	  
 
  Literature  
 
-XIV- 
217	   Wright,	  C.	  S.	  Structural	  comparison	  of	  the	  two	  distinct	  sugar	  binding	  sites	  in	  wheat	  germ	  agglutinin	  isolectin	  II.	  Journal	  of	  molecular	  biology	  178,	  91-­‐104	  (1984).	  218	   Rothwangl,	  K.	  B.,	  Manicassamy,	  B.,	  Uprichard,	  S.	  L.	  &	  Rong,	  L.	  Dissecting	  the	  role	  of	  putative	  CD81	  binding	  regions	  of	  E2	  in	  mediating	  HCV	  entry:	  putative	  CD81	  binding	  region	  1	  is	  not	  involved	  in	  CD81	  binding.	  Virology	  journal	  5,	  46,	  doi:10.1186/1743-­‐422X-­‐5-­‐46	  (2008).	  219	   Orentas,	  D.	  M.	  &	  Miller,	  R.	  H.	  A	  novel	  form	  of	  migration	  of	  glial	  precursors.	  Glia	  
16,	  27-­‐39,	  doi:10.1002/(SICI)1098-­‐1136(199601)16:1&lt;27::AID-­‐GLIA4&gt;3.0.CO;2-­‐8	  (1996).	  220	   Lee,	  J.	  C.,	  Mayer-­‐Proschel,	  M.	  &	  Rao,	  M.	  S.	  Gliogenesis	  in	  the	  central	  nervous	  system.	  Glia	  30,	  105-­‐121	  (2000).	  221	   Stallcup,	  W.	  B.	  &	  Beasley,	  L.	  Bipotential	  glial	  precursor	  cells	  of	  the	  optic	  nerve	  express	  the	  NG2	  proteoglycan.	  The	  Journal	  of	  neuroscience	  :	  the	  official	  journal	  
of	  the	  Society	  for	  Neuroscience	  7,	  2737-­‐2744	  (1987).	  222	   Chang,	  M.	  Y.,	  Park,	  C.	  H.,	  Son,	  H.,	  Lee,	  Y.	  S.	  &	  Lee,	  S.	  H.	  Developmental	  stage-­‐dependent	  self-­‐regulation	  of	  embryonic	  cortical	  precursor	  cell	  survival	  and	  differentiation	  by	  leukemia	  inhibitory	  factor.	  Cell	  death	  and	  differentiation	  11,	  985-­‐996,	  doi:10.1038/sj.cdd.4401426	  (2004).	  223	   Fernandez,	  M.	  E.,	  Croce,	  S.,	  Boutin,	  C.,	  Cremer,	  H.	  &	  Raineteau,	  O.	  Targeted	  electroporation	  of	  defined	  lateral	  ventricular	  walls:	  a	  novel	  and	  rapid	  method	  to	  study	  fate	  specification	  during	  postnatal	  forebrain	  neurogenesis.	  Neural	  
development	  6,	  13,	  doi:10.1186/1749-­‐8104-­‐6-­‐13	  (2011).	  224	   Pastrana,	  E.,	  Cheng,	  L.	  C.	  &	  Doetsch,	  F.	  Simultaneous	  prospective	  purification	  of	  adult	  subventricular	  zone	  neural	  stem	  cells	  and	  their	  progeny.	  Proceedings	  of	  
the	  National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America	  106,	  6387-­‐6392,	  doi:10.1073/pnas.0810407106	  (2009).	  225	   Harada,	  T.	  et	  al.	  Functions	  of	  the	  two	  glutamate	  transporters	  GLAST	  and	  GLT-­‐1	  in	  the	  retina.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  the	  United	  
States	  of	  America	  95,	  4663-­‐4666	  (1998).	  226	   Lehre,	  K.	  P.,	  Davanger,	  S.	  &	  Danbolt,	  N.	  C.	  Localization	  of	  the	  glutamate	  transporter	  protein	  GLAST	  in	  rat	  retina.	  Brain	  Res	  744,	  129-­‐137	  (1997).	  227	   Reichenbach,	  A.,	  Derouiche,	  A.	  &	  Kirchhoff,	  F.	  Morphology	  and	  dynamics	  of	  perisynaptic	  glia.	  Brain	  research	  reviews	  63,	  11-­‐25,	  doi:10.1016/j.brainresrev.2010.02.003	  (2010).	  228	   Tuppen,	  H.	  A.,	  Blakely,	  E.	  L.,	  Turnbull,	  D.	  M.	  &	  Taylor,	  R.	  W.	  Mitochondrial	  DNA	  mutations	  and	  human	  disease.	  Biochimica	  et	  biophysica	  acta	  1797,	  113-­‐128,	  doi:10.1016/j.bbabio.2009.09.005	  (2010).	  229	   Consalez,	  G.	  G.	  &	  Hawkes,	  R.	  The	  compartmental	  restriction	  of	  cerebellar	  interneurons.	  Frontiers	  in	  neural	  circuits	  6,	  123,	  doi:10.3389/fncir.2012.00123	  (2012).	  230	   Takayasu,	  Y.	  et	  al.	  Differential	  roles	  of	  glial	  and	  neuronal	  glutamate	  transporters	  in	  Purkinje	  cell	  synapses.	  J	  Neurosci	  25,	  8788-­‐8793,	  doi:10.1523/JNEUROSCI.1020-­‐05.2005	  (2005).	  231	   Yamada,	  K.	  et	  al.	  Dynamic	  transformation	  of	  Bergmann	  glial	  fibers	  proceeds	  in	  correlation	  with	  dendritic	  outgrowth	  and	  synapse	  formation	  of	  cerebellar	  Purkinje	  cells.	  The	  Journal	  of	  comparative	  neurology	  418,	  106-­‐120	  (2000).	  232	   Fletcher,	  C.,	  Norman,	  D.	  J.	  &	  Heintz,	  N.	  Genetic	  mapping	  of	  meander	  tail,	  a	  mouse	  mutation	  affecting	  cerebellar	  development.	  Genomics	  9,	  647-­‐655	  (1991).	  
 
  Literature  
 
-XV- 
233	   Koepsell,	  H.,	  Lips,	  K.	  &	  Volk,	  C.	  Polyspecific	  organic	  cation	  transporters:	  structure,	  function,	  physiological	  roles,	  and	  biopharmaceutical	  implications.	  
Pharmaceutical	  research	  24,	  1227-­‐1251,	  doi:10.1007/s11095-­‐007-­‐9254-­‐z	  (2007).	  234	   Sato,	  T.	  &	  Nakamura,	  H.	  The	  Fgf8	  signal	  causes	  cerebellar	  differentiation	  by	  activating	  the	  Ras-­‐ERK	  signaling	  pathway.	  Development	  131,	  4275-­‐4285,	  doi:10.1242/dev.01281	  (2004).	  235	   Logan,	  C.	  Y.	  &	  Nusse,	  R.	  The	  Wnt	  signaling	  pathway	  in	  development	  and	  disease.	  Annual	  review	  of	  cell	  and	  developmental	  biology	  20,	  781-­‐810,	  doi:10.1146/annurev.cellbio.20.010403.113126	  (2004).	  236	   Machold,	  R.	  P.,	  Kittell,	  D.	  J.	  &	  Fishell,	  G.	  J.	  Antagonism	  between	  Notch	  and	  bone	  morphogenetic	  protein	  receptor	  signaling	  regulates	  neurogenesis	  in	  the	  cerebellar	  rhombic	  lip.	  Neural	  development	  2,	  5,	  doi:10.1186/1749-­‐8104-­‐2-­‐5	  (2007).	  237	   Sivakumar,	  K.	  C.,	  Dhanesh,	  S.	  B.,	  Shobana,	  S.,	  James,	  J.	  &	  Mundayoor,	  S.	  A	  systems	  biology	  approach	  to	  model	  neural	  stem	  cell	  regulation	  by	  notch,	  shh,	  wnt,	  and	  EGF	  signaling	  pathways.	  Omics	  :	  a	  journal	  of	  integrative	  biology	  15,	  729-­‐737,	  doi:10.1089/omi.2011.0011	  (2011).	  238	   Barker,	  N.	  et	  al.	  Identification	  of	  stem	  cells	  in	  small	  intestine	  and	  colon	  by	  marker	  gene	  Lgr5.	  Nature	  449,	  1003-­‐1007,	  doi:10.1038/nature06196	  (2007).	  239	   Barker,	  N.,	  Tan,	  S.	  &	  Clevers,	  H.	  Lgr	  proteins	  in	  epithelial	  stem	  cell	  biology.	  
Development	  140,	  2484-­‐2494,	  doi:10.1242/dev.083113	  (2013).	  240	   Alenina,	  N.,	  Bashammakh,	  S.	  &	  Bader,	  M.	  Specification	  and	  differentiation	  of	  serotonergic	  neurons.	  Stem	  cell	  reviews	  2,	  5-­‐10,	  doi:10.1007/s12015-­‐006-­‐0002-­‐2	  (2006).	  241	   Leto,	  K.,	  Carletti,	  B.,	  Williams,	  I.	  M.,	  Magrassi,	  L.	  &	  Rossi,	  F.	  Different	  types	  of	  cerebellar	  GABAergic	  interneurons	  originate	  from	  a	  common	  pool	  of	  multipotent	  progenitor	  cells.	  J	  Neurosci	  26,	  11682-­‐11694,	  doi:10.1523/JNEUROSCI.3656-­‐06.2006	  (2006).	  242	   Pascual,	  M.	  et	  al.	  Cerebellar	  GABAergic	  progenitors	  adopt	  an	  external	  granule	  cell-­‐like	  phenotype	  in	  the	  absence	  of	  Ptf1a	  transcription	  factor	  expression.	  
Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America	  
104,	  5193-­‐5198,	  doi:10.1073/pnas.0605699104	  (2007).	  243	   Kim,	  E.	  J.,	  Battiste,	  J.,	  Nakagawa,	  Y.	  &	  Johnson,	  J.	  E.	  Ascl1	  (Mash1)	  lineage	  cells	  contribute	  to	  discrete	  cell	  populations	  in	  CNS	  architecture.	  Molecular	  and	  
cellular	  neurosciences	  38,	  595-­‐606,	  doi:10.1016/j.mcn.2008.05.008	  (2008).	  244	   Leto,	  K.,	  Bartolini,	  A.	  &	  Rossi,	  F.	  The	  prospective	  white	  matter:	  an	  atypical	  neurogenic	  niche	  in	  the	  developing	  cerebellum.	  Archives	  italiennes	  de	  biologie	  
148,	  137-­‐146	  (2010).	  245	   Chung,	  S.	  et	  al.	  Wnt1-­‐lmx1a	  forms	  a	  novel	  autoregulatory	  loop	  and	  controls	  midbrain	  dopaminergic	  differentiation	  synergistically	  with	  the	  SHH-­‐FoxA2	  pathway.	  Cell	  stem	  cell	  5,	  646-­‐658,	  doi:10.1016/j.stem.2009.09.015	  (2009).	  246	   Yuasa,	  S.	  Bergmann	  glial	  development	  in	  the	  mouse	  cerebellum	  as	  revealed	  by	  tenascin	  expression.	  Anatomy	  and	  embryology	  194,	  223-­‐234	  (1996).	  247	   Rash,	  J.	  E.	  et	  al.	  Identification	  of	  cells	  expressing	  Cx43,	  Cx30,	  Cx26,	  Cx32	  and	  Cx36	  in	  gap	  junctions	  of	  rat	  brain	  and	  spinal	  cord.	  Cell	  communication	  &	  
adhesion	  8,	  315-­‐320	  (2001).	  248	   Gazit,	  R.,	  Krizhanovsky,	  V.	  &	  Ben-­‐Arie,	  N.	  Math1	  controls	  cerebellar	  granule	  cell	  differentiation	  by	  regulating	  multiple	  components	  of	  the	  Notch	  signaling	  pathway.	  Development	  131,	  903-­‐913,	  doi:10.1242/dev.00982	  (2004).	  
 
  Literature  
 
-XVI- 
249	   Fleming,	  J.	  T.	  et	  al.	  The	  Purkinje	  neuron	  acts	  as	  a	  central	  regulator	  of	  spatially	  and	  functionally	  distinct	  cerebellar	  precursors.	  Developmental	  cell	  27,	  278-­‐292,	  doi:10.1016/j.devcel.2013.10.008	  (2013).	  250	   Kimelberg,	  H.	  K.	  Supportive	  or	  information-­‐processing	  functions	  of	  the	  mature	  protoplasmic	  astrocyte	  in	  the	  mammalian	  CNS?	  A	  critical	  appraisal.	  Neuron	  
glia	  biology	  3,	  181-­‐189,	  doi:10.1017/S1740925X08000094	  (2007).	  251	   Cai,	  J.	  et	  al.	  A	  crucial	  role	  for	  Olig2	  in	  white	  matter	  astrocyte	  development.	  
Development	  134,	  1887-­‐1899,	  doi:10.1242/dev.02847	  (2007).	  252	   Sauvageot,	  C.	  M.	  &	  Stiles,	  C.	  D.	  Molecular	  mechanisms	  controlling	  cortical	  gliogenesis.	  Current	  opinion	  in	  neurobiology	  12,	  244-­‐249	  (2002).	  253	   Hochstim,	  C.,	  Deneen,	  B.,	  Lukaszewicz,	  A.,	  Zhou,	  Q.	  &	  Anderson,	  D.	  J.	  Identification	  of	  positionally	  distinct	  astrocyte	  subtypes	  whose	  identities	  are	  specified	  by	  a	  homeodomain	  code.	  Cell	  133,	  510-­‐522,	  doi:10.1016/j.cell.2008.02.046	  (2008).	  254	   Cammer,	  W.	  Glutamine	  synthetase	  in	  the	  central	  nervous	  system	  is	  not	  confined	  to	  astrocytes.	  Journal	  of	  neuroimmunology	  26,	  173-­‐178	  (1990).	  255	   Rothstein,	  J.	  D.	  et	  al.	  Localization	  of	  neuronal	  and	  glial	  glutamate	  transporters.	  
Neuron	  13,	  713-­‐725	  (1994).	  256	   Takumi,	  T.	  et	  al.	  A	  novel	  ATP-­‐dependent	  inward	  rectifier	  potassium	  channel	  expressed	  predominantly	  in	  glial	  cells.	  The	  Journal	  of	  biological	  chemistry	  270,	  16339-­‐16346	  (1995).	  257	   Lee,	  Y.,	  Messing,	  A.,	  Su,	  M.	  &	  Brenner,	  M.	  GFAP	  promoter	  elements	  required	  for	  region-­‐specific	  and	  astrocyte-­‐specific	  expression.	  Glia	  56,	  481-­‐493,	  doi:10.1002/glia.20622	  (2008).	  258	   Schwandt,	  E.	  [Protides	  of	  biological	  fluids.	  Report	  on	  the	  19th	  colloquium	  Brugge-­‐Belgium].	  Fortschritte	  der	  Medizin	  89,	  8-­‐13	  (1971).	  259	   Corver,	  W.	  E.,	  Cornelisse,	  C.	  J.,	  Hermans,	  J.	  &	  Fleuren,	  G.	  J.	  Limited	  loss	  of	  nine	  tumor-­‐associated	  surface	  antigenic	  determinants	  after	  tryptic	  cell	  dissociation.	  
Cytometry	  19,	  267-­‐272,	  doi:10.1002/cyto.990190311	  (1995).	  260	   Shen,	  Q.	  et	  al.	  Adult	  SVZ	  stem	  cells	  lie	  in	  a	  vascular	  niche:	  a	  quantitative	  analysis	  of	  niche	  cell-­‐cell	  interactions.	  Cell	  stem	  cell	  3,	  289-­‐300,	  doi:10.1016/j.stem.2008.07.026	  (2008).	  261	   Beurel,	  E.	  &	  Jope,	  R.	  S.	  Differential	  regulation	  of	  STAT	  family	  members	  by	  glycogen	  synthase	  kinase-­‐3.	  The	  Journal	  of	  biological	  chemistry	  283,	  21934-­‐21944,	  doi:10.1074/jbc.M802481200	  (2008).	  262	   Daley,	  D.	  O.	  The	  assembly	  of	  membrane	  proteins	  into	  complexes.	  Current	  
opinion	  in	  structural	  biology	  18,	  420-­‐424,	  doi:10.1016/j.sbi.2008.04.006	  (2008).	  263	   Matesic,	  D.	  F.,	  Manning,	  D.	  R.,	  Wolfe,	  B.	  B.	  &	  Luthin,	  G.	  R.	  Pharmacological	  and	  biochemical	  characterization	  of	  complexes	  of	  muscarinic	  acetylcholine	  receptor	  and	  guanine	  nucleotide-­‐binding	  protein.	  The	  Journal	  of	  biological	  
chemistry	  264,	  21638-­‐21645	  (1989).	  264	   Kaboord,	  B.	  &	  Perr,	  M.	  Isolation	  of	  proteins	  and	  protein	  complexes	  by	  immunoprecipitation.	  Methods	  in	  molecular	  biology	  424,	  349-­‐364,	  doi:10.1007/978-­‐1-­‐60327-­‐064-­‐9_27	  (2008).	  265	   Birikh,	  K.	  R.,	  Sklan,	  E.	  H.,	  Shoham,	  S.	  &	  Soreq,	  H.	  Interaction	  of	  "readthrough"	  acetylcholinesterase	  with	  RACK1	  and	  PKCbeta	  II	  correlates	  with	  intensified	  fear-­‐induced	  conflict	  behavior.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  
of	  the	  United	  States	  of	  America	  100,	  283-­‐288,	  doi:10.1073/pnas.0135647100	  (2003).	  
 
  Literature  
 
-XVII- 
266	   Walsh,	  C.	  Posttranslational	  modification	  of	  proteins:	  Expanding	  nature's	  inventory.	  Roberts	  and	  Co.	  Publishers,	  Englewood,	  CO.	  ISBN	  0974707732.	  (2006).	  267	   Bleckmann,	  C.	  et	  al.	  O-­‐glycosylation	  pattern	  of	  CD24	  from	  mouse	  brain.	  
Biological	  chemistry	  390,	  627-­‐645,	  doi:10.1515/BC.2009.044	  (2009).	  268	   Stanley,	  P.	  &	  Cummings,	  R.	  D.	  in	  Essentials	  of	  Glycobiology	  	  	  (eds	  A.	  Varki	  et	  al.)	  	  (2009).	  269	   Merkle,	  F.	  T.,	  Tramontin,	  A.	  D.,	  Garcia-­‐Verdugo,	  J.	  M.	  &	  Alvarez-­‐Buylla,	  A.	  Radial	  glia	  give	  rise	  to	  adult	  neural	  stem	  cells	  in	  the	  subventricular	  zone.	  Proceedings	  
of	  the	  National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America	  101,	  17528-­‐17532,	  doi:10.1073/pnas.0407893101	  (2004).	  270	   Hockfield,	  S.	  &	  McKay,	  R.	  D.	  Identification	  of	  major	  cell	  classes	  in	  the	  developing	  mammalian	  nervous	  system.	  The	  Journal	  of	  neuroscience	  :	  the	  
official	  journal	  of	  the	  Society	  for	  Neuroscience	  5,	  3310-­‐3328	  (1985).	  271	   Obermair,	  F.	  J.	  et	  al.	  A	  novel	  classification	  of	  quiescent	  and	  transit	  amplifying	  adult	  neural	  stem	  cells	  by	  surface	  and	  metabolic	  markers	  permits	  a	  defined	  simultaneous	  isolation.	  Stem	  cell	  research	  5,	  131-­‐143,	  doi:10.1016/j.scr.2010.05.001	  (2010).	  272	   Stump,	  G.	  et	  al.	  Notch1	  and	  its	  ligands	  Delta-­‐like	  and	  Jagged	  are	  expressed	  and	  active	  in	  distinct	  cell	  populations	  in	  the	  postnatal	  mouse	  brain.	  Mechanisms	  of	  
development	  114,	  153-­‐159	  (2002).	  273	   Kero,	  D.	  et	  al.	  Expression	  of	  Ki-­‐67,	  Oct-­‐4,	  gamma-­‐tubulin	  and	  alpha-­‐tubulin	  in	  human	  tooth	  development.	  Archives	  of	  oral	  biology	  59,	  1119-­‐1129,	  doi:10.1016/j.archoralbio.2014.05.025	  (2014).	  274	   Leto,	  K.,	  Rolando,	  C.	  &	  Rossi,	  F.	  The	  genesis	  of	  cerebellar	  GABAergic	  neurons:	  fate	  potential	  and	  specification	  mechanisms.	  Frontiers	  in	  neuroanatomy	  6,	  6,	  doi:10.3389/fnana.2012.00006	  (2012).	  275	   Naruse,	  M.,	  Shibasaki,	  K.,	  Yokoyama,	  S.,	  Kurachi,	  M.	  &	  Ishizaki,	  Y.	  Dynamic	  changes	  of	  CD44	  expression	  from	  progenitors	  to	  subpopulations	  of	  astrocytes	  and	  neurons	  in	  developing	  cerebellum.	  PloS	  one	  8,	  e53109,	  doi:10.1371/journal.pone.0053109	  (2013).	  276	   Cai,	  N.,	  Kurachi,	  M.,	  Shibasaki,	  K.,	  Okano-­‐Uchida,	  T.	  &	  Ishizaki,	  Y.	  CD44-­‐positive	  cells	  are	  candidates	  for	  astrocyte	  precursor	  cells	  in	  developing	  mouse	  cerebellum.	  Cerebellum	  11,	  181-­‐193,	  doi:10.1007/s12311-­‐011-­‐0294-­‐x	  (2012).	  277	   Leto,	  K.	  et	  al.	  Laminar	  fate	  and	  phenotype	  specification	  of	  cerebellar	  GABAergic	  interneurons.	  J	  Neurosci	  29,	  7079-­‐7091,	  doi:10.1523/JNEUROSCI.0957-­‐09.2009	  (2009).	  278	   Corbeil,	  D.	  et	  al.	  Expression	  of	  distinct	  splice	  variants	  of	  the	  stem	  cell	  marker	  prominin-­‐1	  (CD133)	  in	  glial	  cells.	  Glia	  57,	  860-­‐874,	  doi:10.1002/glia.20812	  (2009).	  279	   Alcock,	  J.	  &	  Sottile,	  V.	  Dynamic	  distribution	  and	  stem	  cell	  characteristics	  of	  Sox1-­‐expressing	  cells	  in	  the	  cerebellar	  cortex.	  Cell	  research	  19,	  1324-­‐1333,	  doi:10.1038/cr.2009.119	  (2009).	  280	   Alvarez-­‐Dolado,	  M.,	  Gonzalez-­‐Sancho,	  J.	  M.,	  Bernal,	  J.	  &	  Munoz,	  A.	  Developmental	  expression	  of	  the	  tenascin-­‐C	  is	  altered	  by	  hypothyroidism	  in	  the	  rat	  brain.	  Neuroscience	  84,	  309-­‐322	  (1998).	  281	   Grimaldi,	  P.,	  Parras,	  C.,	  Guillemot,	  F.,	  Rossi,	  F.	  &	  Wassef,	  M.	  Origins	  and	  control	  of	  the	  differentiation	  of	  inhibitory	  interneurons	  and	  glia	  in	  the	  cerebellum.	  
Developmental	  biology	  328,	  422-­‐433,	  doi:10.1016/j.ydbio.2009.02.008	  (2009).	  
 
  Literature  
 
-XVIII- 
282	   Lee,	  E.	  Y.	  et	  al.	  Hedgehog	  pathway-­‐regulated	  gene	  networks	  in	  cerebellum	  development	  and	  tumorigenesis.	  Proceedings	  of	  the	  National	  Academy	  of	  
Sciences	  of	  the	  United	  States	  of	  America	  107,	  9736-­‐9741,	  doi:10.1073/pnas.1004602107	  (2010).	  283	   Corrales,	  J.	  D.,	  Rocco,	  G.	  L.,	  Blaess,	  S.,	  Guo,	  Q.	  &	  Joyner,	  A.	  L.	  Spatial	  pattern	  of	  sonic	  hedgehog	  signaling	  through	  Gli	  genes	  during	  cerebellum	  development.	  
Development	  131,	  5581-­‐5590,	  doi:10.1242/dev.01438	  (2004).	  284	   Lutz,	  S.	  E.	  et	  al.	  Deletion	  of	  astrocyte	  connexins	  43	  and	  30	  leads	  to	  a	  dysmyelinating	  phenotype	  and	  hippocampal	  CA1	  vacuolation.	  J	  Neurosci	  29,	  7743-­‐7752,	  doi:10.1523/JNEUROSCI.0341-­‐09.2009	  (2009).	  285	   Larsen,	  K.,	  Momeni,	  J.,	  Farajzadeh,	  L.	  &	  Bendixen,	  C.	  Porcine	  SLITRK1:	  Molecular	  cloning	  and	  characterization.	  FEBS	  open	  bio	  4,	  872-­‐878,	  doi:10.1016/j.fob.2014.10.001	  (2014).	  	  
 
 
 
 
    
 
-I- 
IV Acknowledgement 
  I am very grateful to Prof. Dr. Elena I. Rugarli and Prof. Dr. Thomas Langmann for 
taking over university supervision of my PhD project. Thank you very much for your help 
and support. In addition, I would like to thank Stefan Miltenyi for the possibility to 
perform my PhD project at Miltenyi Biotec. At this point I would also like to thank  
Dr. Andreas Bosio and Dr. Melanie Jungblut for the initiation of this project, their support 
and advice throughout this study.   
Besides, I would like to thank Dr. Harold Cremer and Dr. Marie-Catherine Tiveron for 
their supervision during my internships at the IBDM. In addition, I am grateful to  
Dr. Marie-Catherine Tiveron and Dr. Philipp Follert for teaching me the in vivo 
electroporation technique and in company with Dr. Serena Barral for teaching me IHC 
stainings.  
In addition, I would like to thank Dr. Annalisa Buffo and Dr. Elena Parmigiani from the 
NICO in Turin for their support in previous and ongoing collaborations.  
 
I am grateful to all people that further supported me during my PhD project at Miltenyi 
Biotec including: Dr. Stefan Tomiuk and Michail Knauel for bioinformatic support,  
Dr. Frank Single, Paul Colesar and Merlin Siewert for providing animals and supporting 
breeding and animal shipping. Thanks to all members of the Neuroscience group (Ina 
Herzig, Sandy Reiß and Katrin Portugall), to supervisors and (former) students at Miltenyi 
Biotec for great discussion at Studi Clubs and symposia. I thank Dr. Eva Almajan and  
Prof. Dr. Elena Rugarli for providing sections of their mouse model. I thank Dr. Bernd 
Wollscheid, Dr. Andreas Frei, Dr. Jens Hellmer as well as Dr. Tobias Haas for their 
support on proteome analysis, immunoprecipitation and mass spectrometry analysis.  
In addition, I’d like to thank Dr. Thomas Rockel and Jan Drewes for help with the MICS 
experiments.  
I am very grateful to all people involved in the proofreading process, especially Dr. Tilo 
Eichler. Next, I have to mention two people that became really good friends during my 
PhD and I don’t want to miss any day we spend together:   
Dr. Andrea (Fratelli) Aloia and Daniela Lehnen.  
Last but not least, I would like to thank my mother for her support – Although, she never 
really knew what my work is all about.  
 
 
    
 
-II- 
 
Erklärung 
Ich versichere, dass ich die von mir vorgelegte Dissertation selbständig 
angefertigt, die benutzten Quellen und Hilfsmittel vollständig angegeben und 
die Stellen der Arbeit − einschließlich Tabellen, Karten und Abbildungen −, 
die anderen Werken im Wortlaut oder dem Sinn nach entnommen sind, in 
jedem Einzelfall als Entlehnung kenntlich gemacht habe; dass diese 
Dissertation noch keiner anderen Fakultät oder Universität zur Prüfung 
vorgelegen hat; dass sie − abgesehen von unten angegebenen 
Teilpublikationen − noch nicht veröffentlicht worden ist sowie, dass ich eine 
solche Veröffentlichung vor Abschluss des Promotionsverfahrens nicht 
vornehmen werde. Die Bestimmungen der Promotionsordnung sind mir 
bekannt. Die von mir vorgelegte Dissertation ist von Frau Prof. Dr. Elena I. 
Rugarli betreut worden.  
 
 
Köln, den 23.04.2015  
 
 
Christina Kantzer  
 
Teilpublikationen:    
---------------------------------------------------------------------------------------------- 
Die vorliegende Arbeit wurde in der Zeit von Oktober 2011 bis April 2015 
unter der Betreuung von Frau Prof. Dr. Elena I. Rugarli, Institut für Genetik 
der Universität zu Köln angefertigt. Dabei wurden die zugrunde liegenden 
Experimente in der Forschungs- und Entwicklungsabteilung der Miltenyi 
Biotec GmbH in Bergisch Gladbach durchgeführt.  
Betreuer dieser Arbeit innerhalb der Firma Miltenyi Biotec GmbH waren:   
Dr. Andreas Bosio und Dr. Melanie Jungblut. 
